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The bacteriophage HK97 capsid assembly and maturation pathway has been well studied. 
Despite this, little is known about the initial steps of assembly. How do 415 capsid proteins, 
~120 copies of protease protein, and 12 copies of portal protein interact to form a correctly sized 
and shaped capsid? Most dsDNA phages and herpesviruses require the use of separate 
scaffolding proteins in order to assemble properly. HK97 does not have a separate scaffolding 
protein; instead it has a 102 amino acid N-terminal extension of its major capsid protein, called 
the delta domain. Like other well-known viral scaffolding proteins, the delta domain is present 
during initial assembly but is absent in the mature structure, is mostly -helical in nature, has a 
high propensity of forming coiled coil interactions, and is flexible. We hypothesize that the delta 
domain is playing a scaffolding-like role in capsid assembly. Because the scaffolding-like region 
is actually part of the capsid protein, studying how a scaffolding protein contributes to capsid 
assembly is easily achievable using HK97. Using mutational analyses in a plasmid based system, 
I have tested the effects of delta domain point mutations, small insertions, and deletions on 
capsid assembly. Even single point mutations can cause assembly defects, rendering the capsid 
protein nonfunctional. Using biochemical and genetic assays, I have shown that different regions 
of the delta domain play different roles in capsid assembly. The HK97 delta domain is a 
multifunctional protein that is important for capsid protein solubility and expression, capsid 
shape, capsid size, protease incorporation, and portal incorporation. The flexibility and structure 
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of the delta domain plays an important role in its ability to regulate the assembly process. 
Learning about how the delta domain interacts with different proteins during assembly provides 
a greater understanding of how a single protein functions in order to build macromolecular 
complexes. Important roles and regions identified in the HK97 delta domain are applicable to 
other related phage and herpesvirus scaffolding proteins, providing insight on the biological 
processes and requirements of viral capsid formation. 
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1.0  INTRODUCTION 
1.1 BACTERIOPHAGES AND THEIR LIFECYCLES 
Bacteriophages are the most abundant organism on our planet with their total numbers estimated 
to be about 1031 particles (Roger W. Hendrix and Casjens 2006).  They have been discovered in 
almost every type of habitat, possess a wide range of structural differences, and play important 
roles in controlling bacterial populations and evolution (Wommack and Colwell 2000; Suttle 
2007). dsDNA tailed phages belong to the order Caudovirales and are grouped by taxonomists 
into three families, Podoviridae, Myoviridae, and Siphoviridae. Podoviruses have short stubby 
tails, Myoviruses have long contractile tails, and Siphoviruses have long flexible tails. The 
general structure of these bacteriophages consists of a capsid (icosahedrally symmetric, prolate, 
or filamentous) protein shell where the genetic material is stored, a tail for contacting the host, 
and a connector or portal protein which connects the head to the tail and through which the 
genetic material is packaged and later injected (Ackermann 2006). During bacterial infection, the 
phage uses its tail fibers to contact and attach to host protein receptors. After injecting its 
genome, it usurps the host cell machinery for replication (Mosig and Eiserling 2006).  There are 
two types of phage lifecycles, some phages are temperate and can cycle between lytic and 
lysogenic phases, while others are purely lytic. During a lysogenic phase, the phage remains 
dormant after its genome has integrated into the host genome and replicates along with the host. 
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Upon cellular stress responses, the phage can activate its lytic cycle by excising itself from the 
host chromosome, replicate its genome, assemble new phage particles, and lyse the host for 
release into the environment. On the other hand, lytic phages never integrate, and lyse the host 
after phage assembly is complete (Little 2006). 
 
1.2 CAPSID ASSEMBLY AND THE USE OF SCAFFOLDING PROTEINS 
 
Bacteriophage capsid assembly is a complex and highly coordinated process involving the 
interaction of many different structural components and chaperone proteins. Capsids are 
icosahedral and isometric in most cases, or prolate in shape, though still based largely on 
icosahedral symmetry. They may include ‘decoration’ proteins as well, which are proteins that 
help to stabilize the capsid during genome packaging (Dokland and Murialdo 1993). The 
icosahedron is made of 20 equilateral triangular faces and 12 vertices, with 2-, 3-, and 5-fold 
rotational symmetries. The simplest capsid would be composed of 12 pentamers, and have a total 
of 60 subunits. In this case, all 60 subunits could be placed in strictly equivalent positions. The 
introduction of hexamers into the capsid means that some subunits can no longer be placed in 
equivalent positions; their relations to each other are now described as quasi-equivalent. The 
theory of quasi-equivalence uses the triangulation number (T number) to characterize viral 
capsid size. The smallest capsid would have a triangulation number of T=1. The formula for the 
T number is h2 + hk + k2 = T (Caspar and Klug 1962). h and k are integers which indicate the 
number of steps, in two directions, on the icosahedral capsid to get from one pentamer to 
another. “Steps” are defined as a jump between two adjacent vertices by stopping on hexavalent 
capsomers. In an icosahedral capsid, the triangulation number represents the number of subunits 
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in an “asymmetric unit”. The capsid can be described as 60 such asymmetric units, arranged in 
icosahedral symmetry. Based on this theory and equation, not all numbers are possible 
triangulation numbers. For larger capsids with bigger T numbers, it would be more advantageous 
for the phage to have more subunits rather than bigger subunits, possibly to increase protein 
folding efficiency and efficacy. The most abundant T number discovered to date is T=7 (Jianfei 
Hua, Bob duda, personal communication), and this includes the capsid of phage HK97, the 
subject of this thesis. 
Capsid assembly is very similar among dsDNA bacteriophages and herpesviruses 
(Casjens and Hendrix 1988; Homa and Brown 1997). In general, bacteriophage capsid assembly 
requires the coordination of a number of structural and chaperone proteins (Dokland 1999; Peter 
E. Prevelige and Fane 2012). Most dsDNA phage capsids are composed of one type of capsid 
protein subunit that forms pentamers and hexamers. Phage T4 has two different types of capsid 
proteins, one that produces the hexamers, and a different though similar protein that produces the 
pentamers (van Driel, Traub, and Showe 1980). With the aid of phage scaffolding proteins, the 
capsid proteins assemble into hexamers and pentamers, which then assemble along with portal 
protein into a procapsid, the immature form of the capsid. After assembly, the scaffolding protein 
leaves the procapsid, either intact or more commonly following proteolysis by a phage-encoded 
protease, resulting in an empty capsid. DNA is then packaged through the portal, which causes 
expansion of the shell through conformational changes of the subunits, to form the mature 
capsid, commonly referred to as the head. This genome-filled capsid can then attach to the 
separately assembled tail to create a phage (Casjens and Hendrix 1988; Hendrix and Garcea 
1994; Casjens 1997).  
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Scaffolding proteins aid assembly by ensuring the proper size and shape capsid. There are 
two classes of scaffolding proteins, external, and internal, and some viruses utilize both (Dokland 
1999).  They are present during the initial stages of assembly but are absent in the mature virion 
(Dokland 1999; Jonathan King and Casjens 1974; Casjens and Hendrix 1988). The scaffolding 
proteins take up space inside the capsid, suggesting that another role scaffolding proteins play is 
to occupy space and exclude cellular components from being incorporated into the assembling 
capsids (Casjens 1997; Earnshaw and Casjens 1980). Internal scaffolding proteins are predicted 
to be elongated in structure with their C-terminal ends interacting with the internal surface of the 
capsid shell and the N-terminal ends facing towards the interior of the capsid (Dokland 1999; 
Zhou et al. 1998). They are mostly -helical in secondary structure (Morais et al. 2003; Tuma et 
al. 1996; Dokland 1999; Prevelige and Fane 2012) but are also quite flexible, which makes 
structure determination difficult, whether by crystallography or electron microscopy. The N-
terminal region of the phi29 scaffolding protein has been crystalized and the structure solved. 
This shows a mostly -helical and coiled coil structure (Morais et al. 2003). The C-terminal ends 
of the scaffolding protein, which are closer to the interior surface of the shell, are more ordered 
than the regions of the scaffolding protein at the center of the capsid (Thuman-Commike et al. 
1996). In P22, the C-terminal capsid binding domain of its scaffolding protein was solved by 
NMR and showed a helix turn helix motif (Sun et al. 2000). 
 In phages with known scaffolding proteins, one scaffolding protein can interact with 
several capsid proteins during assembly. For P22, there are about 250 scaffolding molecules that 
interact with the 415 capsid proteins (King and Casjens 1974). However, 120 molecules of 
scaffold are required for assembly (Prevelige, Thomas, and King 1988), which exist mostly as 
dimers (Parker et al. 1997), though monomeric forms are required for complete capsid assembly 
 5       
 
in vitro (Tuma et al. 1998). In T7, about 110-140 copies of the scaffolding protein interact with 
the 415 copies of capsid proteins. They are visible in cryoEM reconstructions as small 
protrusions (“nubbins”) underneath the hexamers (Cerritelli et al. 2003). During P22 assembly, 
the capsid and scaffolding proteins assemble together in the growing shell (Prevelige et al. 1993), 
their interactions allowing for proper assembly (Thuman-Commike et al. 1996). After exit from 
the capsid, the intact scaffolding proteins are recycled for further rounds of assembly (King et al. 
1973). There are regions of the hexameric subunits with projections that extend towards the 
interior of the capsid. These extensions are possible connection points between the capsid 
proteins and the scaffolding proteins. In this case, scaffolding proteins are believed to be 
arranged as dimers underneath the hexons and five copies underneath the pentons (Thuman-
Commike et al. 1996). Herpes simplex virus assembly is very similar to those of dsDNA phages 
(Casjens and Hendrix 1988) but has a scaffolding like core, which the capsid proteins assemble 
around (O’Callaghan, Kemp, and Randall 1977; Newcomb and Brown 1991; Rixon 1993). 
In a number of dsDNA phage and herpesvirus, when the scaffolding protein is not 
present, or is mutated, capsid assembly fails to occur or abnormal tubes and irregular shaped 
structures, referred to as “monsters”, are made (Cerritelli and Studier 1996; Earnshaw and King 
1978; Hagen et al. 1976; Lee and Guo 1995; Roeder and Sadowski 1977). In some cases, 
polyheads (Howatson and Kemp 1975; Kellenberger 1980) or smaller than normal sized capsids 
are made (Earnshaw and King 1978; Thuman-Commike et al. 1998; Choi et al. 2006). Not only 
can the lack of scaffolding protein or mutant scaffolding protein affect the capsid shape and size, 
but it can also affect the inclusion of other important proteins in the capsid. Previous P22 studies 
show that mutants in the scaffolding protein affect incorporation of pilot and portal proteins in 
the capsid and the release of pilot proteins later (Bazinet and King 1988; Greene and King 1996). 
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Mutants in the scaffolding protein can also block later release of the scaffold after assembly is 
complete, which prevents the DNA packaging step (Thuman-Commike et al. 1996). The 
incorporation of core proteins in T4 is also dependent on the scaffolding protein (Paulson, 
Lazaroff, and Laemmli 1976). Mutations in the herpesvirus scaffolding protein have been shown 
to affect portal incorporation (Newcomb, Homa, and Brown 2005). 
1.3 HK97 CAPSID ASSEMBLY AND THE DELTA DOMAIN 
HK97 is a dsDNA temperate phage that infects Escherichia coli. It was discovered in Hong 
Kong in 1980 (Dhillon et al. 1980) and is very similar to the well-studied phage Lambda. HK97 
is made of an icosahedral capsid with a triangulation number of 7 and a long flexible tail 
(Dhillon et al. 1980) (Figure 1).  A schematic of HK97 capsid assembly is shown in Figure 2. 
HK97 capsids are composed of three genes: gene product 3 (gp3) which encodes the 47 kDa 
portal, gene product 4 (gp4), which encodes the 25 kDa protease, and gene product 5 (gp5), 
which encodes the 42 kDa major capsid gene (mcp) (Duda, Martincic, and Hendrix 1995).  
With the aid of chaperonin proteins GroEL and GroES, the mcp folds and assembles into 
hexamers and pentamers, collectively called capsomers (Popa, M 1988; Ding et al. 1995; Duda, 
Martincic, and Hendrix 1995). 415 capsomers, along with the 12 subunit dodecameric portal 
protein interact with approximately 120 copies of the phage encoded protease to build the 
immature procapsid, Prohead I. Prohead I is about 470 Å in diameter, has a fairly bumpy surface, 
and the hexamers have a skewed symmetry (Conway et al. 1995). Once assembly is complete, 
the protease becomes activated and the 42 kDa mcp is processed to 31 kDa. 102 amino acids 
have been removed to produce this truncated mcp product (Duda, Hempel, et al. 1995). Regions 
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of the major capsid protein that are not present in the mature structure were termed delta 
domains, a term originally used to describe the corresponding part of the Phage T4 mcp (Tsugita, 
Black, and Showe 1975). HK97 possess a delta domain instead of a separate scaffolding protein. 
Proteolysis produces Prohead II, which is similar in structure to Prohead I, but the interior has 
been remodeled (Conway et al. 1995) by the removal of the delta domain and the protease 
(Duda, Martincic, and Hendrix 1995). Like most dsDNA phages, the HK97 genome is packaged 
through the portal and fills the capsid (Bazinet and King 1985). During packaging, the capsid 
undergoes a series of structural changes and expands. The capsid shell becomes thinner and more 
angular, and the hexamers become symmetrical (Lata et al. 2000). The capsid subunits auto-
catalytically crosslink, to create a catenated, chainmail like pattern throughout the mature capsid, 
known as Head II (Popa et al. 1991; R L Duda, Martincic, et al. 1995; Robert L. Duda 1998; 
William R. Wikoff et al. 1999; W R Wikoff et al. 2000; Helgstrand et al. 2003; Gan et al. 2004). 
The enclosed volume has increased by about 100% (Conway et al. 1995). In phage , expansion 
follows directly after DNA packaging begins (Hohn 1983) and this is predicted to be true for 
HK97 also. In dsDNA phages, the expansion step is believed to stabilize the capsid (Steven et al. 
1976; Ross et al. 1985; Steven et al. 1992; Conway et al. 2001; Teschke et al. 2003; Ross et al. 
2005; Duda et al. 2009). The mature capsid is now ready to attach to the tail, which is assembled 
simultaneously in a separate pathway. 
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Figure 1. Bacteriophage HK97 
Transmission electron micrograph of HK97 stained with 1% Uranyl Acetate. HK97 consists of an icosahedral T=7 
capsid, long tail, and tail fibers. Image taken by Bob Duda. 
 
 
 
  
 
Figure 2. Schematic of the HK97 capsid assembly pathway. 
Capsid assembly involves the interaction of three gene products: gp3 (portal), gp4 (protease), and gp5 (major capsid 
protein, mcp). With the aid of chaperone proteins, the capsid proteins assemble into hexamers and pentamers, which 
are collectively called capsomers. The capsomers, along with the portal and protease form the icosahedral immature 
capsid, Prohead I. Internal cleavage by the protease creates the empty Prohead II shell. DNA is packaged through 
the portal, causing a series of expansion and cross-linking steps to produce the mature capsid, Head II. This figure 
was made by Bob Duda 
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  HK97 capsid assembly and maturation has been studied in great detail, however, not 
much is known about the initial steps of assembly, in particular, about the role that the delta 
domain plays in assembly. Phages T5, D3, and phi1026b also possess delta domains instead of 
separate scaffolding proteins (Effantin et al. 2006, Duda and Conway, unpublished data). Raman 
spectroscopy shows that this domain in HK97 is mostly -helical (Benevides et al. 2004). The 
delta domain secondary structure is composed of three predicted -helical regions and a -sheet 
region near the C-terminal end. However, like other known scaffolding proteins, this domain is 
flexible and has so far resisted all attempts to determine its structure at high resolution. The 1st 
and 2nd predicted helices have a high propensity for coil coiled interactions (Conway et al. 1995). 
The published X-ray structure of Prohead I revealed little about the delta domain, which was 
found to be disordered compared to the rest of the major capsid protein. Samples of soluble 
purified delta domain were studied using NMR spectroscopy. However, the delta domain seemed 
to aggregate, possibly due to the highly -helical nature of this protein. Upon cryo-Electron 
Microscopy of Prohead I, low resolution images of the delta domains show them to be shaped as 
blob-like densities protruding from the internal surface of the capsid. The delta domains are 
grouped as one ‘blob’ underneath the pentamers, and ‘two’ blobs underneath the hexamers 
(Conway et al. 2007). The delta domain holds the same position in the genome as most 
scaffolding protein genes, directly upstream of the capsid gene. While some scaffolding proteins 
have a C-terminal capsid binding domain (Dokland 1999), the C-terminal end of the delta 
domain is connected to the rest of the capsid protein. The lack of structural information about the 
delta domain led us to study the functional roles of this domain using biochemical and genetic 
methods in plasmid and phage systems. 
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1.4 HK97 MODEL SYSTEM 
The HK97 capsid protein fold seems to be important in an evolutionary sense because it is found 
in prokaryotic, eukaryotic, and archaeal viruses and also in capsid like particles called 
encapsulins (Akita et al. 2007; Sutter et al. 2008; Duda, Oh, and Hendrix 2013; Suhanovsky and 
Teschke 2015). HK97 has been used as a model system to study capsid assembly due to its ease 
of expression requiring only a small number of genes. Because there is no separate scaffolding 
like those found in other phages, HK97 Prohead I can assemble in vitro with only the major 
capsid protein (Duda, Martincic, and Hendrix 1995; Xie and Hendrix 1995). Also, expression of 
the major capsid and protease proteins are sufficient to assemble Prohead II particles (Duda, 
Martincic, and Hendrix 1995). Like Phage P22, in vitro HK97 assembly is independent of the 
presence of the portal (Prevelige, Thomas, and King 1993; Duda, Martincic, and Hendrix 1995; 
King, Lenk, and Botstein 1973; King and Casjens 1974; Bazinet and King 1988). In vitro 
expression of HK97 produces a high concentration of capsid proteins, which are able to 
spontaneously assemble. During phage infection, it is believed that the portal acts as a nucleator 
of assembly (Hendrix 1998). Capsid expansion can be achieved spontaneously in vitro when 
incubated with certain solvents. For example, urea, cholorform, n-butanol, Guanidine 
hydrochloride, pH 4 buffer, and room temperature incubation of proheads in SDS gel buffer 
cause expansion and/or cross-linking (Duda, Hempel, et al. 1995). The capsid assembly process 
can be manipulated in multiple ways, allowing us to study different aspects of capsid assembly 
and maturation.  
For most of the studies described here, HK97 capsid genes are expressed from a T7 
promoter-containing plasmid in E. coli strain BL21(DE3)pLysS (Studier et al. 1990; Studier 
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2005). Different combinations of HK97 genes were expressed for biochemical and 
complementation tests. Some of the plasmids that I used for my mutational analyses are pV0 and 
pVP0 g4 H65A. The WT (i.e., wild type sequence for the included HK97 DNA) pV0 plasmid 
produces the protease and major capsid protein, which are able to produce proheads that can 
cleave and expand to heads. A schematic of the pV0 plasmid is shown in Figure 3. pVP0 g4 
H65A is a plasmid that contains the portal, protease, and major capsid genes. However, there is 
an inactivation mutation (H65A) in gene 4, the protease, which prevents the cleavage event 
because it inactivates the proteolytic active site. Therefore, the capsids are trapped in the Prohead 
I stage. A more detailed description of the different plasmids that I have used can be found in the 
Materials and Methods section. Sub-cloning mutant fragments into our expression plasmids 
allows us to test the effects of delta domain mutations on capsid assembly. 
     
 
                                          
Figure 3. Schematic of WT pV0 plasmid. 
Plasmid expression is driven by a T7 promoter. The protease and major capsid genes (mcp) are sufficient to produce 
Prohead II. This expression plasmid carries an ampicillin resistance marker (ampR). Delta domain mutations are 
sub-cloned into the expression plasmid and tested in protein preps. Plasmids including the portal gene, and/or having 
an inactivated protease are also used to test the effects of mutations on capsid assembly. 
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A useful biochemical tool that we use to study capsid mutants is gel electrophoresis. 
Capsid assembly intermediates can be differentiated on native agarose gels; free capsomers, 
proheads, and heads run at different mobilities (Figure 4). Mutant phenotypes are easily 
discernable from WT phenotypes. If a mutant produces only capsomers, we can predict that the 
mutation has disrupted the ability of the capsid proteins to assemble correctly. If only proheads 
are present, then we can predict that the mutation has disrupted the cleavage of the delta domain. 
Denatured protein samples electrophoresed on SDS gels provide useful information about mcp 
processing. Full length mcp is 42 kDa, while properly cleaved and processed mcp runs at 31 
kDa. We can compare mutant and WT protein samples to see if a mutation has affected delta 
domain cleavage. SDS gel data is complementary to agarose gel data to show how a mutation 
affects capsid assembly. Along with these biochemical tests, complementation assays using 
expression plasmids and phage with amber mutations allow us to test for mutant protein 
functionality. Negative stain electron microscopy is also used to assay the assembly state of 
mutants. 
 
 
 13       
 
 
Figure 4. Representative native agarose gel of HK97 protein expressed from plasmids 
Purified HK97 protein assemblies have different mobilities on native agarose gels. This representative 
0.8% agarose gel contains purified capsomers, Prohead I, Prohead II, and Head samples. Capsomers (hexamers and 
pentamers) form a fuzzy round spot, which runs slower than assembled particles in this gel. Prohead I and Prohead 
II bands have similar mobilities and run faster. Some of the Prohead II sample has expanded to form Heads. Heads 
particles run slightly slower than Proheads. 
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Using this HK97 plasmid expression system, we can manipulate the delta domain and 
gain insight about the initial capsid assembly process. HK97 capsids have 415 delta domains, 
one connected to each capsid subunit. How do these 415 domains interact inside the capsid? 
Does the delta domain play a scaffolding like role? And if it does, how does it coordinate the 
interaction of 500+ copies of capsid, protease, and portal proteins to form an icosahedral capsid. 
How does one protein function in the assembly of a macromolecular structure? By studying how 
the delta domain functions, we can learn more about the specific characteristics of scaffolding 
proteins which allow them to help form large protein complexes.  
 
 
 
 
 
 
 
 
 
 
Figure 5. Proposed model of the HK97 Delta Domain 
This model shows the three predicted helical regions of the delta domain, labeled α1, α2, and α3. The two red 
helices are pictured in a coiled coil conformation because these two helices have a high predicted propensity for 
making coiled coil interactions (Conway et al. 1995) (Model courtesy of Alasdair Steven). N: N-terminal, C: C-
terminal. 
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In this document, I will describe the different types of mutations made in the delta 
domain and how they affect capsid assembly. The effects of a series of deletions, point 
mutations, and small insertions in the delta domain will be discussed. From these mutational 
studies, it is clear that the delta domain plays multiple roles in assembly. Not only is this domain 
required for capsid protein solubility, it is important for ensuring proper size and shape of the 
capsid. Like other scaffolding proteins, the delta domain plays a role in the incorporation of other 
proteins into the capsid. Interestingly, different regions of the domain are responsible for these 
different roles. Chapter 2 discusses how delta domain deletions and linker insertion mutations 
show that the delta domain is important for proper protein expression and assembly. Also, point 
mutations and a ‘hinge’ region deletion near the C-terminal end of the delta domain show that 
the delta domain is important for proper capsid geometry and size. Chapter 3 discusses how 
mutations in the N-terminal region of the delta domain affect the incorporation of the protease 
proteins and mutations in the middle or 2nd predicted helical region of the delta domain affect the 
incorporation of the portal into the capsid. The different roles of the delta domain map to specific 
regions, showing that the delta domain is very dynamic, allowing it to play multiple functional 
roles during assembly. The structure of the delta domain and the specific interactions that it is 
involved with allows it to function and interact with a variety of different proteins to ensure 
proper assembly. The appendices will include details on a point mutation of the delta domain that 
has a unique phenotype, and touch briefly on studies of delta domain stabilization.  
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2.0 THE DELTA DOMAIN IS REQUIRED FOR CASPSID PROTEIN SOLUBILITY, 
CAPSID ASSEMBLY, AND SIZE 
2.1 INTRODUCTION 
It has been shown in other dsDNA phages and herpesviruses that scaffolding proteins are 
required to assemble the proper sized and shaped capsid. In studies where the scaffolding protein 
is absent, the major capsid protein (mcp) assembles incorrectly and forms abnormal structures 
(Cerritelli and Studier, 1996; Earnshaw and King, 1978; Hagen et al., 1976). The common 
structural characteristics between delta domains and scaffolding proteins lead us to hypothesize 
that the delta domain is playing a scaffolding like role in assembly.  One fundamental question 
that we want to answer is whether the delta domain is required for capsid assembly? In order to 
answer this, we can remove the delta domain and test if the capsid protein can still function 
correctly to assemble proheads.  
Crystal Moyer, a previous student in the lab, deleted the delta domain from the capsid 
protein in the HK97 expression plasmid construct (pV0), which contains the protease and capsid 
genes. The first deletion, which we call pNoDelta1 is a full length deletion of the delta domain. 
The Methionine start codon was moved directly upstream of Serine-103 in the expression 
plasmid. Upon protein expression, radiolabelling experiments were conducted and the pellet and 
supernatant samples were collected over time (1, 5, 45 minutes) to test for mcp expression and 
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processing. The resulting soluble and pellet fractions were also collected and analyzed by 
electrophoresis. Although WT capsids are well expressed and fully cleaved (31 kDa band), 
pNoDelta1 showed barely detectable protein on the SDS gel, even after 45 minutes (Figure 6B). 
A second construct, pNoDelta2, was made which included the T7 ribosome binding site and the 
first four codons (MASMT) of the bacteriophage T7 major capsid protein sequence just directly 
upstream of the relocated start codon (Figure 6A). These additions have been previously shown 
to enhance protein production in plasmid expression studies (Olins and Rangwala 1989; Olins et 
al. 1988). In the radiolabelling experiments, WT showed cleaved and soluble mcp. pNoDelta2 
showed a 31 kDa mcp band, which was mostly present in the pellet fraction (Figure 6B) (Oh et 
al. 2014), suggesting it is insoluble. These radiolabelling experiments suggest that the delta 
domain may play some chaperone-like function with regards to proper capsid protein folding. To 
delve more deeply into the role of the delta domain in capsid assembly, I studied the effects of 
different mutations on assembly in a plasmid-based system. In total, 63 distinct mutations have 
been made in the HK97 delta domain; a majority of these are single point mutations, but some 
are small insertions and deletions. About half of these mutations cause major defects in regards 
to protein solubility, capsid structure and assembly, or portal and protease incorporation, 
indicating that the delta domain plays major multiple roles in capsid assembly. 
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B. 
 
 
 
Figure 6. Radiolabelling data of full length deletions (pNoDelta1, pNoDelta2) of the delta domain 
A) Sequence of the pNoDelta2 deletion mutant. The T7 RBS (underlined) and tag upstream was added upstream of 
the mature capsid protein sequence. B) Radiolabelled protein gel comparing WT major capsid protein (mcp) (gene 
product 5= gp5), pNoDelta1, and pNoDelta2 expression. Samples collected 1, 5, and 45 minutes after induction, 
along with the soluble and pellet fractions, were loaded on an SDS gel. WT showed cleaved (31 kDa) mcp appearing 
after 45 minutes, which was mostly in the soluble fraction. pNoDelta1 produced barely detectable protein that was 
mostly in the pellet fraction. pNoDelta2 produced higher levels of 31 kDa protein but was found mostly in the pellet 
fraction. The other bands visible in the gel may be from non-specific binding from the labeling experiment 
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2.2      RESULTS 
2.2.1 Full length delta domain is required for capsid protein solubility, assembly, and size 
Radiolabelling experiments of the pNoDelta plasmids provided incomplete evidence that HK97’s 
delta domain is essential for assembly. To pursue this further, I conducted small scale protein 
expression experiments (miniprohead preps) to test the full length deletion construct, pNoDelta2. 
The miniprohead preps are based on F. William Studier’s method of auto-induction (Studier 
2005). Three samples were collected from each construct: pellet, supernatant, and 
polyetheyleneglycol (PEG) precipitate. A plasmid with the protease gene knocked-out (pVB) 
was used as a control. The control and mutant samples were loaded on a 12% low cross-linking 
SDS gel. The control produced uncleaved mcp as expected. pNoDelta2 produced an uncleaved 
mcp band in the pellet fraction only (indicated by circle) (Figure 7A). On native agarose gels, the 
control produced proheads. pNoDelta2 did not produce any obvious prohead or head bands 
(Figure 7B). There were also no capsomers visible on the agarose gel, suggesting that the delta 
domain is responsible for facillitating the formation of the earliest assembly form, capsomers. 
Spot complementation tests were performed to test protein functionality. By comparing 
the mutant complementation results to the WT control, we can see how well the protein 
expressed from the plasmid is able to complement phages with an amber mutation in their capsid 
or protease genes. Dilutions of different phage mutants are spotted on soft agar lawns of cells 
expressing WT and mutant HK97 proteins. WT phage serve as a positive control and should be 
able to efficiently form plaques at all dilutions. A capsid gene amber mutant phage (am1) is used  
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Figure 7. Miniprohead prep results of pNoDelta2 deletion 
 
A) Pellet, supernatant, and PEG samples were run on an SDS gel. The protease- control has a knocked-out protease 
gene, which produced only uncleaved mcp (42 kDa gp5) in all three fractions. pNoDelta2 produced cleaved mcp (31 
kDa gp5*) in the pellet fraction only (indicated by circle). B) On a 0.9% agarose gel, protease- produced prohead 
and capsomer bands (in the supernatant only). pNodelta2 did not produce any obvious HK97 structures. The smear 
of protein in the supernatant fractions correspond to cell host proteins and is commonly found in these crude preps.
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to test if the capsid protein expressed from the plasmid is able to complement and efficiently 
form plaques. A protease gene amber mutant phage (amU4) is used to test if the protease protein 
expressed from the plasmid is able to complement and efficiently form plaques. An amber phage 
mutant in an unrelated gene (amC2) is used as a control. With pNoDelta2, the spot 
complementation tests show no detectable complementation (Table 1). Negative stain 
transmission electron microscopy (TEM) of the pNODelta2 pellet sample does not show any 
soluble assembly products, only cell debris, which supports the biochemical evidence that no 
soluble capsid products are expressed from this deletion mutant.   
2.2.2  Different sized deletions prevent capsid protein expression and functionality 
We know that the full length delta domain is required for capsid assembly, but will the delta 
domain be able to function with smaller deletions? Small deletions could show whether specific 
regions of the delta domain are important for specific aspects of capsid assembly. Four different 
sized deletions were made using the pV0 plasmid construct, all with a common starting point. 
Del1 removes residues 4-13, a portion of the first predicted helix. Del2 removes residues 4-29, a 
majority of the first predicted helix. Del3 removes residues 4-50, the first predicted helix and 
about half of the second predicted helix. Del4 removes residues 4-62, the first predicted helix 
and a majority of the second predicted helix. A schematic of the deletions are shown in Figure 
8A. 
 Miniprohead preps were again used to analyze the mutants. The pellet, supernatant, and 
PEG samples were run on agarose and SDS gels (Figure 8B, C) The WT control produced 
proheads and heads as shown in the agarose gel. Del1 was the only deletion which produces an 
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identifiable product on the agarose gel- a light prohead band. The other three larger deletions, 
Del2, 3, and 4, did not produce any obvious assembled structures in the agarose gel (Figure 8B). 
On the SDS gel, small circles denote the predicted band sizes for the deletion mutants. The WT 
control produced cleaved mcp. Del1 produced uncleaved mcp in all three fractions. Del2 did not 
produce any HK97 bands in any fractions in this experiment and when repeated (not shown). 
Del3 and Del4 produced mcp (of their expected sizes, denoted by circles) in their pellet fractions 
only (Figure 8C). In the spot complementation tests, all four deletion mutants were defective in 
complementing capsid gene amber phage, suggesting that these deletions are detrimental to 
capsid protein function (Table 1). Selected fractions containing truncated mcps from these 
deletions were examined by TEM. Del1 produced WT like procapsids whereas the other 
deletions did not produce any assembled structures. Even though Del1 is able to produce WT 
like proheads, the capsid protein made is nonfunctional and unable to incorporate into viable 
phage particles. The anomalous phenotype of Del1 will be discussed in further detail in Chapter 
3. All four different-sized deletions in the delta domain render the capsid protein non-functional, 
suggesting that the full length of the delta domain is required for capsid protein solubility and 
proper capsid assembly. The next question we want to answer is if there are particular regions or 
residues of the delta domain that are critical for its function during capsid assembly.  
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Figure 8. Different sized delta domain deletions are deleterious to capsid assembly 
A) Schematic of the different sized deletions and the predicted secondary structure of the delta domain. B) 0.9% 
non-denaturing agarose gel of miniprohead prep samples of WT and deletions. WT produces proheads and heads. 
Del1 is the only deletion that was able to assemble into prohead like capsids. Del2, 3, and 4 did not produce any 
obvious structures. C) Pellet, supernatant and PEG fractions were precipitated with 10% TCA and run on a 12% low 
cross-linking SDS gel and stained with commassie. WT produced cleaved 31 kDa mcp, which was mostly in the 
PEG. Del1 produced only uncleaved mcp in all fractions (denoted by small circle in lane 6). Del2 was never able to 
express mcp, even after multiple trials. Del3 and Del4 show uncleaved mcp at their expected sizes in the pellet 
fractions only (small circles in lane 10 and 13). 
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2.2.3 Mutations in the delta domain’s C-terminal region affect capsid assembly and 
geometry 
Available structural information was used to design informative mutants in the delta domain. An 
HK97 Prohead I X-ray model (3QPR, pdb) with 5.2Å resolution was available (Huang et al. 
2011), however, the delta domain was not ordered in the crystal and is therefore not present in 
the model. A Prohead I density map (unpublished) reconstruction made by James Conway can be 
used to identify potential mutant targets. Figure 9 shows an internal view of the capsid, as if it 
were cut in half. The red blob-like clusters underneath each pentamer, and the dimer of blobs 
underneath each hexamer represent the delta domain densities. Compared to the rest of the 
capsid protein, the delta domain is less dense in density maps because it is less ordered.  In the 
Prohead I reconstruction, there are tubes of density, one per subunit, which lie against the 
internal capsid surface and are arranged in a spoke-like pattern (highlighted in Figure 9A). We 
call these densities ‘spokes’ and believe them to contain the C-terminal end of the delta domain. 
It is possible they also represent part of the N-arm of the major capsid protein, a region which is 
also not present in the X-ray model. While the majority of the delta domain is less ordered and 
only partly visible as the ‘blob’ density, the spoke region that is interacting with the internal 
surface of the capsid subunit is apparently more stable. We believe these to contain part of the 
delta domain because they are present in the Prohead I structure, but absent in the reconstructed 
Prohead II (Steven et al. 2005).  
The densities visible on the interior of the Prohead I map allow us to infer delta domain 
residues which could be responsible for making contacts between capsomers. Upon inspection of 
these spokes, there appears to be a possible 3-spoke interaction between a pentamer and two  
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Figure 9. Internal spoke like densities may be possible inter-capsomer interaction sites. 
 
A) Cut-away view of the internal densities of the Prohead I reconstruction (James Conway). This density map is 
contoured so that the left half of the radially colored surface is rendered using a lower cutoff value to include less 
dense (less ordered) parts of the map. The yellow and orange spoke-like regions and the spidery blobs represent the 
delta domain densities (arrows). The rest of the major capsid protein is much more ordered compared to the delta 
domain. It is possible that the 3rd predicted helical region is responsible for some of the spoke density. A possible 
inter-capsomer 3-spoke interaction site is highlighted by the circle. B) The delta domain protein sequence with 
predicted secondary structure. Residues W89 and D90 lie directly after the 3rd predicted helix (arrows) and are large 
or charged residues which may be involved with the 3-spoke interaction between capsomers. (a=predicted alpha 
helix, b= predicted beta sheet). The scale bar represents 132 nm.  
132 nm 
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hexamers and between three hexmaers (circle in Figure 9A). If the spoke density correlates with 
the C-terminal end of the delta domain, then we can hypothesize which residues are interacting at 
this predicted inter-capsomer interaction site. In the delta domain sequence, there are some 
charged and aromatic side groups near the end of the 3rd predicted helix and the beginning of the 
predicted -sheet region (arrows, Figure 9B). Tryptophan 89 (W89), and aspartic acid 90 (D90) 
reside in this region and could be participating in important hydrophobic or charged interactions 
at the 3-spoke interaction sites. These residues were mutated to alanines and tested for assembly 
defects. For example, if these residues are important for intercapsomer interaction, then these 
mutations might only produce capsomers, with no higher order structures being made.  
W89A and D90A were tested against three different controls using miniprohead preps. 
The pellet, supernatant, and polyethyleneglycol (PEG) precipitation protein samples were run on 
native agarose gels and SDS gels to study the resulting assembly products. WT produced 
prohead and head bands in the PEG sample lane (Figure 10A). D231E is a control that only 
produces capsomers, which is detectable in the supernatant fraction. W89A and D90A did not 
produce any obvious structures in the agarose gels (Figure 10A, B). On the SDS gels, WT 
produced cleaved mcp in all fractions. D231E produced uncleaved mcp in all fractions. W89A 
and D90A produce uncleaved mcp in the pellet fraction only. There were also higher molecular 
weight bands present in the pellet fractions, which are usually indicative of crosslinking induced 
by premature expansion (Figure 10C, D). In normal capsids, the delta domain must be cleaved 
before it can be fully cross-linked (Duda, Martincic, et al. 1995). Expansion and cross-linking 
have begun before mcp cleavage in the mutant sample. This is seen when abnormal tube-like 
structures are formed. The mutants were tested using spot complementation to test for protein 
functionality.  
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Figure 10. Miniprohead prep results of W89A and D90A show cleavage defects 
 
A and B) Pellet, supernatant (left gel) and PEG (right gel) samples were run on agarose gels. WT control produced 
proheads and heads. W89A and D90A did not produce any obvious assemblies. The smears are nonspecific cell 
proteins. C and D) Pellet, supernatant (left gel), and PEG (right gel) samples were run on SDS gels and stained with 
commassie. WT showed cleaved 31 kDa gp5* in the supernatant and PEG lanes. W89A and D90A mostly showed 
uncleaved 42 kDa gp5 in the pellet lanes along with higher molecular weight bands. 
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Both W89A and D90A were unable to efficiently complement phage with amber mutations in 
the capsid gene as indicated by a 3-4 log reduction in complementation. Interestingly, these 
mutants were also unable to complement phage with an amber mutant in the protease gene 
(Table 1).  
To identify whether there were any assembled forms of HK97 major capsid protein 
present in the pellet fractions of W89A and D90A, we imaged the samples using TEM. Figure 11 
shows representative images of the W89A and D90A samples, compared to WT Prohead I. In the 
agarose gels, there was stained protein present in the pellet fraction wells. The proteins that did 
not enter the gel could be the abnormal spontaneously cross-linked structures which were 
indicated by the higher molecular weight bands in the SDS gels. The electron micrographs show 
that W89A and D90A pellet samples contained round abnormal structures, some open, some 
closed and some open short tubes. There were large clusters of these abnormal structures, 
making it difficult to tell if some of the tubes are closed on both ends (Figure 11). Using the 
program ImageJ, I measured the sizes of some of the tube assemblies. The diameter of the tubes 
is similar to the diameter of WT proheads. The presence of tubes suggests a lack of pentamers.  
The two point mutations from the suspected C-terminal spoke region, W89A and D90A, 
have very interesting assembly defects. Are there other residues in this region of the delta 
domain which play a similar role in capsid assembly? Five point mutants were tested: F77S, 
L85R, D90G, and F96L. Some were mutants that had been previously made in the lab, others 
were mutated based on the sequence alignment and changed to a residue with a drastically 
different property. These mutants showed similar phenotypes to W89A and D90A. In the agarose 
gels, F77S produced a very light but fuzzy prohead band only. L85R, D90G, and F96L did not 
produce any prohead or head bands. (Figure 12A). In SDS gels, the mutants all produced  
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Figure 11. Representative EM images of W89A and D90A pellet samples. 
WT Prohead I is shown for comparison. W89A and D90A pellet samples show that these mutant proteins assemble 
into abnormal and tube like structures, and that are sometimes kinked or bent. All samples were either undiluted or 
diluted 1/10 in 1x Calorimetry buffer and stained with 1% uranyl acetate. All images are taken at 56,0000x 
magnification. Scale bar: 100 nm. 
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uncleaved mcp, mostly present in the pellet fraction. D90G had uncleaved mcp in both the pellet 
and PEG fraction. Each mutant also produced high molecular weight bands near the top of the 
gel, leading us to believe there were tubes or premature cross-linking occurring (Figure 12B).  
In the spot complementation tests, they were 3-4 logs down in major capsid gene amber 
phage complementation indicating they all produced non-functional capsid protein. L85R, 
D90G, and F96L were also defective in protease amber complementation while F77S was about 
1 log down (Table 1). When the PEG and pellet fractions were studied by TEM (Figure 13), it 
was obvious that these mutants produced abnormal products, which correlates with the gel data. 
F77S, L85R, and D90G produced abnormal round structures, which tended to aggregate, and 
very few WT like proheads. F96L produced abnormal tube like structures, which also tended to 
aggregate.  
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Figure 12. Miniprohead prep results of C-terminal mutations. 
 
A) Pellet, supernatant, and PEG samples were collected and run on a agarose gels. WT produced proheads and 
heads. F77S produced a very light prohead band. L85R, D90G, and F96L did not produce any detectable HK97 
assemblies B) On SDS gels, WT showed cleaved 31 kDa mcp. F77S produced uncleaved mcp that was mostly in the 
pellet and supernatant fraction, with very little in the PEG fraction. D90G produced uncleaved mcp and higher 
molecular weight bands (indicative of premature expansion and cross-linking) which was strongly present in both 
pellet and PEG fractions. F96L produced a strong uncleaved mcp band in the pellet fraction only, along with higher 
molecular weight bands. 
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Figure 13. Representative EM images of C-terminal point mutations 
WT Prohead I is shown as a control. Miniprohead preps samples were stained with 1% uranyl acetate. Undiluted 
PEG sample of L85R shows small round abnormal assemblies, aggregating. There were very few regular looking 
capsids. A 1/10 diluted PEG sample of F77S shows abnormal assemblies and some WT like proheads. An undiluted 
PEG sample of D90G shows mostly abnormal assemblies, some tubes, and very rarely, WT like proheads. An 
undiluted pellet sample of F96L shows abnormal tube like structures, which are slightly longer than other tube 
forming mutants. Scale bar: 100 nm. Images taken at 56,000x magnification.  
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Charged and bulky residues play an important role in the delta domain C-terminus 
Seven mutants located near the C-terminal end of the delta domain show assembly defects by 
causing premature cross-links and forming abnormal and tube like structures. Does the delta 
domain require bulky, aromatic sidechains or charged residues in this region to ensure proper 
assembly? For example, is a large bulky group like tryptophan required at residue 89? Four of 
these tube mutants were changed to other amino acids with similar characteristics to the WT 
residue to test if it would recreate a WT like phenotype. L85V, W89Y, D90E, and F96Y were 
made in the pv0 expression plasmid and tested in miniprohead preps.  
On the agarose gel, F96Y had WT-like phenotypes, and produced proheads and heads. 
L85V and W89Y also produced proheads and heads, but at less than WT levels. D90E showed a 
very light prohead band only (Figure 14). On the SDS gel, L85V showed mostly uncleaved mcp 
in the pellet fraction and mostly cleaved in the PEG fraction. W89Y showed mostly uncleaved in 
all three fractions. D90E produced uncleaved mcp, mostly in the pellet fraction with barely any 
detectable cleaved mcp in the PEG sample. L85V, W89Y, and D90E also showed higher 
molecular weight bands, indicative of premature expansion, cross-linking, and abnormal 
structures. F96L showed a WT phenotype with cleaved mcp (Figure 14). These mutants were 
tested for protein functionality with spot complementation tests. L85V and F96Y both have WT-
like spot complementation for both protease and capsid gene amber phage. W89Y complements 
phage with an amber mutation in the capsid gene like WT and is about ½ a log down in protease 
amber phage complementation. D90E produces non-functional capsid protein because it is 
unable to complement capsid gene amber phage. D90E is also about 1 log down in protease  
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Figure 14. Miniprohead prep results of C-terminal mutants that ‘mimic’ the WT residue 
 
A) Pellet, supernatant, and PEG samples were run on an agarose gel. L85V and W89Y produced prohead and head 
bands, but at less than WT levels. D90E produced very light prohead and head bands. F96Y produced proheads and 
heads, like the WT control. B) In the SDS gels, L85V and W89Y produced both uncleaved and cleaved mcp, but at a 
lower than WT level of protein expression. D90E produced mostly uncleaved mcp which was mostly in the pellet 
fraction. There were very light uncleaved and cleaved mcp in the PEG lane. L85V, W89Y, and D90E also had 
higher molecular weight bands. F96Y showed cleaved mcp, like WT. 
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amber phage complementation (Table 1). The PEG or pellet fraction protein samples were 
diluted 1/10 and visualized by TEM (Figure 15). L85V showed proheads, heads, and a few 
abnormal structures. W89Y showed proheads, heads, and some abnormal and tube like 
structures. D90E showed proheads, tubes, and abnormal structures. F96Y showed WT like 
prohead and head particles.  
It is very interesting that multiple mutations made in this region of the delta domain cause 
the formation of tube-like structures, which may be cross-linked. Wild-type capsids have a ratio 
of 6:1 hexamers to pentamers. Tubes contain a larger ratio of hexamers to pentamers than 
icosahedral capsids. In order to see if the ratio is different with these point mutants, we can 
dissociate the capsids and visualize the hexamer and pentamer bands on 6% native 
polyacrylamide gels using capsid dissociation buffer. Prohead I as a positive control produces 
two bands on this native gel: a pentamer band, and a higher molecular weight stronger hexamer 
band. Prohead II does not dissociate due to its increased stability. Also, cross-linked capsids, like 
Head, do not dissociate in this buffer. L85R, L85V, W89A, D90A, and D90E were incubated 
with capsid dissociation buffer for 4.5 hours and the samples were run on a gel. Compared to the 
Prohead I control, none of the abnormal tube mutants dissociated into hexamers and pentamers, 
indicating that these abnormal structures are more stable (Figure 16). The lack of dissociation 
does not mean that they are not cross-linked, but it does mean that the mutant subunits have a 
similar stability as WT Prohead II. To assay for cross-linking, the residues in the capsid protein 
required for covalent cross-linking (K169 and N256) (Wikoff et al. 2000) could be mutated in 
these tube mutants. These double mutants can be expressed to test if their abnormal structures are 
held together by crosslinks.  
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Figure 15. Representative EM images of C-terminal mutants that ‘mimic’ the WT residue 
WT Prohead I is shown as a control. Mutant samples are from miniprohead preps and were diluted 1/10 in 1x 
Calorimetry PBS. L85V, W89Y, and D90E all produce some prohead head particles but also abnormal and tube like 
structures. F96Y produced WT like proheads and heads, but they look fragile compared to WT. All samples were 
stained with 1% uranyl acetate and all images were taken at 56,000x magnification. Scale bar: 100 nm.  
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Figure 16. C-terminal point mutant protein products may be cross-linked and do not dissociate 
Miniprohead prep pellet, supernatant, and PEG samples were incubated with capsid dissociation buffer for 4.5 hours 
before loading on a 6% native acrylamide gel. Prohead I with portal was used as a positive control to show the 
dissociation into hexamers and pentamers. Hexamers and pentamers are in a 6:1 ratio in the capsid and hexamers 
have a slower mobility than pentamers. None of the C-terminal mutants which make tubes and/or abnormal 
structures dissociated into hexamers and pentamers. 
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2.2.4 The search for 2nd site suppressors of W89A 
These protein expression studies provided a great biochemical method of understanding how 
delta domain mutations affect capsid assembly and processing. We can expand the study and 
characterization of these mutations by moving interesting (lethal) mutations into an HK97 
prophage and testing for the presence of 2nd site suppressors in the genome. This genetic method 
could provide support for our biochemical results or shed new light on the kinds of interactions 
the delta domain can make. If we can identify 2nd site suppressors in the phage genome of our 
initial lethal mutation, we can learn more about how the delta domain could be interacting inside 
the capsid. Recombineering (homologous recombination mediated genetic engineering) can be 
used to move lethal mutants into a prophage (Marinelli, Hatfull, and Piuri 2012). This method 
uses homologous recombination and a positive and negative selection system to integrate 
mutations into a region of interest. Recombineering has been used successfully to mutate regions 
of interest in bacteria by taking advantage of phage Lambda’s recombination system. (Court, 
Sawitzke, and Thomason 2002; Oppenheim et al. 2004; Sawitzke et al. 2007; Thomason et al. 
2007).  
The Lambda recombination genes are beta, exo, and gam. Beta, a ssDNA binding protein, 
helps complementary strands of DNA anneal to the 3’ overhang and binds to Exo.  Exo, a 
dsDNA-dependent exonuclease degrades the 5’ end of the dsDNA constructs to allow for 
complementary ssDNA to anneal to the 3’ single strand overhangs that are generated. Gamma is 
a protein which protects DNA from nuclease degradation by RecBCD (Court, Sawitzke, and 
Thomason 2002). With recombineering, these recombination genes can be expressed under a lac 
promoter on a multicopy plasmid to manipulate bacterial or phage genes in vivo  (Thomason et 
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al. 2007; Sawitzke et al. 2007). Recombeering was optimized for studying E. coli. However, this 
system can also be applied to studying E. coli phage (Court, Sawitzke, and Thomason 2002). 
Recombineering involves a two-step positive and negative selection system to select for possible 
recombinants.  The first (positive) selection replaces the gene of interest with a selectable 
marker. The second (negative) selection replaces the first marker with a mutation of interest in 
the target gene (A schematic of galK recombineering is shown in Figure 17). This produces 
positive recombinants, containing the mutation of interest that can used for further studies. 
To study the delta domain, I can use this method to move a lethal mutation into a HK97 
prophage. A gene fragment of interest requires only 35-50 base pairs of homology flanking 
either end for recombination to occur (Court, Sawitzke, and Thomason 2002). Using a PCR 
fragment of a mutation of interest flanked by homology arms, I can transform the 
recombineering cell line for the negative selection process. The genotype of the recombineering 
strain BW25113 is F-, ∆(araD-araB)567, ∆lacZ4787(::rrnB-3), -, rph-1, ∆(rhaD-rhaB)568, 
hsdR514 ((Datsenko and Wanner 2000). Danju Tso, a previous graduate student, modified this 
strain to contain an HK97 prophage and the Lambda Red recombination plasmid, pKD46. She 
used positive selection to recombineer the galactokinase gene, galK, into the major capsid gene 
(Tso 2010; Warming et al. 2005). I used this galK-containing prophage for the negative selection 
process. I prepared a linear dsDNA construct of my delta domain mutation of interest containing 
200 base pairs of homology arms on either end. These long homology arms were designed to 
increase recombination. 200-400 ng of mutant fragment DNA was transformed into cells 
expressing the recombination genes and were plated on 2-deoxygalactose (2-DOG) plates. 
Galactokinase phosphorylates the galactose analog, producing a product that cannot be 
metabolized, resulting in cell toxicity. Cells that have undergone homologous recombination  
 41       
 
 
  
Figure 17. Schematic of galK Reocmbineering and sequential steps to isolate 2nd site suppressors 
The recombineering strain (BW25113 HK97 galK pkD46) that was used in the initial experiments was prepared by 
Danju Tso. She inserted the galactose kinase gene into the major capsid gene in a HK97 prophage. Positive 
recombinants were selected on galactose plates. A delta domain mutation with homology arms to the HK97 
sequence was used to replace the galK gene. This mutant fragment was transformed into competent cells (made 
from the recombineering cell line) expressing the Lambda Red recombination genes on plasmid pKD46. Positive 
recombinants were selected on 2-deoxygalactose (2-DOG) plates. After one round of re-streaking on selection plates 
to purify the colonies, colony PCR was conducted to identify possible recombinants. Restriction digestions were 
performed on possible recombinants. Once a recombinant is identified, a cell culture is grown, suspended in 
induction buffer and exposed to UV light to induce lytic growth. Phage are collected by centrifugation and plaques 
are isolated for sequencing. There are different possibilities to the phage that can be made: 1)WT revertant that has 
changed the mutation of interest back to WT, 2) tolerated mutant phage that are viable, and 3) phage containing a 2nd 
suppressor elsewhere in the genome. This suppressor has rescued the initial lethal mutation that was inserted and the 
two residues are likely in close contact.  
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with my mutant fragment will have lost the galK gene, allowing for cell growth on DOG plates 
(Warming et al. 2005).  
This negative selection process allows for the identification of positive recombinants. In 
order to ensure a pure recombinant colony, individual colonies are picked and re-plated on 
selection plates to purify. Streak tests of colonies across a line of WT phage confirmed that the 
colonies I picked were indeed lysogens. An issue that I encountered was the high level of 
background colonies on the selection plates. The transformation efficiencies were not optimal, at 
an average of 10^6 cfu/mL transformants. Different delta domain mutations were tested using 
this method. All mutations contain a unique restriction site that can be used to identify their 
presence in the genome. When tested with PCR and restriction digestion, no positive 
recombinants were ever identified. 
I then began recombineering using Tetracycline resistance selection in the same 
BW25113 HK97 lysogen strain with pKD46. Using PCR and fragment ligation, I prepared a 
gene fragment containing the tetracycline resistance gene flanked by HK97 homology arms. In 
the positive selection process, I was able to isolate a positive recombinant from colonies grown 
on tetracycline plates. Using this HK97 lysogen tetR pkD46 cell line, I transformed in lethal 
delta domain mutants and plated the cells onto Bochner-Maloy plates. These selection plates 
contain Chlorotetracyline, Fusaric Acid, and Zinc Chloride. The exact mechanism is still 
unknown but the chelating action of the Fusaric Acid with the Zinc allows for the negative 
selection of colonies that have lost the tetR gene (Bochner et al. 1980; Maloy and Nunn 1981). 
After multiple recombineering experiments, I was unable to isolate any recombinants. Therefore, 
I decided to try using a LE392 E. coli strain for tetracycline recombineering. I transformed the 
pKD46 recombineering plasmid into a LE392 HK97 lysogen strain. Using this, I was again 
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successful in inserting the tetR fragment, creating the recombineering line. I then began testing 
with D90A and W89A. These were two point mutations that produce abnormal tube like 
structures. Colony PCR and restriction digestions were done to identify colonies containing the 
delta domain mutation.  I was able to identify one positive recombinant from a W89A 
recombineering experiment. Sequencing for the HK97 capsid gene in the lysogen showed that 
this lethal mutation was successfully moved into the prophage.  
Now that a positive W89A prophage was identified, I proceeded to induce lytic phage 
growth to collect the phage for sequencing. My goal was to identify 2nd site revertants or 
suppressors in the phage genome which would represent an interacting partner with W89. I used 
WT HK97 phage as a control during the UV light induction tests. The lysogens were grown to an 
OD550~0.2. The cells were then spun down and resuspended in induction buffer. The cells were 
exposed to low wavelength UV light for 0, 10, and 20 seconds. After induction, the cells were 
shaken at 37˚C for 1.5 hours. Chloroform was added for the last 30 minutes to help with lysis. 
Phage supernatants were collected and plated on LE392 plates to test for plaque growth. For the 
WT control, plaques were produced. However, after multiple tests, I was never able to produce 
plaques with the W89A prophage.  
2.2.5 Linker Insertion Mutations (LIMs) affect capsid assembly 
Linker Insertion Mutations are 12 base pair oligo (four amino acids) insertions made in HK97. 
These mutations were randomly made throughout the major capsid gene in order to study their 
effects on capsid assembly. While these LIMs were made previously in the lab, I tested four that 
were located in delta domain using the miniprohead expression method. LIM 20 (GLES), LIM 
33 (WTRV), LIM49 (GLES), and LIM82 (GLES) (letters represent the amino acid linker) are 
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mapped onto the delta domain protein sequence (Figure 18A). The number corresponds to the 
amino acid directly preceding the insertion sequence. Each LIM contains a unique restriction 
site.  
Pellet, supernatant, and PEG samples were collected and separated by electrophoresis 
through SDS and agarose gels.  On the agarose gels, WT produced proheads and heads. LIM 20 
produced a light prohead band.  LIM 49 produced a prohead band which runs slightly slower 
than WT. LIM 33 and LIM 82 did not produce any discernable products (Figure 18B). All four 
LIMs produced uncleaved mcp, which mostly resided in the pellet fractions (Figure 18C). LIM 
49 showed a fairly strong mcp band in the PEG fraction also. LIM 20 and LIM 82 had lighter 
uncleaved mcp bands in their PEG fractions. Higher molecular weight bands are present in LIM 
20, LIM 49, and very strongly in LIM 82 fractions, indicative of premature expansion and 
crosslinking or abnormal structures (Figure 18C). While some of these insertions were able to 
produce WT like capsids, in complementation tests, none were able to complement phage with 
an amber mutation in the capsid gene, showing that they all produced non-functional capsid 
protein. LIM 20 and LIM 33 were 1 log down while LIM 49 and LIM 82 were multiple logs 
down in complementation against phage with an amber mutation in the protease gene (Table 1).  
Undiluted pellet or PEG samples of these mutants were visualized in the TEM (Figure 19). LIM 
20 showed few prohead like structures, and some abnormal assemblies. LIM 33 did not show 
any regular HK97 products, mostly very small round assemblies. LIM 49 showed prohead like 
structures. LIM 82 produced round, abnormal structures, and some tubes, which aggregate 
together with cell debris. Most of the miniprohead prep samples contain cell debris due to the 
crude purification steps. WT Prohead I containing portals are shown as a control. LIM20 and 
LIM49 will be studied in further detail in Chapter 3. 
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Figure 18. Miniprohead preps of the Linker Insertion Mutants (LIMs) 
A) Protein sequence of delta domain showing predicted secondary structure and the positions of the LIMs B) Pellet, 
supernatant and PEG samples were run on a 0.8% agarose gel. WT produced proheads and heads. LIM 20 produced 
a very light prohead band. LIM 49 produced a prohead band that ran slightly slower than WT. LIM 33 and LIM 82 
did not produce any detectable assembly products. C) The pellet, supernatant, and PEG samples were prepared for 
SDS gels. WT samples showed cleaved 31 kDa mcp. Each LIM produced mostly uncleaved mcp, which mostly 
ended up in the pellet fraction. LIM 13, 49, and 82 produced some uncleaved mcp in the PEG fractions. LIM 82 also 
showed strong higher molecular weight bands, while LIM 49 showed weaker higher molecular weight bands. LMW: 
lower molecular weight marker. 
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Figure 19. Representative EM images of Linker Insertion Mutations (LIMs) 
Purified WT Prohead I is shown for comparison. Undiluted pellet or PEG samples from the miniprohead preps were 
stained with 1% uranyl acetate and visualized with transmission electron microscopy. LIM 20 produced very few 
WT like particles and some abnormal structures. LIM 33 did not produce any detectable WT like products, but small 
round assemblies. LIM 49 produced WT like proheads. LIM 82 produced abnormal round assemblies and some 
small tube like structures. All images were taken at 56,000x magnification. Scale bar: 100 nm. Cell debris is present 
in these crude purification samples (as seen by large vesicles in LIM 49 image).  
 48       
 
2.2.6 ‘Hinge’ deletions affect capsid assembly and size 
The cryo-EM density map of the HK97 Prohead I shows the delta domains as blob-like 
structures. We believe that it is the inherent flexibility of the delta domain that prevents high 
resolution visualization. This flexibility may play an important role during capsid assembly. 
Secondary structure prediction algorithms suggest that the delta domain has three helical regions. 
It is possible that the regions between these predicted helices, which we will call ‘hinge’ regions, 
are responsible in part for the flexibility of this domain. In addition, the first two predicted 
helical segments are predicted to form coiled coils (Conway et al. 1995). By deleting these 
‘hinge’ regions, we can study whether they are important for delta domain function. Two 
deletion mutants were made: Del1stHinge, which deletes residues S31-S36 and Del2ndHinge, 
which deletes residues G67-E73 (Figure 20A). These deletion mutants were analyzed using our 
miniprohead expression system, as described above. Del1stHinge did not produce any 
discernable assembly products (Figure 20B). In contrast, Del2ndHinge produced a weak prohead 
band (denoted by circle), a stronger band that ran slightly faster than WT proheads, and a fuzzy 
capsomer band (Figure 20B). Del1stHinge produced apparently insoluble uncleaved mcp, which 
was found in the pellet fraction only. Del2ndHinge produced uncleaved mcp in all fractions; the 
mcp band in the PEG fraction suggest some protein was soluble (Figure 20C).   
Complementation tests showed that these two deletions were 3 orders of magnitude down 
in their ability to complement phage with an amber mutation in the capsid gene. Unexpectedly, 
the WT control phage and the protease amber mutant phage were 1 log down in 
complementation for Del2ndHinge (Table 1) suggesting a possible dominant negative effect of 
the mutant. Previous work with mutant M357G showed that smaller proheads run slightly faster 
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Figure 20. Del 1st and 2nd Hinge mutants affect capsid assembly 
 
A) Delta domain protein sequence showing predicted secondary structure and regions of ‘hinge’ deletions. B) Pellet, 
supernatant, and PEG samples from miniprohead preps were run on a 0.8% native agarose gel. WT produced 
proheads and heads. Del 1st Hinge did not produce any discernible products. Del 2nd Hinge produced a fuzzy 
capsomer band, a very weak prohead band (denoted by circle), and a strong prohead band that ran faster than WT. 
Other HK97 studies have shown that protein bands with faster mobilities than WT could be indicative of smaller 
than normal particles. C) In the SDS gel, WT produced cleaved 31 kDa mcp. Both ‘hinge’ deletion mutants created 
uncleaved mcp. Del 1st Hinge’s 42 kDa mcp was exclusively in the pellet fraction while Del 2nd Hinge mcp was 
present in all fractions. D) Representative EM image of Del 2nd Hinge (diluted 1/2 in 1x calorimetry buffer) shows 
abnormal structures, a few WT sized proheads, and smaller than normal capsids. WT Prohead I is shown for 
comparison. Samples were stained with 1% uranyl acetate and all images were taken at 56,000x magnification. 
Scale bar:100 nm. Del 1st Hinge produced inclusion bodies (not shown). 
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than normal sized proheads on agarose gels (Duda, Maurer, Conway, Hendrix, unpublished). The 
agarose gel data suggests that this mutant may produce small capsids. The TEM data supports 
this as we were able to visualize a variety of structures: WT-like proheads, proheads which 
appear smaller than normal, and abnormal round and tube assemblies. When compared to WT 
Prohead I, a few particles were WT sized while the rest were smaller. Del1stHinge pellet 
samples only showed inclusion bodies and cell debris when visualized (Figure 20D). 
To further study Del2ndhinge, this deletion was moved into a plasmid that contains the 
portal and inactivated protease genes (pVP0 g4 H65A) to allow us to test for portal and protease 
incorporation and determine the T-number of the small particles. This plasmid would show if 
these mutant capsids are unable to cleave or unable to complement amber phage due to a 
protease or portal incorporation defect. The active site mutation H65A in the protease gene 
inactivates the protein, allowing for proper protein expression and incorporation, but no protease 
activity (Duda, Oh, and Hendrix 2013). This plasmid provides a sensitive assay to test for portal 
incorporation.  
Capsids containing the WT portal and capsid genes but the inactivated protease only 
produce Prohead I. When Proheads containing the portal and inactivated protease are purified 
through sucrose or glycerol gradients (as is done with our large scale Prohead preps), a unique 
banding pattern emerges. We can see multiple prohead bands compared to the single prohead 
band in a Prohead II containing portal prep (Figure 21A) (Crystal Moyer, unpublished results). 
These multiple bands correspond to proheads with and without the portal. The top band 
correlates with portal-less proheads, while the bands below correlate with portal containing 
proheads. These portal containing proheads are creating prohead dimers and trimers because the 
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multiple capsids adhered to cell membrane fragments by their portals, causing them to band 
together as dimers, trimers, etc. in the gradient.  
For preps with Prohead I containing the portal, we run the samples on special SDS gels 
made with twice the normal concentration of bis-acrylamide, which clearly separates the portal 
and uncleaved mcp, which migrate almost identically in normal SDS gels. An SDS gel shows the 
absence of the portal in the top band fraction, and the presence of the portal in the middle and 
bottom band fractions (Figure 21B). This is supported by a representative agarose gel showing 
the presence of these prohead dimers in the middle and bottom band fractions whereas the top 
band only contains prohead monomers (Figure 21C). We can also visualize these prohead dimers 
and trimers with TEM, as shown in Figure 21D. The arrows are pointing at pieces of cellular 
membrane that are connecting these portal-containing capsids. It is commonly believed that 
capsid assembly may occur on the cellular membrane with the phage portal acting as the initiator 
of capsid assembly (Simon 1969; Simon 1972; Murialdo and Becker 1978). With the portal at 
the cell membrane, capsid proteins assemble around the portal and create Prohead I. After delta 
domain cleavage and processing by the protease, we believe that there are conformational 
changes that allow the portal to detach from the membrane. Then, DNA can be packaged through 
the portal and phage assembly can progress. This hypothesis also ensures that there is only one 
portal per capsid. During our purification steps in the Prohead prep, our inactivated protease 
capsids are trapped on the cell membrane. When lysis occurs, the capsids are still attached to 
pieces of membrane, which have been released by treatment with detergent during lysis, 
allowing for the formation of prohead dimers and trimers. While this dimer and trimer 
phenomenon is not biologically relevant during phage infection and assembly, this provides us 
with a unique and sensitive assay to test for portal incorporation.  
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Figure 21. Prohead I with portal and inactivated protease (pVP0 g4 H65A) used to test for portal and 
protease incorporation 
 
A) Sucrose gradient image by Crystal Moyer. Prohead II (WT protease) creates one band in gradient purification. 
Prohead I (inactivated protease) creates multiple bands due to portal incorporation. The top band correlates with 
proheads with little to no portal, the middle band correlates with prohead dimers - two proheads sticking to bits of 
cell membrane by their portals, and the bottom band correlates with trimers of proheads and lower bands with larger 
complexes. B) Prohead I samples pulled from a top, middle, and bottom band of a glycerol gradient were prepared 
and run on a 12% SDS acrylamide gel containing 1.6% (double the normal amount) bis-acrylamide. The top band 
contains no detectable portal while the middle and bottom bands contain portal. The 25 kDa protease band is present 
in all fractions. C) PII and PI containing portal controls and top, middle, and bottom band samples were run on a 
0.9% native agarose gel. P II produced proheads and heads. PI produced proheads and prohead dimers. The top band 
produced mostly proheads and some prohead dimers. The middle band produced more prohead dimers than prohead 
monomers. The bottom band produced proheads and prohead dimers. D) Representative TEM image of PI with 
portal capsids showing prohead dimers connected by bits of cellular membrane (arrows). Scale bar: 100 nm. Image 
was taken at 56,000x magnification.  
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Del 2nd Hinge is defective in portal and protease incorporation 
Assembled particles were purified from a 1 L culture of the Del 2nd Hinge mutant in the portal 
and defective protease plasmid. In the glycerol gradient (Figure 22A), there was a strong band 
and a smear of protein underneath. The top portion and smear were separated into two fractions, 
which I will refer to as the top band and bottom band. The top band was used in the gel analyses. 
In the agarose gel, Prohead II and portal control showed prohead and head bands. Prohead I with 
portal showed proheads and prohead dimers. Del2ndHinge did not show any dimer or trimer 
bands. Instead, there was a strong prohead band that ran faster than WT, along with a weaker 
prohead band that ran at the same molecular weight as the WT prohead (denoted by circle) 
(Figure 22A). The extra band with faster mobility suggests the presence of smaller-than-normal 
capsids. In the SDS gel, Prohead II control produced cleaved mcp, while Prohead I with portal 
showed portal, uncleaved mcp, and protease bands. Del2ndHinge showed uncleaved mcp (as 
expected with the inactivated protease) and a light protease band. There was no detectable portal 
band present (Figure 22B).  
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Figure 22. Del 2nd Hinge is defective in portal and protease incorporation 
  
A) Del 2nd Hinge was expressed in the pVP0 g4 H65A plasmid to test for portal and protease incorporation. A larger 
Prohead Prep was conducted and samples were purified using a glycerol gradient. On the native 0.9% agarose gel, 
WT Prohead II and WT Prohead I with portal are shown as controls. Prohead II produced proheads and heads. 
Prohead I with portal produced proheads and prohead dimers. Del 2nd Hinge produced a prohead band (WT, denoted 
by circle), capsomers, and a band of faster mobility which may be smaller than normal proheads. B) On the SDS gel, 
Prohead II showed cleaved mcp while Prohead I showed portal, uncleaved mcp, and an inactivated protease band. 
Del 2nd Hinge showed an uncleaved mcp band, and a weaker protease band. 
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Del 2nd Hinge produced capsids of different sizes  
The initial micrographs and gel data showed the presence of smaller than normal capsids. In 
order to determine the T number of these mutant small proheads, higher resolution data was 
needed. Both top and bottom band samples collected from the Prohead prep were further purified 
using an HQ20 anion exchange column and separated into multiple peaks. Graphs of the 
absorbance (280 nm) peaks detected over time are shown in Figure 23A and B. Both top and 
bottom band samples separated into five peaks. The bottom sample contained less protein, as 
shown by the lower levels of absorbance. The peak fraction numbers are labeled for each sample 
and the asterisks denote the fractions collected for agarose gel analysis. The first peak consisted 
of capsomers. The 2nd peak showed a smear of protein and a band, which is believed to be 
abnormal expanded prohead I particles (Duda, Maurer, Hendrix, unpublished data). The 3rd small 
peak did not show any discernable protein products on the agarose gel. The large fourth peak 
consisted of small proheads and some capsomers. The last peak/shoulder of the graph consisted 
of mostly WT proheads and some small proheads (Figure 23C). Peak fraction #14 from the top 
band sample contained a strong band of small proheads. This fraction was pelleted in the 
ultracentrifuge and resuspended in a small volume to ensure a high concentration.   
The purified Del2ndHinge #14 prohead sample was visualized by cryo-EM using a FEI 
Polara mircrscope and a Falcon 2 direct detection camera (James Conway). Figure 24 shows a 
representative micrograph, which confirms that this mutant does indeed produce smaller-than-
normal capsids. A preliminary reconstruction (Conway, unpublished) using only 23 particles 
showed that the smaller-than-normal particles express a T=4 triangulation number. Along with a 
large number of abnormal structures, there were few ‘normal’ T=7 sized particles (Figure 24).  
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Figure 23. Purification of Del 2nd Hinge isolates different sized particles 
 
Top and bottom band samples were run on an ion exchange HQ20 column. A) and B) show the absorbance peaks 
over time from the top and bottom sample fractions, respectively. The samples produced a complicated five peak 
pattern. The peak fraction numbers are labeled, and the fractions used for gel analyses are denoted with an asterisk. 
C) The main peaks were collected and run on a 0.9% agarose gel. Both samples displayed a similar peak pattern, but 
the bottom band sample had a smaller amount of protein, shown by the lower absorbance levels. The first peak 
(fractions 6, 19) was made of capsomers. The 2nd peak (fractions 8, 22) showed a band and smear, which could 
possibly be expanded Prohead I particles. The 3rd small peak (10, 25) did not contain any obvious assemblies. The 
4th peak (fractions 14, 29) contained small proheads and some capsomers. The last peak/shoulder (fractions 15, 30) 
was made of mostly WT sized proheads and some small proheads. 
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Figure 24. Cryo-Electron Micrograph of a purified Del 2nd Hinge small prohead band sample 
 
A) Using a FEI Polara cryo-electron microscope, James Conway took this representative micrograph of the purified 
mutant sample. A majority of the protein products are abnormal assemblies. The second most abundant products are 
the small capsids, and the rarest structures were the WT sized capsids. From a preliminary reconstruction, he 
determined that the small capsids have a triangulation number of 4. White arrows point out some of the small 
capsids. Black arrow points out a rare T=7 capsid. Radial lines of internal density are visible in the small and larger 
icosahedral capsids. These densities are possibly the delta domains.  
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Del 2nd Hinge T=4 and T=7 capsids have more stable delta domains than WT 
This reconstruction using 850 Del 2nd Hinge small particles from 151 micrographs produced a 
8.7 Å resolution map (Figure 25A-C). Figure 25A shows an external view of the T=4 capsid 
density map, with a skewed hexamer in the middle. This map was also able to resolve the E-
loops protruding from each subunit. Figure 25B shows an interior view of the T=4 capsid, 
revealing tall towers of density from underneath the pentamers, which protrude towards the 
center of the capsid. These stable towers are the delta domains, in a very different conformation 
from WT delta domains (compare to interior view of T=7 ‘normal’ capsid, Figure 25D). Along 
with the elongated delta domain towers, there are pairs of smaller delta domain protrusions 
underneath each hexamer. Unlike the stronger spoke densities in the WT T=7 density map, there 
are varying degrees of spoke densities in the hexamers of the T=4 mutant (weaker spoke 
densities highlighted with ovals in 25B and C). Much more of the delta domains (red colored 
densities) are visible in these mutant Del 2nd Hinge particles compared to WT. Figure 25C shows 
an interior view of the T=4 mutant capsid using a different contour density level to highlight the 
spoke regions (yellow and orange densities). The small capsids have a triangulation number of 4, 
so each asymmetric unit is composed of half of a hexamer (three subunits) and one subunit of the 
adjacent pentamer. Therefore, the two halves of the skewed hexamer are equivalent and opposite 
so each pair of opposing spoke densities are equal. The spokes of a hexamer that are in an 
interface between three hexamers along the 3-fold symmetry axis are the strongest (highlighted 
by circle). The spokes of a hexamer that are interacting with a spoke from a pentamer are 
weaker. The weakest hexamer spoke densities are highlighted by ovals (Figure 25B, C) and do 
not contribute to the delta domain bundles on each half of the skewed hexamer (Figure 25B)  
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In a pentamer, the spoke densities are relatively equal due to the five-fold symmetry 
imposed. The WT Prohead I reconstruction shows relatively equal spoke density in each capsid 
subunit (Figure 25D). A slice of the mutant T=4 capsid with an increased contour density level 
shows the less dense areas of the map (Figure 26). We can visualize the delta domains from each 
pentamer joining together to form what we hypothesize is a stable and elongated five helix 
bundle. We can also see that in a hexamer, a bridge-like density appears to make a connection 
between the two small delta domain protrusions (Figure 26). 
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A.      B. 
 
C.      D. 
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Figure 25. 8.7 Å map of Del 2nd Hinge T=4 capsid compared to WT T=7 
 
A) External view of mutant T=4 capsid. Using 151 micrographs, 850 particles were used to create this 
reconstruction. Hexamers are skewed, just like they are in the WT capsid. The E-loops (the slightly protruding loops 
on the outer surface of each subunit) are visible. B) An internal view of the T=4 mutant capsids show much more of 
the delta domains (red blobs) than the WT T=7 capsids (D). The delta domains of the pentamers assemble into a 
more stable tower like protrusion towards the capsid center. The hexamer delta domains assemble into two bundles, 
similar to the WT capsid.  In WT T=7 capsids (D), each spoke (orange/yellow colored) is mostly equal in density to 
contribute into the red blobs of the delta domains. C) The internal view of the T=4 capsid has been contoured to 
highlight the spokes (orange/yellow colored). Possible inter-capsomer spoke interaction site is shown. The pentamer 
spokes are relatively equal in density. Under the hexamers, different spokes have different densities. The weakest of 
the spoke densities are highlighted. D) The internal view of a WT T=7 capsid is shown for comparison. The scale 
bar for the T=4 capsids represents 102 nm. The scale bar for the T=7 capsid represents 132 nm. (Images from James 
Conway)  
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Figure 26. Slice of the Del 2nd Hinge T=4 capsid density map 
 
The delta domains are more stable in this mutant compared to WT. The strong tower like densities of the pentamers 
could be forming a stable and elongated 5 helix bundle. At this lower contour level, the less dense areas of the map 
are visible, showing a possible connection of the two bundles in the hexamers, forming a ‘bridge’ like connection 
(highlighted by oval). Scale bar represents 102 nm. 
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Deleting seven residues in this predicted ‘hinge’ region has altered the stability of the 
delta domain, allowing us to visualize more of this flexible protein. To see if there were any 
differences in the predicted secondary structure of the delta domain, the mutant sequence was put 
through PSIPRED’s structure prediction program (http://bioinf.cs.ucl.ac.uk/psipred/). From this 
program, Del2ndHinge contains two predicted helices compared to the WT three predicted 
helices (Figure 27). The deletion removes exactly seven residues between two regions that are 
strongly predicted to be -helical. This change could have caused the elongation and 
stabilization of the delta domain to form the conformations seen in the density maps.  
Del2ndHinge produced a low frequency of WT sized capsids. For about every 50 small 
particles there was only one T=7 sized capsid. In the unprocessed electron micrographs, tower 
like internal densities inside the T=7 capsids are also visible, suggesting that these larger capsids 
might be forming similar tower structures as seen in the mutant T=4 capsids. These internal 
densities are not visible in micrographs of the WT capsid. Using about 100 T=7 sized particles, 
James Conway and Alexis Huet created a reconstruction of the mutant T=7 Del2ndHinge capsid 
(Figure 28A, B). The delta domains possess similar characteristics that were seen in the smaller 
mutants: towers underneath the pentamers and two smaller protrusions under the hexamers 
(Figure 28B). Compared to WT HK97 (Figure 28C), more of the delta domains are visible in the 
T=7 mutant particle. 
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WT delta domain Del 2nd Hinge delta domain
 
Figure 27. PSIPRED secondary structure prediction of Del 2nd Hinge sequence compared to WT 
 
This secondary structure prediction program predicts the WT delta domain to have three helical regions (left). After 
the Del 2nd Hinge (deleted residues highlighted in red box), the program predicted this mutant delta domain to only 
have two helical regions. 
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A.      B. 
Del 2nd Hinge T=7 (external view) Del 2nd Hinge T=7 (internal view)
132 nm
 
C. 
 
 
Figure 28. Density map of Del 2nd Hinge T=7 capsids compared to WT HK97 
 
Using about 100 particles, a reconstruction of this mutant T=7 capsid was made. A) An external view of the capsid 
looks similar to WT. The hexamers are skewed as is seen in WT Prohead I. B) An internal view of the mutant capsid 
shows the delta domains as red blobs and the spoke regions as yellow-greenish. Like in WT, there is one group of 
delta domains per pentamer and two blobs per hexamer. However, even at this lower density contour, the pentamer 
delta domains are more extended towards the center of the capsid than they are in WT. Similar to the T=4 capsids, 
the delta domains seem to be more stable in this mutant. C) Internal view of WT HK97 capsid is shown as a 
comparison. The scale bar represents 132 nm. 
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Figure 29A shows the mutant capsid using a reduced contour level to show less dense 
regions of the map, so we can visualize more of the delta domains. At this level, we can again 
see the stable towers of a possible 5 helix bundle underneath the pentamers and we can 
hypothesize that the two bundles underneath the hexamers may connect to form a bridge across 
the skewed hexamer. In a slice through this mutant capsid, we can see that the pentamer delta 
domain densities are very strong, showing a drastic difference in stability between this mutant 
and the WT (Figure 29B) 
 
A.      B. 
pentamer
towers
hexamer
bundles
132 nm
 
Figure 29. Density map of Del 2nd Hinge T=7 particles show similar delta domain conformations as T=4 
mutant particles.  
 
A) An internal view of the T=7 mutant capsid shows the dimers of delta domain from each hexamer and the tall 
tower from each pentamer. B) A cross-section through the capsid highlights the elongated towers of density in the 
pentamers. We can hypothesize a five helix bundle is formed. In the hexamers, there is a more stable and elongated 
delta domain density as well. At even lower contour density levels, it is possible that the two hexamer delta domains 
form a bridge connecting the two bundles, similar to what is be seen in the T=4 mutants. 
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A noticeable difference between the three different types of capsids lies in the spoke 
densities. As mentioned before, in the WT T=7 Prohead I, there is a distinct spoke density 
underneath each capsid subunit and they are mostly equal in strength (Figure 30A). With 
Del2ndHinge T=4 mutant capsids, there are spokes underneath each capsid subunit, but they are 
not all at equal densities. The pentamer spokes show relatively equal densities because of the 
five-fold symmetry imposed. These spokes also visibly show a connection into the rigid 
pentamer towers. In the hexamers, different spokes have different densities. The weakest spoke 
densities (highlighted by ovals) do not have an obvious connection towards the ‘bridge’ bundles. 
As mentioned earlier, the strongest spokes interact at the 3-fold symmetry axis between three 
adjacent hexamers (highlighted by circles) (Figure 30A, B). With Del2ndHinge T=7 mutant 
capsids, there are again equal density spokes underneath each pentameric subunit due to the 
imposed symmetry. In the hexamers, the spokes of the subunits that are in direct contact with 
spokes of a pentamer are not visible (ovals). The other four adjacent spokes of the hexamers are 
strong and we can see their connections to form the ‘bridge’ bundles (Figure 30C). This deletion 
mutant has created a drastic assembly defect that can produce different sized capsids. Because of 
this change, the delta domains are more stable, allowing us to visualize more of this region of the 
major capsid protein. The different point mutations, insertions, and deletions have shown that the 
delta domain not only plays a role in capsid protein solubility and capsid assembly, but in capsid 
size determination as well.   
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A.      B. 
Internal view of Del 2nd Hinge T=4Internal view of WT T=7
 
C. 
Internal view of Del 2nd Hinge T=7
 
Figure 30. The spoke densities are different between all capsids (WT T=7, Del 2nd Hinge T=4, and T=7) 
 
Cropped sections of the internal densities of the WT and mutant capsids are shown. A) In the WT capsid, the spoke 
densities are mostly equal in strength in each subunit. B) In the Del 2nd Hinge T=4 capsids, the spoke densities are 
equal in each subunit of the pentamer. In the hexamers, one opposing pair of spokes are less dense than the other 
four (highlighted with ovals). There also seems to be one dominant pair of spokes at the 3 fold symmetry axis. C) In 
the Del 2nd Hinge T=7 capsid, the spokes of the pentamer subunits are equal in density. In the hexamer, there are 
also a pair of adjacent, weaker, barely visible spokes (highlighted with ovals). The missing spokes are also only 
located at a pentamer-hexamer interface. The capsid subunits in the hexamers surrounding the pentamers are 
missing their spokes. The four visible spokes continue to form the red colored densities of the delta domain. Capsids 
are not to size.  
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2.3 DISCUSSION 
The full length delta domain is required for capsid protein expression 
Previous lab members and I have conducted a large number of mutational analyses to better 
understand the role that the delta domain plays in capsid assembly. Our initial deletion 
experiments were done to answer an important question: is the delta domain required for HK97 
capsid assembly? Our full deletion studies show that the delta domain is required for capsid 
protein expression solubility. Even when plasmid expression was enhanced by the addition of the 
T7 RBS and tag sequence with the pNoDelta2 construct, the capsid protein was still mostly 
insoluble. These results show that the delta domain, like other known viral scaffolding proteins, 
plays an important role in capsid assembly. The capsid protein cannot function properly without 
the delta domain. This domain could be acting as a chaperone in regards to capsid protein folding 
upon translation. The delta domain’s presence as part of the capsid protein is somehow aiding its 
folding and solubility. From the experiments with different sized deletions, we learn that the full 
length delta domain is required. Even Del1, a deletion of just 9 residues near the N-terminal 
region of the delta domain, produced non-functional capsid protein. It was not able to 
complement phage with an amber mutation in the capsid gene. This slightly shortened delta 
domain is unable to carry out its roles to ensure proper capsid assembly. More in-depth studies of 
the Del1 mutant proheads, presented in Chapter 3 identify the reason behind its inability to form 
viable phage particles. Del2 never made detectable HK97 protein products suggesting that this 
deletion reduces expression or makes the protein very unstable. The larger deletions (Del3 and 
Del4) produced insoluble protein, similar to the results with the full length deletion.  These 
general deletions show us that the delta domain plays a critical role in capsid assembly.  
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The C-terminus of the delta domain is involved with specifying proper capsid geometry  
In the WT Prohead I reconstruction, spoke like densities are visible which are not seen in the 
Prohead II reconstruction. We hypothesize that these densities may contain parts of the delta 
domain that are lying against the internal surface of the capsid proteins. The C-terminal region of 
the delta domain was targeted for mutations because we believed this region may be a part of the 
spoke interactions. Two point mutations in the C-terminal segment of the delta domain, W89A, 
and D90A showed drastic capsid assembly defects. Further biochemical tests show that a total of 
five point mutants (included W89A and D90A) cause similar abnormal assembly phenotypes. 
L85R, W89A, D90A, D90G, and F96L all produce uncleaved mcp, which resides mostly in the 
pellet fractions, along with higher molecular weight bands, indicating possible cross-linking due 
to premature expansion and/or the formation of tube like structures. All of these point mutants 
produce abnormal assembly products. These mutations prevent the capsid from assembling 
correctly into T=7 icosahedral capsids. They mostly made irregular round structures or short tube 
like structures which aggregated with cellular debris. This aggregation explains their strong 
presence in the pellet fractions. These mutants were still able to produce soluble capsids subunits 
which could form hexamers and pentamers. The folding of the subunits appears to be correct, but 
the interaction of the subunits is somehow altered. In some cases, it seems that capsid assembly 
begins normally, as many of the tubes have at least one closed end and some of their diameters 
are similar to the diameter of WT capsids. As assembly progresses, however, the capsid proteins 
begin to spontaneously expand before cleavage has occurred, leading to the monster or tube 
formation. If these C-terminal residues are located in the spoke region, then a mutation could be 
disrupting the interactions between the delta domain spoke and the internal surface of the rest of 
the mcp. Adding a charged group or removing a large or charged group in this region could 
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affect the conformation of the mcp subunit, triggering the formation of abnormal or tube like 
structures and resulting in loss of functional protein. This loss of function is confirmed by spot 
complementation tests.  
The mutated mcps are unable to complement amber phage to produce viable phage. 
However, these mutants were also decreased in complementation efficiency for protease amber 
phage. The protease produced from the plasmid is wild-type, so in theory, the protein should be 
able to complement and form plaques at all dilutions. If a mutation shows a defect in protease 
complementation, then this could indicate an interaction between the mutant capsid protein and 
the WT protease that are expressed from the plasmid. The mutant protein is sequestering the WT 
plasmid-expressed protease, which prevents the protease from fully being able to complement 
the amber phage. This suggests that the abnormal and tube like assemblies might still be capable 
of binding and incorporating the protease, but due to the altered capsid protein conformation and 
premature expansion and cross-linking, the protease cannot activate and function to cleave the 
delta domain. This inability of the protease to function correctly and at the correct time could 
explain why all these mutants produced uncleaved mcp. Also, the assembly efficiency of these 
abnormal structures could be drastically decreased, allowing for protease degradation before the 
structures finish assembling. A way of testing for protease incorporation is to express the 
mutation with the inactivated protease, which would be visible on an SDS gel if incorporated. 
However, our purification protocols are optimized for soluble products that are precipitated by 
PEG. These tubes are present and aggregate in the pellet fractions, preventing proper purification 
away from cell debris. Therefore, I am unable to determine if these tubes are able to incorporate 
the protease like WT.  
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 Charged, and bulky side chains in the C-terminus make crucial interactions to ensure proper 
capsid geometry 
Perhaps the deleterious assembly affects were due to the drastic changes in amino acid at these 
locations. If we change, for example, the hydrophobic Leucine 85 to another similar hydrophobic 
residue, or Phenylalanine 96 to another bulky sidechain residue, would the capsid protein be 
functional and able to assemble properly, like WT? Are these particular residues or types of 
residues required at these locations to ensure proper capsid geometry? Four new point mutations 
were created in this C-terminal region: L85V, W89Y, D90E, and F96Y to try and conserve the 
original amino acid properties. In three of these mutants, L85V, W89Y, and F96Y, protein 
functionality was restored to or very close to WT levels. Even though L85V and W89Y now 
showed a partial mcp cleavage defect, and produced a few abnormal or tube like structures, they 
were able to complement major capsid gene and protease gene amber phage like WT (W89Y had 
a half log decrease in protease complementation). These mutations which were made to similar 
residues showed WT like phenotypes. These results show that large, aromatic resides at 89 and 
96 are required to make the necessary interactions to ensure proper capsid protein conformation, 
assembly, and maturation. Mutant studies in the C-terminus of the internal scaffolding protein of 
phiX174 showed that aromatic side chains were important for making contact with capsid 
protein (Dokland et al. 1999). It is possible that W89 and F96 make contacts with the interior of 
the capsid shell. When this interaction is disrupted, the capsid shell takes on the wrong geometry.  
D90E, on the other hand, still has a mcp cleavage defect. This mutation creates abnormal 
and tube like structures and very few Prohead I like structures. D90E is still defective in capsid 
gene amber complementation and shows a 1 log decrease in protease gene complementation. 
Even though Glutamic acid is a negatively charged residue, position 90 seems to require the 
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negatively charged properties of Aspartic Acid in order for proper assembly to occur. Aspartic 
Acid is slightly smaller than Glutamic Acid, so perhaps its size is important for the electrostatic 
interactions in this location. The major changes that were created in this region significantly 
altered capsid geometry suggesting that large aromatic, hydrophobic, and charged residues are 
important in this region of the delta domain. Perhaps mutating this region of the delta domain 
forced the capsid subunits to interact in a way that favors the assembly or interaction of 
hexamers, thus causing the formation of tubes. The capsid subunits appear to spontaneously 
expand before the delta domain is cleaved by the protease. A 42 kDa ladder of uncleaved mcp 
formed as a result of their premature expansion. Are these C-terminal changes favoring hexamer 
conformations, thus allowing tubes to form? Due to the premature cross-linking, I was unable to 
dissociate these abnormal assemblies to test if the ratio of hexamers to pentamers was different 
than a WT capsid. One future experiment would be to mutate the cross-linking residues of the 
capsid protein, K169 and N356, which would prevent premature cross-linking from occurring. If 
the mutant tube like structures are still able to assemble into tubes or other anomalies, then we 
would be able to dissociate the assemblies and determine the capsomeric ratios. However, the 
abnormal structures may be unstable without crosslinking and easily dissociate into capsomers.  
It would be interesting to learn if the hexamers that make up the tubes are symmetrical or 
skewed. In Prohead I and II, the hexamers are normally skewed, but in the mature capsid, 
through expansion, they become symmetrical. If the tube mutant hexamers are symmetrical, it 
would suggest that mutating the delta domain in this region pushes the capsid protein towards a 
mature-like conformation. If the hexamers are skewed, then it would support the idea that the 
removal of the delta domain must precede the maturation steps that lead to hexamer symmetry. 
However, the tubes are not regular in their structure, they are different lengths and some are 
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kinked and bend. This would make a reconstruction to visualize the state of the tube hexamers 
impossible. 
Prohead II is more stable than Prohead I and cannot be dissociated into capsomers using 
glucose or salt. Studying the crystal structures of Prohead I and Head II, there is a difference in 
the main -helix backbone of the mature capsid protein. In Prohead I, there is a slight bend in the 
helix while in Head II, the helix is straight. The delta domain may play in a role in the skewing 
of the hexamers and cause the bend in the helix backbone. Then, once the delta domains are 
removed, the hexamers remain in this energetically favorable state. This is disrupted when DNA 
packaging occurs to cause expansion and cross-linking (Gertsman et al. 2009). The skewing of 
the hexamers in the prohead is an interesting mystery. Currently, we do not know if the hexamers 
are skewed as individual capsomers, or if the skewing is induced during capsid assembly. Does 
the delta domain play a role in the skewing? Do the six delta domains bundle into two groups 
underneath the hexamer and cause the skewing? Or is this a combination of delta domain 
interaction and subunit interaction between capsomers? With more studies on the interactions in 
the interfaces of the capsid subunits and on the delta domain’s role in assembly, we can learn 
more about the finer details of the interesting and complex HK97 capsid assembly pathway.  
 
The search for 2nd site suppressors of delta domain point mutations 
To learn more about how the delta domain may be interacting with other delta domains or other 
capsid proteins during assembly, we can move mutations of interest into an HK97 prophage and 
induce lytic phage growth. If there are 2nd site suppressors elsewhere in the genome, then we can 
hypothesize that the initial mutation and the 2nd site mutation are close to each other and may 
interact. 
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Recombineering was used to move mutant fragments of DNA into the prophage. My 
initial attempts using galK recombineering were with LIM 49. However, I was never able to 
identify positive recombinants. When using tetR selection for recombineering, I was able to 
successfully move the C-terminal mutation W89A into a prophage. However, I was never able to 
produce any phage particles. W89A was made using two base pair changes in the genome. 
Perhaps, it was too difficult for the phage to suppress two base pair changes or revert back to 
WT. Also, W89A caused premature expansion and cross-linking and the formation of abnormal 
capsid structures. Even if there were no suppressors or reversions, it would be be highly unlikely 
that this mutation could have been tolerated in the phage. I noticed a high level of background 
colonies, showing that the selection system was not very efficient. In chapter 3, I will discuss a 
few changes made to the recombineering protocol which resulted in a positive recombinant and 
phage induction.  
 
Deleting predicted flexible regions in the delta domain disrupt capsid solubility, assembly, and 
affect capsid size 
Based on secondary structure prediction algorithms, the delta domain is composed of three -
helical regions and one -sheet region. If this is true, there would be possible flexible regions in 
between the more structured areas. The delta domain is flexible, and less ordered than the rest of 
the major capsid protein, which has prevented its crystallization. Perhaps its flexibility is a part 
of its function. If this is true, then removing its flexibility should have detrimental effects on its 
function and assembly. To test this hypothesis, I deleted two predicted ‘hinge’ regions in 
between predicted -helical regions: Del 1st Hinge and Del 2nd Hinge. Del1stHinge turned out to 
create nonfunctional protein, which was unable to produce soluble capsid subunits. This deletion 
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removed a Glycine, a known player in flexible regions. The deletion of six residues in this 
‘hinge’ showed that this region, and its flexible nature are important for assembly. Without this 
flexible region, the capsid protein precipitated out of solution. The flexibility of the delta domain 
could be an important role of its chaperone like qualities in regards to protein solubility. Like the 
previously discussed deletions: Del2, Del3, and Del4, the length of the delta domain cannot be 
disrupted without sacrificing functionality. This deletion showed that the flexible regions in 
between the predicted helical regions are just as important for protein solubility and 
functionality. 
Del 2nd Hinge is a particularly interesting mutation, as it creates the most drastic 
assembly defects out of all the delta domain mutations studied so far. This deletion has created a 
very interesting phenotype of producing mostly abnormal structures, and two different-sized 
capsids with triangulation numbers of T=7 and T=4. This deletion removed seven residues in 
between predicted helices 2 and 3. Del 2nd Hinge deleted two glycines and a proline, which are 
known for their roles in flexible regions of a protein. Removing this flexible region caused a 
dramatic assembly defect. When I was going through the micrographs and picking particles, it 
was obvious that the majority of the products were abnormal assemblies. This showed that 
removing this region mostly affected how the capsid subunits interacted to make a capsid. This 
deletion was able to make soluble protein, indicating that it did not strongly interfere with protein 
solubility. This strongly showed that the delta domain plays an important role in proper capsid 
formation, and that the delta domain is like a scaffolding protein. The two different sized capsids 
show that this mutation can sometimes assemble into an icosahedral structure.  
In some preliminary flexible fitting models, we are able to fit the HK97 crystal structure 
into the density maps of the T=4 and T=7 reconstructions. This demonstrates that this deletion 
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has not affected the overall fold of the HK97 capsid subunit. The main interactions between delta 
domains and adjacent subunits is affected. It is very exciting that this deletion is able to stabilize 
the delta domain and creates the towers of density under the pentamers and the two bundles 
underneath the hexamers. This is drastically different from the spidery blob like densities that are 
visible in the WT capsid. Del 2nd Hinge has indeed reduced the flexibility and disorder of the 
delta domain, allowing us to visualize more of this part of the capsid protein. We can see the 
spokes of density underneath each pentamer subunit connect and twist into the elongated tower. 
We hypothesize that the delta domains of a pentamer are capable of creating a five helix bundle.  
Secondary structure prediction program PSIPRED predicts that this deletion has 
converted the three helix delta domain into a two helix delta domain. A deletion of seven 
residues, a heptad repeat, likely aided in this elongation of the helical structure of the domain. 
The joining/elongation of two helices into one has stabilized the delta domain and created or 
stabilized this tower like conformation. In the density maps, it seems that = with the hexamers, 
the two delta domain bundles may connect with each other across the hexamer and create a 
bridge of delta domain interaction. Del 2nd Hinge not only has changed the size of some of the 
capsids produced, but it has also changed how the delta domain is structured inside the capsid.  
Because the delta domain is mostly -helical, it is highly probable that it uses coiled coil 
interactions to function. Perhaps these elongated delta domains are more stable because they are 
better able to make coiled coil interactions with neighboring delta domains. The delta domains 
appear to have similar structures in the T=4 and the T=7 mutant capsids. At very low frequency, 
the mcp is still able to assemble into the correct capsid, but is still not functional in 
complementation assays. This may be due to the inability of this mutant to incorporate the portal 
protein and a lowered ability to incorporate the protease; but the portal is a vital component of 
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the phage, as it is required for DNA packaging and injection. In spot complementation tests, we 
expect the WT phage control to produce plaques at all dilutions, but the WT phage spotted on 
these deletion mutation plates showed a decrease in complementation. This is suggesting that the 
mutant capsid protein is exerting a dominant negative effect in complementation. The mutant 
proteins may be interacting with or affecting the WT phage capsid proteins and creating chimeric 
capsids. These mixed capsids, which sequester the WT proteins prevents them from being 
incorporated into viable phage particles. Perhaps this deletion has removed a critical portal 
binding site, or because the deletion has made the delta domain elongated and more stable, it can 
no longer make the correct interactions with the portal. During assembly, the portal is surrounded 
by five hexamers and the delta domains have to be flexible enough to create a different type of 
interaction with the portal than it has by itself or with the protease. The rigid and protruding 
bundles of delta domains may completely prevent binding.  
Another interesting effect of this deletion is the difference in spoke densities among all 
three icosahedral capsids: WT, Del 2nd Hinge T=4 and Del 2nd Hinge T=7. In Del 2nd Hinge T=4 
capsids, two opposing spokes of the six spoke densities of a hexamer were reduced. This 
suggests that two of the delta domains in a hexamer have become more disordered than normal, 
possibly due to a lack of partners to interact with, and were averaged out during the 
reconstruction. The other four delta domains involved with creating the two bundles are more 
stable. In the Del 2nd Hinge T=7 capsids, the densities of two adjacent delta domains of the six 
delta domains in a hexamer are basically non-existent compared to the other four delta domains. 
There is no spoke and no connecting density into the bundle. These missing spokes are in the 
subunits which surround a pentamer. Perhaps these differing spoke densities in the deletion are 
the reason why the capsids are unstable and easily dissociate into capsomers. The different types 
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of capsids and the different spoke interactions that are visible inside leads to hypothesize that the 
spokes may play an important role in capsid stability and possibly even capsid size. It would be 
interesting to learn more about the specific interactions between capsomers and try to identify 
any differences that could help explain how it is assembling into different sized capsids.  
This mutation has allowed towers and bridges of delta domain to be visible in the density 
map, and we can use these mutant reconstructions as models to learn about potential 
conformations the delta domain can make. It is possible that these structures exist in the wild-
type situation, but are only transient and unstable. We can fit helical models into the strong delta 
domain densities to learn how the delta domain could be interacting with its neighbors to form 
these types of interactions. We can also learn how the delta domain could be interacting with the 
internal capsid surface, with the portal, and the protease proteins. It is amazing that this one little 
part of a capsid protein is able to play so many roles during the assembly process.  This region is 
responsible for protein solubility and folding, capsid geometry and overall assembly, and even 
capsid size. The next chapter will focus on more of the specific roles that specific regions of the 
delta domain play during assembly.  
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3.0 THE DELTA DOMAIN HAS A ROLE IN PORTAL AND PROTEASE 
INCORPORATION 
3.1 INTRODUCTION 
The delta domain acts as a scaffolding protein in HK97 capsid assembly. Initial deletions and 
mutations show that the full length delta domain is required for proper capsid protein expression, 
while other mutations affect capsid assembly, and capsid size. Also, by testing point mutations, 
we have identified that the C-terminal end of the delta domain plays an important role in capsid 
geometry.  
Other phage scaffolding proteins, like those in P22, have been shown to play a role in 
incorporating minor proteins into the capsid (Weigele et al. 2005). HK97 capsids contain two 
other proteins that are necessary for maturation and DNA packaging: a phage encoded protease, 
and a portal. The C-terminal end of the protease is believed to interact with the major capsid 
protein, thus allowing its incorporation into the capsid during assembly (Duda, Oh, and Hendrix 
2013). The N-terminal region of the capsid protein, the delta domain, could be facilitating this 
interaction. The portal is a 12-subunit ring structure located at one vertex of the capsid. It is 
predicted that for some viruses the portal nucleates assembly. This could be a way to ensure that 
there is only one portal per capsid. There is evidence in Herpes Simplex Virus Type 1 (HSV-1), 
that the scaffolding protein plays a role in interacting with the portal during capsid assembly 
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(Newcomb, Homa, and Brown 2005; Lee and Guo 1995; Moore and Prevelige 2002). 
Previously, I have shown that the delta domain is similar to other viral scaffolding proteins in 
being required for proper capsid assembly. In this section, I will show evidence that the HK97 
delta domain is acting to direct the incorporation of the protease and portal, as other scaffolding 
proteins do. Mutational studies show that distinct regions of the delta domain interact with the 
protease and the portal during capsid assembly.  
3.2 RESULTS 
3.2.1 The 2nd predicted helical region plays a role in portal incorporation 
Amino acid sequence alignments were used to identify features that are conserved between the 
HK97 delta domain and delta domains of similar phages. Conserved patches of resides may 
indicate a functional importance to that region, which can be targeted for mutagenesis. An 
alignment of the HK97 mcp and related proteins was made using BLAST and Clustal (R. Duda, 
http://gigapan.com/gigapans/b806a9da80b4a66bcb1dd1b273d5b7a4/). A portion of the 
alignment is shown in Figure 31. In our alignment we see a series of hydrophobic residues that 
are regular intervals apart, which is a common characteristic of heptad repeats in coiled-coils 
(highlighted in blue). The predicted secondary structure is shown along the top of the figure. As 
described before, the delta domain is predicted to be mostly -helical, separated into three 
helical regions, with a small predicted -sheet at the C-terminal end. This regular pattern of 
hydrophobic residues is typical for helices involved in coiled-coil interactions.  Besides these 
hydrophobic residues, there is a prominent conserved region containing the sequence EQK (E61, 
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Q62, and K63 in HK97). This is seen in about 50% of the sequences in the alignment. These 
three residues lie near the end of the 2nd predicted -helix and could be playing a critical role in 
capsid assembly. Therefore, they were individually mutated to alanines and tested by 
complementation and for assembly defects in miniprohead expression experiments.  
 
 
 
 
 
Figure 31. Portion of HK97 delta domain protein sequence alignment shows a conserved patch 
A sequence alignment of the HK97 major capsid protein and related proteins was made in Clustal by Bob Duda. 
This portion of the alignment shows the delta domain. The sequence highlighted with the asterisks is HK97. The 
colors correspond to conserved residues. The predicted secondary structure is shown on top. Other than a series of 
hydrophobic residues, the EQK patch is present in about 50% of the aligned sequences (boxed region). These 
residues were mutated to alanines to test if their conservation played an important role in delta domain function and 
capsid assembly. 
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The pellet, supernatant, and PEG fractions of E61A and Q62A were run on agarose and 
SDS gels to determine what kind of protein assemblies are made, and if the mcp is processed 
correctly. On an agarose gel, E61A produced only Proheads while Q62A produced proheads and 
heads like WT (Figure 32A). In the SDS gel, E61A produced uncleaved mcp showing that it is 
defective in proteolysis, while Q62A produced cleaved mcp like WT (Figure 32B). Miniprohead 
prep samples were prepared for visualizing with the TEM. In the electron micrographs, E61A 
produced WT like proheads and Q62A produced WT-like proheads and heads. Purified portal-
containing Prohead I is shown for comparison (Figure 33). K63A will be discussed in detail in a 
later section of this chapter (p. 106). Complementation spot tests showed that all three mutations 
had a three log decrease in capsid gene complementation efficiency compared to WT. E61A and 
Q62A were also one log down in protease gene amber phage complementation (Table 1). 
 The charge change mutation, E61A, in the conserved patch caused a cleavage defect. 
Therefore, it is not surprising that it was unable to complement phage with an amber mutation in 
the capsid gene. Perhaps E61A affects the interaction between the capsid proteins and the 
protease. On the other hand, Q62A showed WT like phenotypes in all biochemical assays. Q62A 
proheads were able to cleave properly and expand to form heads in vitro. These initial plasmid 
studies only expressed the protease and capsid genes; the portal gene is not included in the 
plasmids. Perhaps Q62A affects the interaction between the capsid proteins and the portal. These 
mutants were moved into a plasmid that expresses the portal and inactivated protease (pVP0 g4 
(H65A)) so that we could detect incorporation of these proteins using gel electrophoresis.  
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Figure 32. Miniprohead prep results of E61A and Q62A 
A) Pellet, supernatant, and, PEG samples were loaded on a 0.9% agarose gel to detect assembly products. WT 
produced proheads and heads. E61A produced proheads only. Q62A produced proheads and heads like WT. B) On 
the SDS gel, WT showed cleaved 31 kDa mcp. E61A showed uncleaved 42 kDa mcp. Q62A produced cleaved mcp 
like WT. 
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Figure 33. Representative EM images of E61A and Q62A PEG samples 
  
WT Prohead I is used as a comparison. The miniprohead prep PEG samples were diluted 1/10 in 1x calorimetry 
buffer and stained with 1% uranyl acetate. E61A produced WT-like prohead particles. Q62A produced proheads and 
heads. Heads are visible as thinner shelled particles due to their expanded state. 
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E61A and Q62A show portal incorporation defects 
Large scale prohead preps were made of E61A and Q62A in plasmids carrying the portal and 
inactivated protease genes. The purified samples were precipitated with 10% TCA and run on 
SDS gels to detect the presence of portal or protease bands with coomassie staining (Figure 34). 
The SDS gel contains Prohead II with portal and Prohead I with portal as controls. Prohead II 
produced a 31 kDa mcp cleaved mcp band and 47 kDa portal band. Prohead I produced an 
uncleaved 42 kDa mcp band, along with the portal and the 25 kDa protease. E61A produced 
uncleaved mcp.  There was no detectable portal or protease protein in this sample. Q62A 
produced an uncleaved mcp and a protease band, but this mutant did not incorporate any 
detectable portal protein. (Figure 34A). The mutant prohead samples were run on a 0.9% native 
agarose gel to visualize the presence of prohead dimers or larger structures. This sensitive assay 
is able to detect low levels of portal incorporation, even when we cannot detect a strong portal 
band in the SDS gel. Prohead II control produced prohead and head bands. Prohead I control 
produced prohead, prohead dimer, and prohead trimer bands. E61A and Q62A produced very 
strong prohead bands. E61A produced very light prohead dimer and trimer bands while Q62A 
produced a very light prohead dimer band (Figure 34B). These weaker bands show that E61A 
has a protease and portal incorporation defect while Q62A has a portal incorporation defect. 
These results confirm that this conserved region in the delta domain plays important roles in 
capsid assembly.  
 
 90       
 
42 kDa gp5
31 kDa gp5*
portal
protease
 
 
Figure 34. E61A is defective in portal and protease incorporation. Q62A is defective in portal incorporation 
 
A) Purified prohead samples were prepared for SDS gels, and stained with coomassie. Prohead II (P II) and Prohead 
I (P I) with portal act as controls. Prohead II produced the portal and cleaved mcp. Prohead produced portal, 
uncleaved mcp, and protease bands. E61A only showed an uncleaved mcp band. There was no detectable portal or 
protease bands. Q62A showed an uncleaved mcp band and a protease band. B) Purified prohead samples were 
loaded on a 0.9% agarose gel. Prohead II produced proheads and heads. Prohead I produced proheads, prohead 
dimers, and prohead trimers. E61A showed a very strong prohead band, with barely detectable dimer and trimer 
bands. Q62A produced a very strong prohead band, and a barely detectable dimer band. 
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Identifying important residues in the predicted 2nd helix of the delta domain 
Mutant studies on this conserved “EQK” region of the delta domain showed that it contains two 
neighboring residues which are important for portal incorporation: We wanted to test if there 
were other residues in the predicted 2nd helix which were also involved with interacting with the 
portal. The amino acid sequence of the predicted 2nd helix was threaded into a helical projection 
wheel program (http://rzlab.ucr.edu/scripts/wheel/wheel.cgi) to identify neighboring residues that 
might be on the same side of the predicted -helix as E61 and Q62 (Figure 35). Perhaps these 
upstream and downstream residues also make important contacts with the portal during 
assembly. Arrows show the residues that were targeted for mutagenesis. Based on the helical 
projection wheel prediction, point mutations were designed to create drastic changes in side 
chain character.  
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Figure 35. Helical projection wheel model of the 2nd predicted helix protein sequence 
 
The amino acid sequence of the 2nd predicted helix of the delta domain (K37-S66) is shown at the top. E61 and Q62 
are highlighted as the initial residues found to have a role in portal incorporation. The black arrows point to 
surrounding upstream and downstream mutations (mostly on the same side of the predicted helix) that were tested 
for portal incorporation defects. The circles represent uncharged polar residues. The triangles represent negatively 
charged residues. The diamonds represent hydrophobic residues. The pentagons represent positively charged 
residues.  
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17 new point mutations were made in this predicted helical region. The miniprohead prep 
results of 9 mutants (K37A, Q38A, Q40A, S41F, M44K, E48A, T51A, T55I, and T55F) 
produced WT-like phenotypes (Figures 36 and 37) and were able to complement amber phage 
like WT (Table 1). At times, K92A was used as a control in the miniprohead preps because it 
causes a partial cleavage defect and conveniently produces cleaved and uncleaved mcp bands in 
SDS gels and proheads, heads, and capsomer bands on agarose gels. K92A is discussed in further 
detail in Appendix A.  
Eight out of the 17 point mutations (Q38P, L43R, Q47A, G54Y, F58L, D59A, A65E, and 
S66F) showed defects in capsid gene amber phage complementation. L43R, Q47A, and G54Y 
also showed slight defects in protease gene amber complementation (Table 1). The pellet, 
supernatant, and PEG fractions of these defective mutants were loaded on 0.9% agarose gels to 
detect the protein assemblies that were made (Figure 38). WT and K92A were used as controls. 
Q38P produced a very strong prohead band. L43R and Q47A also only produced prohead bands. 
F58L, D59A, A65E, and S66F produced prohead and head bands like WT (Figure 38). On SDS 
gels, Q38P, L43R, and Q47A produced only uncleaved mcp. F58L and D59A produced mostly 
cleaved mcp with very light uncleaved mcp bands in the PEG fractions. A65E and S66F show 
cleaved mcp like WT. However, for S66F, the mcp band is strongest in the pellet fraction (Figure 
39). Q38P, L43R, and Q47A had cleavage defects, indicating a possible defect in protease 
incorporation. F58L, D59A, A65E, and S66F showed phenotypes similar the portal incorporation 
defect mutant Q62A- perhaps these mutants also affect interactions between the delta domain 
and the portal. The PEG fractions were visualized using the EM. Q38P, L43R, and Q47A 
produced proheads whereas G54Y, F58L, D59A. A65E, and S66F produced proheads and heads 
(Figure 40). 
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Figure 36. Agarose gels of the predicted 2nd helix mutants with WT phenotypes. 
 
Miniprohead prep pellet, supernatant, and PEG samples were collected and run on 0.9% agarose gels for analyses. 
WT or K92A were used as controls. WT produced cleaved mcp while K92A produced cleaved and some uncleaved 
mcp. All of these point mutations produced proheads and heads on agarose gels and cleaved mcp on SDS gels like 
WT. 
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Figure 37. SDS gels of the predicted 2nd helix mutants with WT phenotypes 
 
Miniprohead prep pellet, supernatant, and PEG samples were run on 12% low cross-linking SDS gels. WT control 
produced cleaved mcp while K92A produced both cleaved and uncleaved mcp. All of these mutants produced WT 
like phenotypes of mostly cleaved mcp. 
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Figure 38. Agarose gel results for defective mutations in predicted 2nd helix 
 
Miniprohead prep pellet, supernatant, and PEG samples were run on 0.9% agarose gels. WT and K92A samples 
were used as controls for comparison. WT produced prohead and head bands. K92A produced prohead, head, and 
capsomer bands. Q38P, L43R, and Q47A showed only the production of prohead bands. G54Y, F58L, D59A, A65E, 
and S66F showed WT like results of prohead and head bands. 
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Figure 39. SDS polyacrylamide gel results of defective mutants in the predicted 2nd helix. 
 
Miniprohead prep pellet, supernatant, and PEG samples run on SDS gels. WT and K92A samples were used as 
controls. WT produced 31 kDa cleaved mcp and K92A produced both cleaved and uncleaved mcp. Q38P, L43R, 
and Q47A produced only uncleaved mcp. G54Y showed a partial cleavage defect by producing both cleaved and 
uncleaved mcp. F58L and D59A produced mostly cleaved mcp, but there were very light uncleaved mcp bands 
present also A65E showed cleaved mcp and S66F showed cleaved mcp but, at lower expression than the control. 
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Figure 40: EM images of Q38P, L43R, G54Y, F58L, D59A, Q47A, A65E, and S66F 
 
Miniprohead prep PEG samples were diluted 1/10 in 1x calorimetry PBS, stained with 1% uranyl acetate and 
imaged at 56,000x magnification. WT Prohead I is shown for comparison. G54Y, F58L, D59A, A65E, and S66F 
produce WT like proheads and heads. Q38P, L43R, and Q47A produce prohead like particles. Scasle bar: 100 nm. 
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Point mutations in the 2nd predicted helical region are defective in portal incorporation 
These point mutations were moved into a plasmid that makes the portal and inactivated protease 
(pVP0 g4 H65A) and expressed on a larger scale. After the glycerol gradients, and a final 
ultracentrifugation step to concentrate them, the samples were syringe filtered and run on SDS 
and agarose gels to detect the incorporation of portal and protease proteins. On the SDS gel, 
Q38P showed very light portal and inactivated protease bands, indicating less than WT levels of 
incorporation. For L43R there was no detectable portal band but there was a light inactivated 
protease band. Q47A showed a very light portal band but there was no protease band present. 
G54Y showed a light portal band and a WT like protease band. F58L and D59A showed a light 
portal band and WT like protease band. A65E was defective in portal incorporation but was able 
to incorporate the protease at WT levels. S66F showed a very light portal band and had WT-like 
incorporation of the protease. There is a unique band running at about 12 kDa in the S66F 
sample that is a degradation product of the mcp sometimes seen in prohead samples (denoted by 
asterisk) (Figure 41).  
All of these point mutations show a defect in portal incorporation while Q38P, L43R, and 
Q47A show a double defect in portal and protease incorporation. The samples were run on 
agarose gels to identify any prohead dimer or trimer bands (Figure 41). Q38P produced a strong 
prohead band and very light dimer and trimer bands. L43R only produced proheads. Q47A, 
A65E, F58L, and D59A produced proheads, along with weak prohead dimer and trimer bands. 
S66F produced proheads, and less than WT levels of prohead dimers and trimers (Figure 42). 
Even though some of these mutants showed no detectable portal bands in the SDS gel, the 
agarose gel was able to visualize the small number of proheads that do incorporate the portal,  
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Figure 41. Prohead prep SDS gel results of mutants expressed with the portal and inactivated protease. 
 
Purified and syringe filtered proheads were prepared for SDS gels. Prohead II and Prohead I with portal were used 
as controls. Prohead II had portal and cleaved 31 kDa mcp bands. Prohead I control had portal, uncleaved 42 kDa 
mcp, and inactivated protease bands. Q38P and L43R had uncleaved mcp, a weak protease band, but no detectable 
portal band. G54Y showed uncleaved mcp and protease bands, along with a light portal band. F58L and D59A 
showed uncleaved mcp bands, weaker than WT portal bands but WT level protease bands. Q47A showed uncleaved 
mcp, a very light protease band, and no detectable portal band. A65E showed uncleaved mcp and protease bands, 
but no detectable portal band. S66F showed uncleaved mcp and protease bands, and a weaker than WT portal band. 
Compared to WT, these mutants had a portal incorporation defect while Q38P, L43R, and Q47A showed a double 
defect with both portal and protease incorporation. The asterisk (*) denotes a unique 12 kDa band in the S66F, 
which is a trypsin digestion product, sometimes seen in Prohead preps. 
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Figure 42. Prohead Prep agarose gels of mutants expressed in portal and inactivated protease plasmid 
 
Purified prohead samples were run on 0.9% native agarose gels. Prohead II and Prohead I with portal samples were 
used as controls. Prohead II produced proheads and heads. Prohead I produced proheads, and prohead dimers and 
trimers. Q38P produced a stronger prohead band and weak dimer and trimer bands. L43R produced only prohead 
bands. G54Y produced a strong prohead band and weak dimer and trimer bands. F58L and D59A produced strong 
prohead bands and weaker dimer and trimer bands. Q47A and A65E showed prohead bands and barely detectable 
dimer bands. S66F produced prohead bands, along with dimer and trimer bands. The dimer and trimers are slightly 
weaker than WT. S66F had a shifted mobility and runs slightly faster than WT. Dimer and trimer bands weaker than 
WT suggest a defect in portal incorporation. 
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which bind together to create the weak dimer and trimer bands. Q38P also caused defects in 
portal and protease incorporation. However, introducing a proline can cause a kink in an -helix 
and drastically disrupt secondary structure. Q38P could be causing assembly defects solely based 
on this steric disruption. Therefore, I mutated this residue to an alanine and tested its assembly 
affects in a miniprohead prep. Q38A possessed WT like phenotypes and produced functional 
capsid protein (Figure 36 and 37, Table 1), suggesting that it does not play a critical role in delta 
domain function.  
 
Portal incorporation mutants lie on the same side of the predicted 2nd α-helix 
Our analysis of point mutations in the 2nd predicted helix have identified five mutants that solely 
affect portal incorporation during capsid assembly, F58L, D59A, Q62A, A65E, and S66F. In 
contrast, three mutants, L43R, G54Y, and E61A, had interesting double defects for both portal 
and protease incorporation. In order to visualize how these residues may be related to each other 
in space, the amino acid sequence of the 2nd predicted helix was threaded onto a helical model 
using Pymol. Residues in red indicate mutations made at those locations involved with portal 
incorporation. Blue residues indicate mutations at those sites involved with both portal and 
protease incorporation. From the model, all of the portal incorporation mutants lie on the same 
side of this predicted helix (Figure 43), suggesting that this particular region of the delta domain 
plays an important role in making interactions with the portal proteins. 
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Figure 43. Helical model of 2nd predicted α-helix of the delta domain showing portal and protease 
incorporation mutants. 
 
Residues K37 to S66 of the 2nd predicted helical region of the delta domain were threaded onto a helical model 
using Pymol. The side chains of the model are the original WT residues. The mutants made at critical residues are 
labeled. The red residues represent the mutations, which caused portal incorporation defects. The blue residues 
represent the mutations which caused a double defect in both portal and protease incorporation. From this view of 
the model, all of these critical residues lie on the same side of the helix. 
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LIM 49 (in the 2nd predicted helix) also has a portal and protease incorporation defect 
Now that we have some evidence that the 2nd predicted helix plays a role in portal incorporation, 
we can test other mutations for similar defects in this region. LIM 49 was an insertion mutation 
described in the previous chapter which caused a cleavage defect and only produced Proheads. 
Perhaps this mutation has a cleavage defect because it is unable to incorporate the protease. LIM 
49 was moved into a plasmid containing the portal and inactivated protease genes to test for 
portal or protease incorporation defects. Purified mutant and WT control Prohead I and Prohead 
II samples were run on SDS and agarose gels. LIM 49 only showed uncleaved mcp and a very 
light protease band. There was no detectable portal band (Figure 44A). LIM 49 was also run on a 
0.9% native agarose gel to detect the presence of dimers and trimers. Prohead II showed 
proheads and heads. Prohead I showed prohead, prohead dimer, and trimer bands. LIM 49 only 
showed a prohead band (Figure 44B). The lack of portal band in the SDS gel, and the lack of 
dimers and trimers in the agarose gel indicate that this linker insertion mutation is unable to 
incorporate the portal during capsid assembly. Also, the very low level of protease in the SDS 
gel, compared to WT, suggests that this mutation is also defective in protease incorporation. LIM 
49 has a double defect in portal and protease incorporation.  
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Figure 44. LIM 49 is defective in portal and protease incorporation 
  
A) Purified samples were prepared and run on a SDS gel. Prohead II and Prohead I were used as controls. Prohead II 
produced portal and 31 kDa cleaved mcp bands. Prohead I produced portal, uncleaved 42 kDa mcp, and inactivated 
protease bands. LIM 49 did not have a portal band, and only had a very light protease band compared to WT. B) In a 
0.9% agarose gel, Prohead II showed prohead and head bands. Prohead I produced proheads, prohead dimers, and a 
weak trimer band. LIM 49 only showed a prohead band. LIM 49 is defective in both portal and protease 
incorporation. 
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3.2.2 The portal can enhance capsid assembly 
The ring shaped portal takes the place of a pentamer at one vertex of the capsid. The delta 
domain is responsible for making specific interactions with the portal to ensure that there is only 
one portal per capsid. Some believe that the portal acts as an initiator of assembly to make 
assembly more efficient and to prevent the formation of capsids with multiple portals. Does it 
provide the capsid proteins with a base to begin assembly, thus aiding in efficient, proper, and 
complete assembly? While HK97 plasmid expression studies show that the portal is not required 
for capsids to assemble, there are a few mutants (Del1, L6R will be discussed later in this 
chapter) that appear to assemble slowly and we have used them to show that the presence of the 
portal can accelerate capsid assembly.  
E363A shows complete mcp cleavage in the presence of the portal 
E363A was a mutation made and studied by C.L Peebles and R. Duda and studied by a previous 
undergraduate student, Lindsey Dierkes. This mutation removed a cross-linking catalytic site and 
is located in the P-domain of the capsid protein (Dierkes et al. 2009). E363A only produced 
proheads in the agarose gel and produced an approximately equal amount of cleaved and 
uncleaved mcp bands in the SDS gel. This partial cleavage defect could be due to a slowed or 
inefficient assembly. It was speculated that the capsid proteins take longer than normal to build 
the capsid, and the protease is degraded before capsid assembly is complete (Dierkes et al. 2009). 
Inadequate protease activity could cause partial mcp cleavage. To test if the portal can enhance 
capsid assembly, and possibly promote complete proteolysis, E363A was moved into a plasmid 
containing the portal gene (pVP0). A large scale Prohead Prep were performed and SDS gels and 
native agarose gels were run to test for mcp cleavage and portal incorporation.  
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 Figure 45 shows the gel data from the Prohead Prep. Prohead I and Prohead II were used 
as controls. When E363A was expressed with the portal, the mcp was able to be cleaved nearly 
completely. There was only a very small amount of uncleaved mcp band present in the SDS gel. 
The agarose gel showed a prohead band and a very light head band (denoted by circle) (Figure 
44), indicating the presence of cleaved and expanded particles.  
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Figure 45. E363A produces cleaved mcp when the portal is present 
Prohead preps were performed for E363A with portal and inactivated protease. A) E363A was run on a SDS gel 
with PII and PI controls. Prohead II produced a cleaved mcp band and portal band. Prohead I produced uncleaved 
mcp, along with a portal and protease band. E363A showed PII like results with cleaved mcp and the portal. There 
was a very small amount of uncleaved mcp. B) On agarose gel, Prohead II produced proheads and heads. Prohead I 
produced proheads, prohead dimers, and trimers. E363A produced proheads and a very light head band (denoted by 
circle). 
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K63A causes a cleavage defect 
K63 lies in the predicted 2nd helix, in the conserved EQK region described earlier. This residue 
was mutated to an Alanine to remove the positive charge property. In initial miniprohead prep 
experiments, this mutation showed a cleavage defect and only produced uncleaved mcp and 
proheads (Figure 46). By EM, K63A PEG samples showed WT-like prohead particles (Figure 
47). In complementation tests, K63A was three log downs in both capsid gene amber and 
protease gene amber phage complementation (Table 1). The K63A mcp is unable to function 
properly and build viable phage, possibly due to an inability to incorporate the protease, which 
could explain why this protein does not cleave like WT. 
 
A.      B. 
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Figure 46. Miniprohead prep results of K63A shows a cleavage defect 
A) Pellet, supernatant, and, PEG samples were loaded on a 0.9% agarose gel to detect the assembly products made. 
WT produced proheads and heads. K63A produced a strong prohead band only. B) Samples were run on a 12% low 
cross-linking SDS gel, and stained with coomassie. WT showed cleaved 31 kDa mcp. K63A showed only uncleaved 
42 kDa mcp. 
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Figure 47. Representative EM images of WT PI and K63A 
WT Prohead I is used as a comparison. The miniprohead prep PEG samples were diluted 1/10 in 1x calorimetry 
buffer and stained with 1% uranyl acetate. K63A produced WT like Prohead I particles. Scale bar:100 nm. 
 
 
K63A is able to incorporate the portal and inactivated protease like WT 
K63A was moved into a portal and inactivated protease plasmid to test for portal and protease 
incorporation. WT Prohead I and II, and K63A purified samples were run on SDS and agarose 
gels. On the SDS gel, K63A showed portal, uncleaved mcp, and protease bands (Figure 48A). 
On the agarose gel, Prohead II produced proheads, and heads while Prohead I produced prohead, 
dimer, and trimer bands as expected. K63A showed a WT Prohead I like banding pattern of 
prohead, dimer, and trimer bands (Figure 48B). These results show that the K63A mutant was 
able to incorporate the portal and protease proteins at WT like levels. The protease protein is 
present inside the mutant proheads, but cleavage did not occur. Therefore, the lack of protease is 
not the cause of the cleavage defect we first detected.  
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Figure 48. K63A shows WT-like portal and inactivated protease incorporation 
A) Purified prohead samples prepared for SDS gels and stained with coomassie. P II and  P I with portal act  
as controls. Prohead II showed the portal and the cleaved mcp. Prohead I showed the portal, uncleaved mcp, and the 
protease. K63A had a WT like phenotype with portal, uncleaved mcp, and protease bands. B) Purified prohead 
samples were loaded on a 0.9% agarose gel. Prohead II produced proheads and heads. Prohead I produced proheads, 
prohead dimers, and prohead trimers. K63A produced proheads, dimers, and trimers like the Prohead I control. 
 
 
K63A produces cleaved major capsid protein when the portal is present 
We moved K63A to a portal-less plasmid that contained an inactivated protease to test if the 
protease can still be incorporated when the portal is not present. Prohead II and Prohead I were 
again used as controls. In the SDS gel, K63A was able to incorporate the protease, although the 
protease band is a little weaker than WT (Figure 49A). In the agarose gel, K63A produced 
prohead band.  The presence or absence of the portal does not affect protease incorporation.  
K63A was yet again moved to another plasmid that contained the portal and active 
protease. The purified samples were run, along with WT Prohead II and Prohead I on SDS and 
agarose gels. On the SDS gel, surprisingly, K63A with portal and active protease produced 
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cleaved mcp like the Prohead II control. There was only a very little bit of uncleaved mcp 
detected (Figure 49B). On the agarose gel, a prohead band and a light head band is present 
(denoted by circle). K63A capsids were only able to cleave and mature properly when the portal 
was present. This suggests that the portal is able to enhance the capsid assembly process. Perhaps 
the presence of the portal has helped to overcome an energy barrier that the point mutation 
created, thus allowing proteolysis. Comparing the effect of the portal on capsid expansion was 
performed and time points were run on SDS gels. By comparing the ratio of heads to proheads, 
the rate of expansion was determined to be approximately 10 times faster when the portal was 
present (Josh Maurer, unpublished results). With HK97, the portal may act as a nucleator of 
assembly and aid in capsid maturation. The portal may allow the capsomers to assemble faster, 
compared to when the capsomers have to assemble around a pentamer, allowing for a faster rate 
of shell completion and maturation. 
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Figure 49. K63A only produces cleaved mcp when the portal is present 
 
K63A was expressed in a plasmid with no portal and an inactivated protease, and also in a WT plasmid with portal. 
PI and P II with portal were used as controls. On SDS gels, Prohead II produced cleaved mcp while Prohead I 
produced uncleaved mcp. On agarose gels, Prohead II produced proheads and heads while Prohead I produced 
proheads, dimers, and trimers. A) On the SD gel, K63A was able to incorporate the protease, even when the portal 
was not present. It produced uncleaved mcp and only proheads on the agarose gel. B) On the SDS gel, K63A 
produced cleaved mcp, and very little uncleaved mcp in the present of portal and active protease. On the agarose gel, 
K63A produced a strong prohead band and a weaker head band (denoted by circle). 
 
 113       
 
3.2.3 Identifying a 2nd site suppressor in the portal 
The site directed mutagenesis approach to studying the delta domain has provided us with an 
array of mutations that cause different types of assembly defects. One of these mutations, A65E, 
produced prohead and head like particles but had a portal incorporation defect. A65E seemed 
like an interesting candidate for moving into a HK97 prophage to select a 2nd site suppressor 
mutation. I again used the technique, recombineering, for making my mutant constructs. After 
many trials of using tetR negative selection, I decided to go back to using galK recombineering. 
An A65E fragment with HK97 homology arms was transformed into galK competent cells. 
Instead of a 4.5 hour outgrowth and recovery period at 30˚C, I did an overnight recovery. The 
next day, I pelleted and washed the cells before plating on 2-DOG selection plates. The plates 
were incubated at 42˚C overnight and then moved to 28˚C until colonies grew. Colonies were 
picked and re-streaked on 2-DOG plates to purify and incubated at 28˚C until colonies grew. 
Colony PCR was conducted to identify HK97 DNA. Restriction digestions were done to identify 
the presence of the A65E mutation in the DNA. When A65E was made, a silent mutation was 
made nearby to add a unique restriction site, KasI to allow for identification.  
There was one colony, out of 96, that digested as expected. A portion of the major capsid 
gene was sequenced and this colony was positive for the A65E mutation! This lysogen carrying a 
recombinant prophage was cultured and prepared for UV induction. The cells were exposed to 0, 
5, and 10 seconds of UV light and shaken in LB medium to allow for phage growth. The lysate 
was collected and plaque assays were conducted. There are different possible types of phage that 
could be made: phage that have reverted to WT, phage that have replaced the glutamate with 
another functional residue, or phage that have created a suppressing mutation elsewhere in the 
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genome. The suppressing mutations are the ones that I am most interested in because these phage 
will show us interactions between the new suppressing residue and the initial lethal mutation 
made in the delta domain.  I was successfully able to produce plaques from the A65E prophage. 
11 plaques were sequenced and three contained the A65E mutation of interest. The portal, 
protease, and major capsid genes were sequenced directly from the three positive phage stocks 
and all three contained a 2nd site point mutation in the portal gene: D135G. This second site 
mutation shows that residue 135 in the portal may be in close contact with residue 65 in the delta 
domain. The initial lethal mutation changed a small residue to a charged residue (A to E) in the 
2nd helix of the delta domain. The suppressing mutation in the portal changed a charged residue 
to a small residue (D to G) possibly to maintain this charge and small residue interaction or 
prevent repulsing forces. This genetic change supports my biochemical data that A65 is an 
important residue for binding and incorporating the portal during capsid assembly.  
D135G in the portal rescues A65E function in vitro 
Our genetic tests showed that D135G (portal) is in some sort of interaction with A65E (delta 
domain). A65E showed a defect in portal incorporation, and was 3 logs down in complementing 
phage with an amber mutation in the capsid gene. (Figures 41 and 42, Table 1). We wanted to 
see if the rescuing effect of this pair of mutations could be replicated using our plasmid 
expression system. Single mutant and double mutant plasmids, pVP0 D135G and pVP0 A65E 
(gp5)/D135G (gp3), were made and expressed in miniprohead preps. Along with WT controls, 
these mutants were run on SDS and agarose gels, and also tested for protein functionality in 
complementation spot assay. On the SDS gel, D135G produced a portal band, mostly uncleaved 
mcp and some cleaved mcp (Figure 50A). D135G on its own causes a partial cleavage defect. In 
the spot complementation tests, D135G was able to complement protease and capsid gene amber 
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phage like WT, showing complete functionality of protein, even though cleavage is incomplete. 
However, D135G causes a slight defect in portal protein functionality because it is one log down 
in complementation efficiency of phage with an amber mutation in the portal gene (Table 2).  
On the SDS gel, the double mutant, A65E/D135G produced equal amounts of cleaved 
and uncleaved mcp (Figure 50A). On the agarose gel, D135G and the double mutant produced 
similar bands: prohead, head, and prohead dimers. Prohead I showed prohead and dimer bands. 
An A65E sample is shown to compare the before and after D135G mutation addition. With the 
addition of D135G, the double mutant showed portal incorporation and the presence of prohead 
dimer bands, showing that D135G was able to rescue the portal incorporation defect phenotype 
(Figure 50B). In the complementation tests, the double mutation is able to complement amber 
phage at WT levels, showing that it produces fully functional protein capable of forming viable 
phage particles (Table 2). 
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Figure 50. Prohead preps of pVP0 D135G(gp3) and double mutant pVP0 A65E(gp5)/D135G(gp3) show that 
the double mutant is able to rescue the portal incorporation defect of A65E. 
 
A) SDS gel of PI and PII controls with mutants. The portal mutant, D135G produced a cleavage defect, having some 
cleaved 31 kDa mcp and mostly uncleaved mcp, and the portal band. The double mutant showed partial cleavage 
with relatively equal amounts of cleaved and uncleaved, along with the portal band. B) The agarose gel shows 
A65E, D135G, and the double mutant. As described before, A65E only produced proheads when expressed in the 
portal and inactivated protease plasmid. It could not form prohead dimers because it was defective in portal 
incorporation. D135G and the double mutant showed prohead and prohead dimer bands, and a light head band. The 
double mutant is now able to produce prohead dimers because it is able to incorporate the portal. 
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Making a homology model of the HK97 portal protein 
There is no crystal structure of the HK97 portal available but there is one phage in the HK97 
family, a Corynebacterium diphtheria phage, whose portal has been solved to a resolution of 2.9 
Å by crystallography (Nocek et al. 2009). The C. diphtheria phage portal is 349 amino acids in 
length while the HK97 portal is 424 amino acids. An alignment using ClustalX showed 
approximately 20% sequence identity between these two proteins. In the alignment, D135 in 
HK97 aligns with D121 in the C. diphtheria phage portal (Figure 51). The residues are located in 
a small region in the portal structure that is conserved in the sequence alignment. Using the 
swissmodel program, a homology model of the HK97 portal was made based on the crystalized 
C. diphtheria phage portal structure (Figure 52).  The left shows the C. diphtheria phage portal 
structure. The crystal structure included two disordered regions, which are shown by the dotted 
lines.  The right image is the HK97 homology model. The corresponding aspartic acid residues 
are highlighted on each structure. The residue is located at the end of a -sheet region located on 
the edge of the portal structure in the interior of the capsid. We can imagine that this edge of the 
portal, exposed to the interior of the capsid, could be making interactions with the surrounding 
delta domains.  
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Figure 51. Sequence alignment of the C. diphtheria phage portal and HK97 portal 
Using the ClustalX alignment program, there is a 20% sequence identity between these two phage portals. The 
arrow points to D121 (C. diptheria phage, top line) and D135 (HK97, bottom line), which is located in a conserved 
region 
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Figure 52. Homology model of HK97 portal based on the C. diphtheria phage portal crystal structure 
 
The left shows the crystal structure of the C. diphtheria phage portal protein subunit. The red residue and the black 
arrow highlights residue D121. The right image shows the HK97 portal homology model. The black arrow 
highlights residue D135. These aspartic acid residues are located at the end of a -sheet region. The highlighted 
areas differentiate the regions that would be in the interior or exterior of the capsid.  
 
 
 
 
 
 
C. diphtheria phage portal HK97 portal model 
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3.2.4 Discussion 
Point mutations in the delta domain have shown us that it plays a role in portal incorporation 
during capsid assembly. I was able to identify a specific region of the delta domain, the 2nd 
predicted -helix, as the main region responsible for making interactions with the portal proteins. 
Nine point mutations: L43R, Q47A, G54Y, F58L, D59A, E61A, Q62A, A65E, and S66F 
resulted in portal binding defects. Interestingly, when mapped onto a helical model, these 
important residues all lie along the same side of the helix, suggesting that one side of a delta 
domain helical region is interacting with the portal. Using coiled coil prediction algorithms, the 
first and second predicted helices have a high probability of making coiled coils 
(http://embnet.vital-it.ch/software/COILS_form.html). The 2nd helix mutations were all able to 
produce proheads; a few were able to expand and crosslink to create head particles. Therefore, 
these mutations do not affect the ability of the capsid protein to fold or interact with each other 
because proheads were made. In some cases, the proheads were able to be processed correctly by 
the protease and produce heads.  
An interaction between the capsid protein and the portal is not required for HK97 capsid 
assembly in vitro. However, in order to form functional phage particles, one portal must be 
incorporated into a capsid. We believe this can be achieved if the portal complex acts as a 
nucleator of assembly. The delta domain is responsible for binding to the portal to begin capsid 
assembly. Without a portal, DNA packaging into the capsid is impossible, which would explain 
the lack of complementation by these particular mutants in the spot tests. L43R, G54Y, and 
E61A showed a protease incorporation defect in addition to the portal defect. LIM 49, a four 
amino acid insertion in the 2nd predicted helix also produced a double portal and protease defect. 
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This slight elongation of the delta domain could have disrupted the structure of this region of the 
delta domain, thus preventing proper interactions with the protease and portal. L43R, G54Y, and 
E61A may be affecting the delta domain to prevent an important protease binding site, or could 
be affecting the secondary structure so that the delta domain is not able to function correctly. 
Along with determining that the delta domain plays an important role in portal incorporation, we 
learned more about how the portal itself affects assembly. As the initiator, the portal aids in 
proper capsid assembly, and ensuring that all capsids contain one and only one portal. When the 
portal is present, it can act as a docking base for hexamers to assemble around, and once this 
interaction is made, additional capsomers can add more easily and quickly, while bringing in the 
protease to complete a functional Prohead I. We learned through point mutations, that the portal 
also enhances the rate of assembly and maturation. In certain mutants, like K63A, and E363A, 
the presence of the portal allowed for complete mcp cleavage. K63A can only cleave the mcp 
when the portal is present. E363A cleaves fully when the portal is present. One explanation is 
that the portal causes an increased rate of capsid assembly, allowing the incorporation of active 
proteases, which have not had time to degrade before assembly is complete. The delta domain 
plays many roles in capsid assembly including protein solubility, capsid geometry, and capsid 
size. Now, we have learned that this dynamic N-terminal extension of the capsid protein is also 
responsible for ensuring proper portal incorporation during capsid assembly.  
K63A is an interesting mutation, as the mcp is only processed when the portal is present. 
We know that this mutation has the potential to cleave and mature, but this process is blocked, 
unless the portal is there. This mutation does not block the binding and interaction between the 
protease and the delta domain. Perhaps this point mutation affects the delta domain conformation 
so that the protease is unable to activate or cleave at necessary points. There are estimated to be 
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60-120 copies of the protease inside the capsid. There are 60 hexamers in a T=7 HK97 capsids; it 
is possible that one or two proteases are binding to each hexamer during shell assembly. When 
the portal is present, we believe that the capsomers assemble around it, so the portal would be 
surrounded by five hexamers. Perhaps these capsomers are bound to proteases and now the extra 
density of the portal has pushed the delta domains into a less sterically hindered conformation. 
Perhaps now, the proteases bound to these specific delta domains can activate or reach necessary 
cleavage sites and begin the cleaving process, starting a chain reaction of delta domain 
processing. It is very interesting that proper assembly depends on many different factors and 
precise protein interactions. Thus, in some cases, protease activity depends on the portal. 
The structural integrity of the delta domain is very important for its function. Q38P 
introduced a proline, a small residue usually found in flexible and bent regions of a protein. 
Q38P is located near the beginning of the 2nd predicted helical region. When the secondary 
structure of the delta domain was disrupted by this proline, the protein was still able to produce 
proheads, but the mcp was unable to be cleaved. Further tests showed that this mutation was 
defective in both portal and protease incorporation. The changes that this mutation made in the 
structure of the delta domain prevented it from appropriately binding to the proteins that are 
crucial for capsid maturation and function. This shows that the structure of the delta domain 
plays an important role in its function. As shown in Chapter 2 with the ‘hinge’ deletion mutants, 
and this Q38P point mutation, disturbing the delta domain structure prevents proper protein-
protein interactions.  
Our biochemical analyses of the delta domain provides evidence that this domain is 
important for portal incorporation, and specifically that the 2nd predicted helix of this domain is 
mainly responsible for this interaction. The identification of a 2nd site suppressor in the portal 
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gene has provided us with genetic evidence to support our mutational assays. Using the portal 
incorporation defect mutant, A65E, in the delta domain, we were able to create viable phage that 
contained a 2nd site mutation in the portal gene, D135G. This result argues that there is an 
interaction between the corresponding regions of the portal and the delta domain that is 
important for portal incorporation during assembly. We can specuate on how this interaction 
occurs but will need more data to thoroughly understand how the portal and delta domain 
interact. For example: this suppressing mutation changed a charged residue to a small residue in 
the portal. The initial mutation created a negatively charged residue, which disrupted the current 
interaction between the portal and the delta domain, as two negatively charged residues would 
repel. Therefore, D135 mutated to a glycine, to keep this negative charge-small residue 
interaction between the delta domain and the portal.  The 2nd site suppressor suggests that the 2nd 
predicted helical region of delta domain is in close proximity to the portal.  
Genetically, we showed that there is some sort of interaction between A65E in the delta 
domain, and D135G in the portal. To test if this double mutation could rescue protein function in 
vitro, D135G and a double mutant, A65E/D135G were moved into plasmids containing the 
portal gene and tested in miniprohead preps. D135G (gp3) showed a partial cleavage defect, 
producing mostly uncleaved mcp. However, the cleaved mcp is functional and can assemble into 
viable phage particles because the complementation tests showed that D135G had WT 
complementation of protease and capsid gene amber phage. However, D135G did show a one 
log decrease in portal protein functionality. This charge change in the portal caused a slight 
decrease in the efficiency of the portal protein to complement phage with an amber mutant in the 
portal gene. This portal mutation could be slightly interfering with how the portal interacts with 
the capsid shell, which could interfere with assembly initiation, causing this slight decrease in 
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complementation efficiency. The double mutation allowed for WT levels of portal incorporation 
but also showed a cleavage defect with relatively equal amounts of cleaved and uncleaved 
protein produced. However, the double mutation showed WT complementation in phage with 
amber mutations in the portal, major capsid, and protease genes. Like D135G, the smaller 
amount of cleaved mcp were sufficient to form viable capsids. Compared to the single mutation, 
A65E, this double mutant rescued protein functionality. The presence of D135G rescued the 
defect, allowing the capsid protein to function properly and bind to incorporate the portal. This 
double mutant brought D135G complementation to WT levels and was therefore able to rescue 
both single point mutation defects. These results support our genetic data that residue A65 in the 
delta domain and residue D135 in the portal are in close contact inside the capsid.  
The portal sequence alignment and homology model created based on the C. diphtheria 
phage portal provides more evidence that this region of the portal could be making contacts with 
the delta domain. To further study the delta domain and the portal, we can model its interaction 
using available capsid density maps and crystal structures. The C. diphtheria phage portal crystal 
structure can be fit into the HK97 crystal structure to hypothesize what a portal containing HK97 
prohead might look like. Using this model, we can learn more about how the delta domains could 
be interacting with the portal. We can also make a hypothetical model based on the 
reconstructions of the Del 2nd Hinge T=7 and T=4 capsids. We can use this model to identify 
possible interacting points between the mcp and the portal. In Del 2nd Hinge, the mutant portal is 
elongated and structured as towers in these mutants, it would be interesting to see how a portal 
crystal structure would fit in and interact with mutant delta domains. We can compare how the 
delta domain interacts with a portal between mutant and WT capsids. By tracing in the sequence 
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in our models, we may learn more about how the delta domain functions as a regulator of capsid 
assembly.  
 
3.2.5 The N-terminal region plays a role in protease incorporation 
Del1, a deletion of 9 residues at the N-terminus of the delta domain was discussed in the 
previous Chapter. This deletion produced only a few Prohead I like particles and was unable to 
efficiently complement phage with an amber mutation in the capsid gene. This phenotype 
suggests a defect in protease incorporation, so this mutation was moved into a plasmid 
expressing the portal and the inactivated protease.  
Del1, a deletion of 9 residues in the N-terminus has defective protease incorporation 
Prohead I and/or Prohead II with portal capsids were used as controls. During purification, there 
were two bands present in the glycerol gradient, but only the top band samples were used for gel 
analyses. On the SDS gel, Del1 produced portal and uncleaved mcp bands. The mcp band was 
weak and there was no detectable protease band. Even when larger amounts of Del1 protein were 
loaded on the gel to match the Prohead I control, there was still no detectable protease protein 
(Figure 53A). On the agarose gel, Del1 produced only prohead dimer and prohead trimer bands; 
there were no prohead monomers (Figure 53B). A small deletion at the N-terminal region of the 
delta domain causes a protease incorporation defect.  I wanted to identify specific residues that 
were involved with this interaction between the delta domain and the protease. Four point 
mutations were made within the Del1 region: L6R, Q8A, I11F, and E12A. Two other mutations 
were made near the end of the first predicted helix: Q20A, and I29F. These residues were  
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Figure 53. Del1 is defective in protease incorporation 
 
Prohead prep samples were banded through a glycerol gradient and then pelleted in the ultracentrifuge in a Ti45 for 
2 hours at 4 °C. Del1 produced two distinct bands in the gradient: a top band, and a bottom band. A) On the SDS 
gel, Prohead I produced a portal, uncleaved mcp, and protease band. Del1 (top band sample shown only) produced a 
portal band and a much lighter uncleaved mcp. Even when a larger amount of protein was loaded to match the 
Prohead I control, no protease band was detected. B) Pelleted purified samples were run on a 0.9% agarose gel along 
with Prohead II and Prohead I controls. Prohead II produced proheads and heads. Prohead I produced proheads, 
prohead dimers, and trimers. The top band sample produced a strong prohead dimer with barely detectable prohead 
or prohead trimer bands. The bottom band sample showed a prohead dimer band and a stronger prohead trimer band. 
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targeted based on sequence alignments of the HK97 delta domain and other related delta 
domains. Conserved hydrophobic residues were mutated to a completely different residue which 
was not found not found elsewhere in the alignment at that site (Figure 31 and R. Duda 
http://gigapan.com/gigapans/b806a9da80b4a66bcb1dd1b273d5b7a4/). The goal was to produce 
the biggest change possible to affect capsid assembly.  
These N-terminal mutants were in a plasmid, pVP1, which is similar to the pV0 plasmid 
and expresses the protease and capsid genes. The pellet, supernatant, and PEG precipitated 
fractions were electrophoresed on native agarose gels and SDS gels, and studied by TEM. The 
functionality of each mutant protein was also tested using spot complementation assays. On the 
agarose gel, WT produced prohead and heads bands, which are mostly in the supernatant and 
PEG fractions, as expected. L6R produced proheads and heads, but at less than WT levels. Q8A, 
I11F, E12A, and Q20A produced proheads and heads. I29F produced less than WT levels of 
proheads and heads (Figure 54A).  On the SDS gels, WT supernatant and PEG fractions showed 
mostly cleaved mcp. L6R, Q8A, I11F, E12A, and Q20A also produce mostly cleaved mcp in 
supernatant and PEG fractions like WT. I29F produced a large uncleaved mcp band in the pellet 
fraction, along with small amounts of cleaved and uncleaved mcp in the supernatant and PEG 
fractions (Figure 54B). In the spot complementation assays, L6R, I11F, E12A, and Q20A were 
able to complement phage with amber mutations in their capsid gene and protease gene, like 
WT. Q8A and I29F, however, were 1 log down in capsid gene amber phage complementation 
(Table 1).  Electron micrographs showed that these mutations were able to produce WT like 
proheads and heads. Some capsids are damaged or broken, which is common from the crude 
purification methods of miniprohead preps (Figure 55). 
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Figure 54. Miniprohead prep results of point mutations in the N-terminus of the delta domain. 
 
A) Pellet, supernatant, and PEG fractions were collected and run on a 0.9% agarose gel. WT control produced 
proheads and heads. L6R produced lower than WT levels of proheads and heads. Q8A, I11F, E12A, and Q20A 
produced W like results. I29F produced less than WT levels of proheads and heads. B) Sample fractions were 
prepared and run on SDS gel, and stained with coomassie. WT control produced mostly cleaved mcp, which mostly 
ended up in the supernatant and PEG fractions as expected. L6R, Q8A, I11F, E12A, and Q20A produced similar 
results to WT. I29F produced mostly uncleaved mcp in the pellet fraction. I29F produced very light uncleaved and 
cleaved mcp in the supernatant and PEG sample lanes. 
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Figure 55. Representative EM images of mutant samples from miniprohead preps. 
 
WT Prohead I is used as a comparison control. PEG samples were diluted in 1x calorimetry PBS, stained with 1% 
uranyl acetate, and imaged. All mutants produced prohead and head like particles. These crude purification samples 
usually contain some broken capsids and background material from cell debris. All images taken with 56,000x 
magnification. Scale bar: 100 nm. 
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I29F shows a protease incorporation defect 
To further characterize these mutants, they were moved into a plasmid that expressed the portal 
and inactivated protease genes to test for portal or protease incorporation. The PEG samples 
from the miniprohead preps were further purified by pelleting in the ultracentrifuge. Prohead II 
and Prohead I were used as controls. On the SDS gel, L6R, Q8A, I11F, E12A, and Q20A 
produced portal, uncleaved mcp, and protease bands. I29F produced portal and uncleaved mcp 
bands only. There was no protease band detectable, indicating a protease incorporation defect. 
I29F also produced less protein than the other mutants (Figure 56A). On an agarose gel, L6R 
produced a very light prohead band, a strong dimer band, and a weak trimer band. Q8A, I11F, 
E12A, and Q20A produced strong prohead and prohead dimer bands, along with weak trimer 
bands. I29F barely produced any protein represented by a weak prohead and prohead dimer 
bands (Figure 56B). These assays showed that these N-terminal mutants are able to incorporate 
the portal during assembly and have mostly WT like phenotypes. However, I29F has a protease 
incorporation defect.  
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Figure 56. N-terminal point mutants expressed with the portal and inactivated protease. 
 
After the miniprohead prep, the PEG fractions were further purified by pelleting in the ultracentrifuge in the Ti80 for 
42 minutes at 41,000 rpm in the cold. Prohead II and Prohead I containing portals were used as controls. These 
control samples were older samples, which explains the weaker bands and the larger number of mcp degradation 
products in the P I lane (the smear and multiple light bands underneath the mcp)  A) Samples were prepared for SDS 
gels. Prohead II showed a portal band and the cleaved mcp band. Prohead I showed a portal, an uncleaved mcp, and 
a protease band. L6R, Q8A, I11F, E12A, and Q20A produced portal, uncleaved mcp, and protease bands. I29F 
produced a portal band, an uncleaved mcp band (which is at lower levels than the others) and no protease band. B) 
Pelleted PEG samples were run on a 0.9% agarose gel. Prohead II produced proheads and heads. Prohead I produced 
proheads and prohead dimer bands. L6R produced a small amount of proheads and mostly prohead dimers and 
trimers. Q8A, I11F, E12A, and Q20A produced strong prohead, prohead dimers, and trimer bands. I29F produced 
very low levels of proheads and prohead dimers, indicated by the weak bands in the gel. 
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LIM 20 shows a protease incorporation defect 
LIM 20 is a mutation located in the N-terminal region of the delta domain that was shown in 
Chapter 2 to have a cleavage defect and only made Proheads. This mutation was moved into the 
portal and inactivated protease plasmid and tested for incorporation defects. LIM20 produced 
three bands in the glycerol gradient, which were all used for gel analysis. Prohead I and Prohead 
II with portal were used as controls. On the agarose gel, the LIM 20 top band produced mostly 
proheads, and a light dimer band. LIM 20’s middle band produced a strong dimer band and 
weaker prohead and prohead trimer bands. LIM 20’s bottom band produced a strong trimer band, 
and weaker monomer and dimer bands (Figure 57A). On an SDS gel, all of the LIM 20 bands 
produced portal protein and uncleaved mcp. The top band had a weaker portal band than the 
other two band samples. There was no protease protein detected, indicating that LIM 20 has a 
protease incorporation defect (Figure 57B).  
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Figure 57. Prohead Prep expressing LIM20 with the portal and inactivated protease. 
 
In the glycerol gradient, LIM20 separated into three protein bands: top, middle, and bottom bands. Prohead I and 
Prohead II containing portals were used as controls. A) Samples were prepared and run on SDS gels. Prohead II 
produced portal and 31 kDa cleaved mcp. Prohead I produced portal, full length uncleaved mcp, and inactivated 
protease bands. The top, middle, and bottom bands of LIM20 contained portal and uncleaved mcp bands. The portal 
band is weaker in the top band than the other fractions. LIM20 samples did not produce any detectable protease 
bands. B) Purified samples were loaded on a 0.9% agarose gel. Prohead II produced proheads and heads. Prohead I 
produced proheads, prohead dimers, and trimers. The top band produced mostly proheads, and some prohead 
dimers. The middle band produced mostly prohead dimers, with weak prohead and prohead trimer bans. The top 
band produced proheads, dimers, and trimers, with the trimer band being the strongest. 
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3.2.6 Discussion 
Mutational analyses of the N-terminal region of the delta domain showed that it plays a critical 
role in interacting with the protease to ensure proper incorporation during assembly. I have 
identified three mutations in the N-terminal predicted helix which cause a defect in protease 
incorporation. Del1, a deletion of amino acid residues 4-13, LIM20, a four amino acid insertion, 
and the point mutation I29F, were only able to produce proheads due an inability to incorporate 
the protease proteins. LIM20 could have disrupted the secondary structure of the delta domain 
and changed how the delta domain can interact with the protease. I29F could have blocked a 
critical binding site that the protease needs to bind with the delta domain, or the assembly 
process could have been slowed, so that by the time the proheads were completed, the protease 
has degraded. These mutations showed that disruptions to the N-terminal helical region affect the 
delta domain’s ability to interact with the protease during assembly.  
The native agarose gel data of Del1 expressed with the portal and inactivated protease 
showed the absence of prohead monomers. This meant that practically all of the proheads 
assembled with the portal. As mentioned earlier, our HK97 expression system is very efficient in 
producing proheads, and the portal is not required for capsid assembly and maturation. The fact 
that almost all of the Del1 capsids contained a portal showed that assembly for this mutant is not 
as efficient as WT, that the portal was needed to initiate capsid assembly. In the earlier 
biochemical tests, this mutant was able to produce a small amount of proheads without the 
portal. However, when the portal was present, there were more proheads made because assembly 
was nucleated more efficiently. All of the proheads incorporated the portal because they needed 
it as an initiator. This supports the idea that the portal can enhance capsid assembly. There is no 
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structure available for the HK97 protease, but secondary structure prediction programs predict 
that the C-terminal region of the protease is -helical. Perhaps the N-terminal region of some of 
the delta domains are making coiled coil interactions with the C-terminal region of the protease. 
This interaction is crucial for protease-delta domain binding, which allows for ~120 copies of the 
protease to be brought into the growing capsid shell. 
 To further delve into Del1, I made specific point mutations within the deleted region to 
identify specific points of contact between the delta domain and the protease. The point 
mutations L6R, Q8A, I11F, E12A, and Q20A produced WT like Proheads, which could cleave 
and mature into Head particles. They also produced functional capsid protein, which could 
assemble into infectious phage particles. Only Q20A showed a one log decrease in capsid gene 
complementation. I was unsuccessful in pinpointing any particular residues in the Del1 region 
that were responsible for protease incorporation. However, L6R showed a slight defect in capsid 
assembly efficiency. In a majority of the biochemistry assays, L6R showed WT like phenotypes. 
However, when this mutant was expressed in the portal and inactivated protease plasmid was run 
on a native agarose gel, there was a strong prohead dimer band, but a very light prohead 
monomer band. As with the Del1 mutation, this phenotype indicated that a majority of the 
proheads contain portal protein. When WT prohead with portal and inactivated protease is 
expressed, efficiency is good enough that the portal is not required to initiate capsid assembly. 
We estimate that about 50% of the capsids produced under these conditions are portal-less in the 
WT background. By producing more prohead dimers than prohead monomers, L6R seems to be 
most efficient when the portal is present. L6R can assemble like WT without the portal, but with 
the portal to initiate, assembly occurs more efficiently. This mutation is another example of our 
hypothesis that the portal, as an initiator of assembly, enhances the assembly process.  
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3.3 DIFFERENT REGIONS OF THE DELTA DOMAIN PLAY DIFFERENT ROLES 
IN CAPSID ASEEMBLY 
The biochemical and genetic tests of delta domain mutations have shown that this region of the 
HK97 capsid protein plays multiple functional roles during capsid assembly.  The full length 
delta domain is required for capsid protein solubility, suggesting that this domain is acting as a 
sort of chaperone to ensure proper capsid protein folding. Even small length deletions and four 
amino acid insertions caused defects in protein solubility and functionality. A deletion of 7 
residues, Del 2nd Hinge, was a very interesting mutation, in that it was able to produce mutant 
capsids of different sizes with triangulation numbers of T=7 and T=4. This deletion was made in 
a predicted ‘hinge’ region in between two predicted -helices. When these capsids were 
reconstructed, we were able to see more stable and elongated delta domains compared to the WT 
Prohead I density map. With further modeling and fitting with these mutant capsids, we can learn 
more about how the delta domain is structured inside the capsid.  
The delta domain is able to affect the size and shape of the capsid. Point mutations in the 
C-terminal region of the delta domain caused abnormal and tube like structures to form. In other 
phage scaffolding proteins, the C-terminal regions interact with the capsid shell. In HK97, the C-
terminal end of the delta domain is attached to the rest of the capsid shell subunit. Therefore, 
changes made in this region can have a direct effect on how the rest of the capsid protein is 
structured. Aside from capsid protein expression, capsid size and geometry, the delta domain is 
also involved with interacting with other proteins that are required for proper capsid assembly. 
The phage-encoded protease is required to be present inside the capsid, and once assembly is 
complete, cleaves the delta domain and itself into smaller peptides, which escape through pores 
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in the capsid. Without the protease, the capsid would not be able to mature. Previous capsid 
assembly experiments showed that when the C-terminal end of the HK97 protease was fused to 
GFP, assembled proheads fluoresced due to the incorporated GFP (Duda et al, unpublished). 
This suggests that the C-terminal region of the protease interacts with the major capsid protein 
during assembly. We have shown that the protease interacts with the N-terminal region of the 
capsid protein, the delta domain, to incorporate into the capsid. We have showed that it is mostly 
the N-terminal region of the delta domain that is responsible for this role. The portal is another 
important protein required for capsid assembly. Without the portal, no DNA packaging and tail 
attachment can occur. Mutational analyses have also shown that the delta domain is important 
for portal incorporation. Specifically, it is the 2nd predicted helical region, or the middle of the 
delta domain, that plays this portal incorporation role.  
It is fascinating that these roles correlate to different regions of the delta domain. Figure 
58 shows a predicted model of the delta domain with a summary of assembly defects and how 
they map to different regions of the domain. The N-terminal region of the delta domain likely 
interacts with the C-terminal region of the protease. The 2nd predicted helical region of the delta 
domain likely interacts with the portal. The C-terminal region of the delta domain likely interacts 
with the rest of the mcp, ensuring proper capsid size and geometry. This multifunctional 102 
amino acid extension of the capsid protein is able to fulfill all of these scaffolding-like roles 
during assembly. While some specific residues play important parts in the delta domain’s 
function, it is the structure of the delta domain- its helical nature, its ability to form coiled coils, 
its flexibility - which allows it to function and coordinate the interaction of different types of 
proteins during the initial stages of capsid assembly.  
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Figure 58. Predicted Model of the Delta Domain shows its multiple functional roles in capsid assembly. 
 
Different regions of the delta domain plays different roles. This model shows the three predicted helical regions of 
the delta domain. The first two helices are modeled as being in a coiled coil interaction. Lethal mutations are 
highlighted throughout the delta domain. The delta domain plays an important role in capsid protein solubility, as 
demonstrated by the deletions studied in Chapter 2. The N-terminal region (yellow mutants) plays a role in protease 
incorporation. The 2nd predicted helical region (red and blue mutants) plays a role in portal incorporation, with 
some protease incorporation defects. The C-terminal region (gray mutants) plays a role in ensuring proper capsid 
geometry. The Del 2nd Hinge mutation is highlighted with a green box. This deletion is in between the 2nd and 3rd 
predicted helices and also showed capsid geometry and size defects. 
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Possible Future Directions 
The delta domain has been a fascinating object of study. It is exciting to learn that this small 
peptide plays so many roles in assembly. Del 2nd Hinge was a very interesting mutation provided 
some support that the delta domain plays some role in capsid size determination. I think it would 
be very interesting to try and make a similar deletion in other phage capsids that contain the 
HK97-like fold. For example, D3 or Phi1026b are T=9 capsids that have the HK97-like fold. If 
we deleted a homologous region in their delta domains, would it also produce different sized 
capsids? While I have made some different sized deletions with this domain, I have not made 
extensions. I think it would interesting to see if we can increase the capsid size or change its 
shape by extending regions of the delta domain, particularly the predicted helical regions. Other 
possible directions are discussed briefly in the appendices. The spokes that we see in the WT and 
mutant capsids have always interested me. It was fascinating that the different types of capsids 
showed different patterns of spoke densities and weakness. It seems that the stability of the 
spokes depends on where it is located inside the capsid. Pentamer spokes always seemed to be 
more stable than hexamer spokes. While they are made of the same subunit, they are in slightly 
different conformations and must be able to make different interactions that we see in the skewed 
and symmetrical hexamers and pentamers. It would be useful to be able to pinpoint the amino 
acids that make up these densities. Delta domains and scaffolding proteins are responsible for 
interacting with a number of proteins to build a macromolecular complex. Their ability to be 
stable and structured in certain cases, and flexible in other cases show us just how versatile a 
small protein, or portion of a protein can be.  
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4.0 MATERIALS AND METHODS 
Expression plasmids 
The expression strains are E. coli BL21(DE3)plysS (Studier et al. 1990). HK97 plasmids contain 
a T7 promoter that can be induced with lactose or IPTG. These strains are used for 
(mini)prohead preps and complementation tests. Plasmids are based on the expression vector 
pT7-5 (GenBank: AY230150). The WT HK97 plasmid, pV0 (pT7-Hd2.9) contains full length 
genes 4 and 5, and a portion of gene 3. pV0SacI contains the same genes as pV0 but contains a 
SacI restriction site in the beginning of gene 5. Plasmid pVP1 is similar to pV0 in expression. 
pVB has the protease gene knocked-out. Mutations of interest are made and sub-cloned into 
either pV0 or pVP1 expression vectors. Sequences are verified using Genewiz. These plasmids 
were generally used for testing and screening new mutants for assembly defects. pVP0 contains 
genes 3, 4, and 5. pVP0 g4 (H65A) contains genes 3, 4, and 5, but has an inactivated protease 
due to the point mutation H65A. This plasmid is typically used to test for portal and protease 
incorporation (Robert L. Duda, Oh, and Hendrix 2013; Oh et al. 2014) 
Site directed mutagenesis 
Mutations were made using PCR and fragment ligation (Adereth et al. 2005) or with the Q5 site 
directed mutagenesis kit (New England BioLabs). N-terminal and C-terminal fragments were 
made using 2 sets of primers. One of the fragments would carry the base change(s) to make the 
mutation. Also, optionally, a silent mutation was also included near the point mutation to allow 
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for later identification when necessary. The two inner primers were phosphorylated on their 5’ 
ends with T4 Kinase. Phusion polymerase was used in the PCR reactions of the upstream and 
downstream fragments before they were extruded from a 0.8-1% agarose gel. The fragments 
were ligated using NEB Ligase for 1 hr at RT or 20-30 minutes at 16-18 ˚C in an ultrasonic 
waterbath. A 2nd round of PCR was done utilizing the two outer primers. This full length 
fragment was then digested using SacI and DraIII enzymes and then ligated with the HK97 
expression vector fragment.  
 The mutant plasmid was transformed into DH10b competent cells and allowed to recover 
in 1 mL SOC media at 37˚C degrees for at least 30 minutes. Cells were plated on LB amp50 
plates, and incubated overnight at 37˚C. Plasmids were collected using the Qiagen miniprep kit 
and sent to Genewiz for sequencing to ensure the correct mutation was present. 0.3 uL of 
plasmid and 0.3 uL of plysS plasmid were transformed into BL21(DE3) competent cells and 
allowed to recover in 1 mL SOC media at 37 ˚C degrees for at least 30 minutes before plating on 
LB amp50 cam25 plates. 
 
Miniprohead preps 
 
An overnight culture of expression cells are grown in MDG (non-inducing media) (Studier 
2005). The culture is diluted into 1.5 mL TYM5052 (autoinduction media) with 50 ug/mL 
ampicillian and 25 ug/mL chloromphenicol and shaken at 300 rpm at 37˚C for 24 hours. The cell 
pellets are suspended in Lysis buffer (50 mM Tris-HCl pH 8.0, 0.008 M EDTA pH 8.0) and 1% 
X100-Triton, frozen in dry ice, and thawed at room temperature. 1 M MgSO4 and 1mM DNase 
was added. The cells were spun in a table top centrifuge at 14 K rpm for 10 minutes in 4 C. The 
supernatant was divided into two tubes: one supernatant and one for PEG precipitation (150 uL 
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each). 150 uL of 20% PEG was added to the PEG tube and incubated on ice for at least 20 
minutes. The PEG samples are spun in a table top centrifuge at 14 K rpm for 10 minutes in 4 C. 
The supernatant is removed and the PEG pellet is gently resuspended in 150 uL Buffer G. The 
sample was separated into three fractions: a pellet, supernatant, and PEG precipitate. The 
remaining pellet is suspended in 300 uL of Buffer DL.  
 In some miniprohead preps, the entire supernatant was PEG precipitated. This sample 
would then be concentrated in the ultracentrifuge by spinning in the Ti80 for 42 min at 41K rpm 
in the cold 
 
Prohead preps 
 
Overnight cultures are diluted 1:500- 1:2000 in LB amp50cam25 and grown at 37˚C at 300 rpm 
until the OD550~0.4. 0.4 mM IPTG was added and the cells were induced overnight at 28˚C. 
Cells were pelleted and resuspended in lysis buffer (50 mM Tris HCl PH 8.0, 5 mM EDTA (pH 
8.0). Triton X-100 was added to 0.4% to cells were cycled between cold and warm (22-24˚C) to 
aid in lysis. MgSO4 is added to 7.5 mM and DNase I is added to 20 ug/mL and the cells are 
incubated at warm temp to reduce the viscosity. Cell debris is pelleted by low speed 
cenrifugation at 10K, 10-15 minutes. The supernatant is PEG precipited by adding NaCl to 0.5 M 
and PEG 8000 (6000) to 6% (w/v) and held in ice for at least 20 minutes. The PEG precipitate is 
pelleted and gently resuspended in TKG50 (20 mM Tris HCL pH 7.5, 50 mM Potassium 
Gluterate). Another spin is done to further purify the PEG sample.  Proheads are diluted and 
pelleted by ultracentrifugation in the Ti45 at 35K rpm for 2 hours in the cold. The pellets were 
resuspended in TKG50 buffer. The insoluble material is removed by spinning at 8K rpm for 10 
minutes. The remaining supernatant is run through a 10-30% (v/v) glycerol gradients for 1.75-2.5 
hours in the cold. The prohead band(s) were pulled from the gradient and dialyzed against 5 mM 
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Tris pH 7.5 at room temperature for an hour. Ion exchange chromatography was performed using 
an HQ20 anion exchange. Peak fractions were collected and concentrated by ultracentrifugation 
at 35K rpm for 2 hours in the cold. The pellets are covered in a small volume of Buffer and 
allowed to resuspend overnight at 4˚C.  
In some prophead preps, the dialysis and chromatography steps were replaced by 
pelleting in the Ti45 at 35K rpm for 2 hours in the cold. The pellets were resuspended in a small 
volume of TKG50 buffer overnight at 4˚C and syringed filtered.  
 
SDS Gel Electrophoresis 
 
For miniprohead preps, 10 uL of samples were diluted in 215 uL 5 mM Tris pH 7.5 buffer. 
Protein was precipitated with 25 uL of 10% TCA, 2 mg/mL sodium deoxycholate (DOC) or 10% 
TCA and incubate on ice for 10-20 minutes. The samples are spun at 14K rpm in the cold for 10 
minutes. Samples were washed with acetone, pelleted, vacuum dried, suspended in 1x SDS 
sample buffer (Laemmli 1970), and boiled for 2.5 minutes. Samples were electrophoresed in 
12% low-crosslinking SDS polyacrylamide gels (33.5% (w/v) acrylamide/0.3% (w/v) methylene 
bisacrylamide). Gels with samples containing portal and/or inactivated protease were run on 12% 
SDS gels with double the amount of bis-acrylamide (30% (w/v) acrylamide/1.6% (w/v) 
methylene bisacrylamde) (Laemmli 1970) and stained with Coomassie Brilliant Blue R250.  
 
Native Agarose Gel Electrophoresis 
 
Protein samples are diluted with TAMg buffer dye-glycerol mix (40 mM Tris base, 20 mM 
acetic acid pH 8.1, 1 mM magnesium sulfate) and run on 0.8-0.9% agarose gel. Gels are 
electrophoresed and stained with Coomassie Brilliant Blue R250 stain (Duda, Hempel, et al. 
1995).  
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Transmission Electron Microscopy 
Samples were applied on carbon/formvar grids (400 mesh, Ted Pella, Redding, CA) (Grids were 
glow-discharged before use) and rinsed with water before staining with 1% uranyl acetate. 
Micrographs were taken using a Morgagni 268(D) Electron Microscope (FEI, Eindhoven, 
Netherlands) at 56000x magnification (one sample at 86000x). 
 
Reconstruction of Del 2nd Hinge Capsids 
 
Sample grids were frozen using a Vitrobot. Images were taken in the Polara FEI cryo-electron 
microscope using a Falcon II direct electron detection camera. About 1,000 images were taken 
from 10 grid squares. Capsids were manually selected as T=4 or T=7 sized using the x3d 
program. Ultimately, 58304 small particles and 1616 T=7 sized particles were collected. An 
average icosahedral map of each sample was calculated using AUTO3DEM (Yan, Sinkovitis, 
and Baker 2007).  
 
Complementation Spot Tests 
 
Bacterial lawns were made form a mixture of overnight cultures of the BL21(DE2)plysS 
expression mutant strains (BL21, ~1% lactose (to induce gene expression) and soft agar on an 
LB (amp50 cam25) plate. Dilutions (10
9 pfu/mL to 104 pfu/mL) of WT phage, am1 (gene 5 amber 
mutation), amU4 (gene 4 amber mutation), amC2 (negative control amber mutation), and 
sometimes am3 (gene 3 amber mutation) were spotted as 4 uL spots. Plates were incubated at 
37˚C overnight. WT pV0 was used as a positive control. Relative complementation efficiency is 
calculated. A score of 10 was assigned for a clear spot and a score of 3 was assigned for a partly 
clear spot and the values are multiplied together. For example, WT usually produces 5 clear 
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spots and one partly clear spot so it’s score would be 10 x 10 x 10 x 10 x 10 x 3 = 3 x 105. The 
mutant complementation efficiency score is divided by the WT control to get the relative value.  
 
Making and selecting for HK97 mutant prophage  
DT005 cells (Tso 2010) are grown up in 30˚C overnight shaking at 300 rpm. The overnight 
culture was then diluted 1:100 in 30 mL SOB (LB + 2.5 mM KCl, 10 mM MgCl2, 10 mM 
MgSO4) and 100 ug/ul ampicillin and shaken at 300 rpm in a 30˚C waterbath until O.D550 ~ 0.4. 
There are two samples prepared-induced and uninduced samples. The induced samples contained 
10 mM L-arabinose. The cultures were cooled in an ice water slurry for about 10 minutes and 
pelleted at 4500 g for 7 minutes at 4˚C. The pellet was initially gently suspended in 1-2 mL ice 
cold dH20. Then 28 mL of ice cold water was added and the cells are pelleted again. Each time, 
the pellet was gently suspended in a small volume, before bringing up the volume. The 
sequential wash volumes were 10, 5, and 1 mL. The 1 mL of cells were then pelleted in a cold 
microcentrifuge at max speed for 30 seconds and resuspended in 200 uL ice cold 10% glycerol.  
For transformation, 30-40 uL of cells are used. There are three test samples: Induced with 
DNA, Induced without DNA, and uninduced with DNA. The controls are used to show the 
background of cells. The cells are electroporated in 0.1 mm cuvettes and transformed with at 
least 200 ng of fragment DNA. The time constant should be greater than 5 ms. After 
transformation, the cells were diluted into 10 mL SOB amp100 and recovered by shaking in a 
30˚C waterbath for at least 4.5 hours or overnight. The recovered cells were then pelleted at 4500 
g for 3-5 minutes in the cold. The cells were gently washed in 1x minimal salts (M9 or M63) and 
1 mM MgSO4 and resuspended as previously described in 10, 5, and eventually 1 mL volumes. 
The final pelleting in 1 mL is repeated. 
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Cells are diluted 103, 104, and 105 and 100 uL is spread on selection plates. Plates are 
incubared at 30˚C overnight and then moved to 42˚C until pickable colonies appear, about 3-4 
days. Colonies are picked, resuspsended in 15 uL T1/10E buffer, and restreaked 6 per plate on 
DOG plates. This restreaking is to reduce the amount of DNA contamination that could be 
present from dead cells. These new plates are incubated at 42˚C for 3-4 days until colonies 
appear.  
 
2-DOG plates for galK recombineering 
2 grams of 2-deoxygalactose is dissolved in 200 mL 5x M63 or M9 salts. 100 uL of 0.1 g/mL 
thiamine and 5 mL 40% glycerol is added before sterile filtering. This mixture is kept warm in a 
55˚C waterbath and added into 1 L LB agar (sterilized). 4 mL of 0.5% Uracil and 10 mL of 0.1 
M MgSO4 are added last.  
 
Bochner-Maloy plates for tetR recombineering  
Flask A: 12 g agar, 4 g tryptone, 4 g yeast, 40 mg chlorotetracycline, 400 mL water 
Flask B: 8 g NaCl, 8 g NaH2PO4, 400 mL water 
Flasks A and B are separately sterilized and allowed to cool. Fusaric Acid dissolved in DMF (9.6 
mg in 500 mL DMF) and 4 mL of 20 mM ZnCl2 is added to Flask B. Both mixtures are combined 
and poured. Best to use within 36 hours. (Bochner et al. 1980; Maloy and Nunn 1981) 
 
Colony PCR 
Using sterile toothpicks, individual colonies are picked and resuspended in 10-15 uL of T1/10E 
buffer in 96 well plates. As each colony is suspended in the 96 well plate, they are subsequently 
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spotted onto LB plates (grown overnight at 37˚C). The plates are UV sterilized for about 10 
minutes before use. PCR using ExpandHF or Phusion enzymes was performed in 10 uL (or 20 
uL) reactions. 4 uL (or 8 uL) of the colony were used. The primers were at concentration of 6 
uM. With tetR recombineering, a set of three different primers were used. Two different forward 
primers (one that was complemented to the HK97 sequence and one that complemented to tetR 
sequence) were used to different between a recombined and tetR fragment. The same reverse 
primer was used that bound to the HK97 sequence downstream of the recombination region. 
With galK recombineering, only one forward and one reverse primer were used. Samples 
underwent 30 cycles. 5 uL of sample were ran in 0.9% agarose gels. The gels were stained with 
0.5 ug/mL Ethidum Bromide and imaged with a UV camera. Samples containing the expected 
fragment size for our HK97 sequence (which had lost the marker sequence) were further tested 
using restriction digestion. 
 
Lysogen Streak Test 
50 uL of WT HK97 phage were pipetted in a line across an LB plate. A sample of the 
resuspended colonies were streaked across the line of phage and the plates were incubated 
overnight at 37˚C. A lack or lower level of colony growth after passing over the phage line 
indicated the presence of a lysogen, which prevented superinfection from the WT phage.  
 
Digestions to check for recombinants 
The mutations used to test for 2nd site suppressors/revertants were made with unique restriction 
sites to allow for identification. The colony PCR samples were digested in 10 uL reactions with 
their unique restriction enzyme for 2 hours at 37 ˚C. Digestions were run on 0.9% agarose gels 
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and stained with 0.5 ug/mL Ethidium Bromide. Colonies that showed a similar digestion pattern 
as the positive control were grown up from their overnight colony (from the LB plate) and frozen 
for glycerol stocks. 
 
Sequencing 
Fragments from the possible recombinant was made using PCR and sent to Genewiz for 
sequencing. The presence or absence of our mutation of interested was identified using the 
program Sequencher.  
 
Phage induction 
An overnight culture was grown from the frozen glycerol stock of our HK97 delta domain 
mutant lysogen. The overnight was diluted 1:60 into a 30 mL of LB and grown at 37˚C at 300 
rpm until the OD550~0.2. Cells were were spun down at room temperature at 6700 rpm for 7 
minutes and resuspended in 30 mL phage induction buffer (10 mM Tris-HCl pH 7.5, 5 mM 
MgSO4). 5 mL of sample were aliquoted into plates and exposed to UV light for 0, 5, or 10 
seconds. 5 mL of prewarmed 2x LB was added to each plated and moved to flasks. 
They were shaken (in the dark) at 37 C for 2 hours. A few drops of chloroform was added after 
1.5 hours to aid lysis. The cell debris is spun down at 7000 rpm for 10 minutes (I used the 15 mL 
centrifuge tubes from Corning®. The supernatants were used in plaque assays on LE392 cells. 
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Mutant WT  
complementation 
Protease amber 
complementation 
MCP amber 
complementation 
WT 1 1 1 
S2C 1 1 1 
L6R 1 1 0.5 
Q8A 1 1 0.1 
I11F 1 1 1 
E12A 1 1 1 
E28A 1 1 1 
I29F 1 1 0.1 
K37A 1 1 1 
Q38P 1 1 0.0001 
Q38A 1 1 1 
Q40A 1 1 1 
S41F 1 1 1 
L43R 1 0.01 0.001 
M44K 1 1 1 
Q47A 1 0.05 0.0001 
E48A 1 1 1 
T51A 1 1 1 
G54Y 1 0.1 0.001 
T55I 1 1 1 
T55F 1 1 1 
F58L 1 1 0.001 
D59A 1 0.1 0.001 
E61A 1 0.1 0.001 
Q62A 1 0.1 0.001 
K63A 1 0.001 0.001 
A65E 1 1 0.0001 
S66F 1 1 0.01 
F77S 1 0.1 0.001 
E83A 1 1 1 
L85R 0.1 0.0001 0.001 
L85V 1 1 1 
S88C 1 1 1 
W89A 0.1 0.0001 0.001 
W89Y 1 1 1 
D90A 0.1 0.001 0.001 
D90G 1 0.01 0.0001 
D90E 1 0.5 0.01 
K92A 1 0.5 0.01 
K92N 1 0.5 0.001 
F96L 1 0.01 0.001 
F96Y 1 1 1 
Table 1. Complementation Spot Test Results 
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Mutant WT  
complementation 
Protease amber 
complementation 
MCP amber 
complementation 
pNoDelta2 1 n/a 0.0001 
Del1 (4-13) 1 1 0.01 
Del2 (4-29) 1 1 0.005 
Del3 (4-50) 1 1 0.001 
Del4 (4-62) 1 1 0.001 
Del 1st Hinge 1 1 0.001 
Del 2nd Hinge 0.1 0.01 0.001 
LIM 20 1 1 0.01 
LIM 33 1 1 0.01 
LIM 49 1 0.01 0.0001 
LIM 82 1 0.0001 0.001 
Table 1. Complementation Spot Tests Results, continued 
 
 
 
Mutant WT phage 
complementation 
Portal amber 
Complementation 
Protease amber 
complementation 
MCP amber 
complementation 
WT 1 1 1 1 
A65E (gp5) 1 n/a 1 .0001 
D135G (gp3) 1 0.1 1 1 
D135G (gp3)/ 
A65E (gp5) 
1 1 1 1 
Table 2. Complementation Spot Tests of A65E and D135G 
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Mutant Spontan-
eous 
XL/tubes  
MCP 
Cleavage 
Agarose gel results Spot test –Does it 
complement?  
mcp                          protease                                                                                                      
amber                          amber 
Electron Micrograph Results Portal  
Incorporation 
Inactive 
protease 
binding
S2C No Yes Prohead, Head Yes Yes Proheads, Heads   
L6R No No Prohead, Head ½ log↓ Yes Proheads Yes Yes 
Q8A No No Prohead, Head I log↓ Yes Proheads Yes Yes 
I11F No No Prohead, Head Yes Yes Proheads Yes Yes 
E12A No No Prohead, Head Yes Yes Proheads Yes Yes 
Q20A No No Prohead, Head Yes Yes Proheads Yes Yes 
E28A Yes partial Prohead, Head Yes Yes Proheads, Heads   
I29F No No Light Prohead band 1 log↓ Yes Proheads Yes No 
K37A No Mostly Prohead, Head Yes Yes Proheads, Heads   
Q38P No No Prohead 4 log↓ Yes Proheads Little Little 
Q38A A little Yes Prohead, Head Yes Yes Proheads, Heads   
Q40A A little Yes Prohead, Head Yes Yes Proheads, Heads   
S41F No Partial Prohead, Head Yes Yes Proheads, Heads   
L43R No No Prohead 3 log↓ 2 log↓ Proheads, few tubes No No 
M44K No Mostly Prohead, Head Yes Yes Proheads, Heads   
Q47A No No Prohead, caps 4 log↓ 1½ log↓ Proheads Little No 
E48A No Partial Prohead, Head Yes Yes Proheads, Heads   
T51A No Mostly Prohead, Head Yes  Yes Proheads, Heads   
G54Y No Partial Prohead, Head 3 log↓ 1 log↓ Proheads, Heads Partial Yes 
T55I No Mostly Prohead, Head Yes Yes Proheads, Heads   
T55F No No Prohead, Head Yes Yes Proheads, Heads Yes Yes 
F58L No Mostly Prohead, head 3 log↓ Yes Proheads, Heads Partial Yes 
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D59A No Mostly Prohead, head 3 log↓ 1 log↓ Proheads, Heads Little Yes 
E61A No No Prohead 3 log↓ 1 log↓ Proheads Little No 
Q62A No Yes Prohead, Head 3 log↓              1 log↓ Proheads, Heads No Yes 
K63A No No Prohead 3 log↓ 3 log↓ Proheads Yes Yes 
A65E No Mostly Prohead, Head 4 log↓ Yes Proheads, Heads No Yes 
S66F No Yes Prohead, Head 2 log↓ Yes Proheads, Heads Partial Yes 
F77S Yes No Light Prohead band 3 log↓             1 log↓ Abnormal round structures   
E83A No Mostly Prohead, head Yes Yes Proheads, Heads   
L85R Yes No None 3 log↓             4 log↓ Abnormal round structures, 
some smaller than normal 
sized capsids 
  
L85V Yes Partial Little Prohead, 
Head 
Yes Yes Proheads, tubes, abnormals   
S88C No Partial Prohead, Head, 
capsomer 
Yes Yes Proheads, Heads   
W89A Yes  No None 3 log↓ 4 log↓ Round, abnormal open and 
closed structures, tubes - 
some kinked 
  
W89Y Yes Partial Little Prohead, 
Head 
Yes Yes Proheads, Heads, tubes, 
abnormals 
Yes Yes 
D90A Yes  No None 3 log↓ 3 log↓ Round, abnormal structures, 
mostly closed, tubes - some 
kinked 
  
D90G Yes No None 4 log↓ 2 log↓ Round, abnormal mostly 
closed structures; some 
capsids; some tubes 
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D90E Yes No Light Prohead 2 log↓ ½ log↓ Tubes, abnormals   
K92A 
 
No  Partial Prohead, Head, 
capsomers 
2 log↓ ½  log↓ Mostly Proheads and Heads, 
some partially assembled 
capsids, few  tubes 
Yes Yes 
K92N No Partial Prohead, Head, 
capsomer 
3 log↓ ½ log↓ Mostly Proheads and Heads, 
some partially assembled 
capsids, few  tubes 
  
F96L Yes  No None 3 log↓ 2 log↓ Some round, abnormal 
closed structures, mostly 
closed tubes (longer than 
other mutants) 
  
F96Y No Yes Prohead, Head Yes Yes Proheads, Head   
LIM 20 No No Prohead 2 log↓ Yes Prohead Yes No 
LIM 33 No No None  2 log↓ Yes Some small round structures, 
very few capsid like particle 
  
LIM 49 Yes(light) No Prohead 
(shifted slower) 
4 log↓ 2 log↓ Proheads No No 
LIM 82 Yes  No  None 3 log↓ 4 log↓ Round, abnormal structures, 
clumps  together 
  
pNoDelta1 No n/a None 3 log↓ n/a Inclusion bodies   
pNoDelta2 No n/a None 4 log↓ n/a Inclusion bodies   
Del1( 4-13) No No Prohead 2 log↓ Yes Proheads Yes No 
Del2 (4-29) No No None 2½  log↓ Yes Inclusion bodies   
Del3 (4-50) No No None 3 log↓ Yes Inclusion bodies   
Del4 (4-62) No No None 3 log↓ Yes Inclusion bodies   
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Table 3. Mutant Summary Table 
Extra Notes: 
 
Del1: requires portal for efficient assembly- almost every particle produced contains portal  
 
L6R produced more dimers than portal-less proheads when expressed with portal and inactivated protease on agarose gel 
 
LIM 20 + portal: 2 bands in gradient- top band is proheads, bottom band is a little bit of proheads and trypsin like cleavage products (24 and 18 kDa) S66F also 
showed digestion products (and ran slightly faster than others in agarose gel when expressed with portal and inactivated protease) 
 
K63A: only cleaves in the presence of the portal even though it can bind protease no matter if portal is present or not 
 
Does portal enhance processing/assembly? E363H and E363A are cleavage defect mutants, H makes tubes along with proheads. With the addition of the portal, 
E363A makes mostly cleaved proheads, but E363H still only has partial cleavage. Both are able to bind the portal. 
 
Del2ndhinge makes smaller than normal capsids (T=4) and some T=7 and mostly monsters 
 
K92A has partial cleavage defect. Incorporates portal and protease at higher than WT levels. In the presence of portal and inactivated protease, K92A is no 
longer able to produce proheads or heads and instead produces partially assembled shells (no closed capsids) and possibly a large number of portals (small round 
things visible in EM). Overexpression of portal causing assembly defect? 
Del1sthinge 
(S31-S36) 
No No None 3 log↓ 
 
Yes 
 
Inclusion bodies 
Del2ndhinge 
(G67-E73) 
Yes (light) No Prohead (runs 
faster) 
light normal 
Prohead band, caps 
in sup 
3 log↓ 
 
 
2 log↓  Few Proheads, mostly 
smaller than normal capsids 
(T=4), many abnormal 
structures 
No Partial 
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APPENDIX A 
A.1 INTERESTING AND DIFFICULT TO EXPLAIN DELTA DOMAIN 
MUTATION K92A 
A few mutations studied in the delta domain gave very interesting phenotypes that are difficult to 
explain. K92A was a useful control because it caused a cleavage defect. However, studies of 
K92A with the portal showed unexpected and difficult to explain results to show how important 
the delta domain is in capsid assembly and protein incorporation. K99E, K103L, and the double 
mutant K99E/K103L produced results that seem contradictory with regards to complementation 
test data but may show us that there is a particular order to the delta domain cleavage process. 
 
K92A has a cleavage defect 
Residue K92 resides in the C-terminal end of the delta domain, near the end of the 3rd predicted 
helical region. This mutation was made because we hypothesized that it resided in the spoke 
densities which lie against the internal surface of the capsid. We thought this charged residue 
could be involved in the 3 point spoke interactions at the 3 fold and quasi 3 fold symmetry axes. 
K92 was mutated to an Alanine and tested in our miniprohead preps. On the agarose gel, K92A 
produced proheads, heads, and capsomers (Figure A-1a). The presence of capsomers in the 
agarose gel shows that either assembly is less efficient than WT, or that the proheads are less 
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stable than WT and fall apart easily, or both. On the SDS gel, K92A showed partial cleavage as 
there are uncleaved and cleaved mcp bands present (Figure A-1b). K92A was about one log 
down in both capsid gene and protease gene amber phage complementation, suggesting a slight 
defect in protein functionality (Table 1). Electron micrographs of the K92A PEG sample show 
heads and proheads, as expected from the gel data. There were also very rarely, abnormal tube 
structures (Figure A-1c). The fact that this mutant produces both cleaved and uncleaved mcp 
makes this a useful control for SDS gel assays. K92 was also mutated to the uncharged polar 
group, Asparagine. From the biochemical and spot tests, K92N is phenotypically equivalent to 
K92A (data not shown). Perhaps this mutation has a cleavage defect because it is defective in 
protease incorporation, or assembly has less efficient so that the protease has degraded before 
capsid assembly is complete. It is possible that this mutation has blocked an important cleavage 
site from being fully accessible to the protease.  
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Figure A-1. K92A has a cleavage defect, and produces proheads, heads, and capsomers 
A) Pellet, supernatant, and PEG samples were run on agarose gels along with WT controls. WT produced prohead 
and head bands. K92A produced proheads, heads, and capsomers. B) Samples were precipitated with 10% TCA, run 
on a 12% acrylamide gel, and stained with commassie. WT produced cleaved mcp while K92A produced both 
cleaved and uncleaved mcp bands. C) The K92A PEG sample was diluted with 1/10 1x calorimetry buffer and 
stained with 1% uranyl acetate for transmission electron microscopy. K92A produced proheads, heads, and few 
abnormal particles. WT Prohead I is shown as a control. Scale bar: 100 nm. 
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A.2 K92A INCORPORATES HIGHER LEVELS OF PORTAL AND PROTEASE 
To further delve into the interesting properties of K92A, this mutation was sub-cloned into the 
portal and inactivated protease plasmid (pVP0 g4 H65A) and a miniprohead prep and 
ultracentrifuge purification was conducted to test for portal and protease incorporation. Figure A-
2a shows the agarose gel results of the pellet, supernatant, and PEG fractions of WT and K92A. 
WT produced proheads and heads while K92A did not produce any prohead bands. Instead, there 
was a fuzzy band that is strongly present in the supernatant and PEG fractions. Usually, when we 
see this type of fuzzy band in the supernatant fraction, this denotes the presence of capsomers. 
However, this is unique in that a fuzzy band is in the PEG fraction. Perhaps this is a combination 
of capsomers aggregated with abnormally assembled structures or abnormal assembly products.   
In the SDS gel, WT produced cleaved mcp while K92A produced uncleaved mcp as expected 
from the inactivated protease (Figure A-2b).   
The PEG samples were further purified by pelleting in the ultracentrifuge and run on 
native and denaturing gels. On the agarose gels, K92A showed a weak band that ran slightly 
slower than where prohead dimers run. There was also a slight smear above that band in the gel 
(Figure A-2c). In the SDS gel, the Prohead I and portal control produced portal, uncleaved mcp, 
and protease bands. K92A produced strong portal and protease bands. This mutant did not 
produce much capsid protein, so for the amount of capsid protein present, there is a high 
proportion of portal protein present (Figure A-2d). It is possible that the mutant assemblies are 
incorporating more than one portal, indicating the interaction between the capsid protein and 
portal have been altered.  
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Figure A-2. K92A is able to incorporate the portal and protease 
A). Pellet, supernatant, and PEG samples were loaded on a 0.9% native agarose gel. WT produced proheads and 
heads. K92A produced capsomers in the supernatant fraction and a fuzzy capsomer-like band in the PEG fraction. 
B) Pellet, supernatant, and PEG samples were run on a SDS gel.  WT fractions show cleaved mcp. K92A fractions 
show uncleaved mcp, which was expected as the protease is inactivated. C) The PEG sample from the K92A 
miniprohead prep was ultracentrifuged for further purification. PI containing portal was used as a control. On a 0.9% 
agarose gel, PI produced proheads and prohead dimers. K92A produced a slightly fuzzy band that runs slightly 
slower than WT prohead dimers. D) Samples from Figure B-7C were run on a SDS gel. P I with portal produced 
portal, uncleaved mcp, and protease bands. K92A shows similar bands. However, for the amount of mcp present, it 
is expressing a much stronger portal band than the control. 
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Figure A-3. Dilutions of K92A expressed with portal and inactivated protease 
 
In order to quantify the amount of portal and protease present with the K92A assemblies, different amounts were 
loaded along with a WT Prohead I sample on a SDS gel. K92A does not produce as much capsid protein as WT, but 
these lower levels of gp5 are accompanied by higher than WT levels of portal and protease incorporation. 
 
 
 
To study this interesting result further, I used gel band intensity analysis to compare the 
relative ratio of portal:mcp and protease:mcp between this mutant and WT. While this type of 
quantification is not always reliable, this will give us some information of the relative amount of 
portal proteins being incorporated into the capsid. A dilution series of this purified pVP0 g4 
(H65A) K92A sample was run on a SDS gel for band quantification. A sample of pVP0 g4 
(H65A) was loaded as a control (Figure A-3). The relative intensities of the portal, major capsid 
protein, and protease bands were quantified and are shown in Table 3. For the WT control, I 
halved the value for the mcp because not all of the WT capsids incorporate the portal from our 
expression preps (The quantified value is shown in parentheses). From our agarose gel assays, 
we estimate that about 50% of the capsids are portal-less (Duda, Maurer, Hendrix, unpublished). 
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In previous agarose gels I have shown that PI with portal and inactivated protease produces a 
prohead band, a prohead dimer, and sometimes a prohead trimer band. We estimate that about 
half of the proheads produced make up the dimer and trimer bands. If all the proheads 
incorporated the portal, we would expect to see only dimer and trimer bands. To estimate the 
amount of portal protein per capsid and protease protein per capsid, I took a ratio of their relative 
intensities. The ratios and the average ratio of the K92A mutant are shown in Table 4. From 
these relative intensities, K92A contains about 5-10x more portal than WT and about 5x more 
protease than WT.  
We can assume that for WT the relative band intensities represent the relative copies of 
proteins in a capsid. For example, the WT value for the portal band (0.0242) represents 12 copies 
of the portal and the value of the mcp band (0.4304) represents 415 copies of the capsid protein. I 
used the 20 uL K92A lane to compare with WT because this sample had the closest value of 
relative mcp intensity as WT (0.4405 vs 0.4304) (shaded in Table 3). With K92A, we can 
assume that 0.4405 represents 415 copies of the mcp. Therefore, we can assume that the portal 
band intensity of 0.2203 represents 118 copies (0.2203/0.0242= 9.1, ~9 x 12 portal proteins = 
118) of the portal. From the 20 uL sample, it seems that K92A contains 9 times the normal 
amount of portal protein. While these are simply crude estimations of the relative band 
intensities, we can see that K92A protein samples do indeed contain more portal and protease 
protein than WT.  
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Bands WT (6 uL) K92A (20 uL) K92A (10 uL) K92A (6 uL) K92A (4 uL) K92A (2 uL) 
Portal 0.0242 0.2230 0.1599 0.1352 0.1917 0.1874 
MCP 0.4304  (0.8608) 0.4405 0.5308 0.5481 0.4809 0.5097 
Protease 0.1150 0.3364 0.3093 0.3167 0.3275 0.3029 
Table 4. Relative Intensities of WT and K92A protein bands on SDS gel 
 
 
 WT 
(6 uL) 
K92A 
(20 uL) 
K92A 
(10 uL) 
K92A 
(6 uL) 
K92A 
(4 uL) 
K92A 
(2 uL) 
K92A 
average 
Portal: mcp 0.056 0.506 0.301 0.247 0.399 0.368 0.291 
Protease: 
mcp 
0.134 0.764 0.583 0.578 0.681 0.594 0.640 
Table 5. Ratios of portal:mcp and protease:mcp for WT and K92A protein bands on SDS gel 
 
 
The gel and band quantification data show that pVP0 g4 (H65A) K92A produces a larger 
amount of portal and protease proteins than WT. Does that mean that there each capsid has 
incorporated multiple portals? Can there be capsids with a portal at each vertex? What would we 
see under the TEM? Undiluted ultracentrifuge purified PEG samples were visualized using the 
electron microscope and the results were very interesting. Figure A-4 shows a comparison of 
K92A expressed without the portal (left image) and K92A with the portal and inactivated 
protease (right image). The presence of the portal and inactivated protease with this mutation has 
caused a drastic assembly defect. K92A with the portal and inactivated protease show very few 
proheads, but many capsomers, abnormal, partially assembled products (Figure A-4). Under 
higher magnification (86,000x), we can see very small round products, which we predict to be 
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portals (black arrows in Figure A-5). With this higher magnification we can also more clearly see 
4 dotted cube like products that are commonly seen in our protein preps (black triangles in 
Figure A-5). These cubes are the E2 components of E coli. 2-oxogluterate dehydrogenase or 
pyruvate dehydrogenase (Knapp et al. 1998; Hendle et al. 1995).  
 
  
 
Figure A-4. EM images of pV0 K92A (left) and pVP0 g4 (H65A) K92A (right) 
K92A expressed without the portal produces proheads and heads (left). When expressed with the portal and 
inactivated protease, there are no regular proheads formed. Instead, there were some irregular assemblies and broken 
shells. Samples were diluted 1/10 in 1x calorimetry buffer and stained with 1% uranyl acetate. Images were taken at 
56,000x magnification. 
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Figure A-5. Representative EM image of pVP0 g4 (H65A) K92A 
With the addition of the portal and inactivated protease, K92A produces irregular assemblies and broken shells. This 
higher magnification image shows more of the smaller objects. The arrows point to small round proteins which we 
believe to be HK97 portals. The black triangles are pointing to the E2 components of E. coli 2-oxogluterate 
dehydrogenase or pyruvate dehydrogenase. The sample was diluted 1/10 in 1x calorimetry buffer and stained with 
1% uranyl acetate. Image taken at 86,000x magnification. 
 
 
 
In HK97, overexpression of the portal can cause a loss in assembly efficiency 
(unpublished data, Duda and Maurer). K92A could be causing an overexpression of the portal, 
which is interfering with the nucleation event of capsid assembly. Perhaps capsids are beginning 
assembly around multiple portals, disrupting proper assembly, and causing the abnormal and 
partially assembled products visible in the EM. If this is the case, this shows that the balance of 
expressed capsid proteins is important for ensuring proper assembly. Is this mutation actually 
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causing more portal to be expressed from the plasmid? Or, are there really capsids with multiple 
portals which fall apart easily into what we visualize in the electron microscope? The images 
were taken about 3 days after the prep was made. It would interesting to see what a fresh sample 
of pVP0 (g4 H65A) K92A looks like in the EM. Other delta domain mutations described earlier 
like E363A, K63A, and Del1 show that the portal can enhance capsid assembly and maturation.  
To test if the presence of the portal could enhance K92A cleavage and assembly, this 
mutation was moved into a plasmid containing the portal and active protease. A miniprohead 
prep was conducted and pellet, supernatant, and PEG fractions were run on agarose and SDS 
gels. WT with portal was used as a control. On the agarose gel, K92A showed similar results as 
when it was expressed without the portal- it produced proheads, heads, and a fuzzy capsomer 
spot in the supernatant fraction (Figure A-6A). On the SDS gel, K92A produced cleaved and 
uncleaved mcp (Figure A-6B). For this cleavage defect mutant, the portal does not aid enhance 
capsid maturation. Complementation tests also show that there was no affect with the presence of 
the portal, this mutant is still slightly defective in protein functionality.  
 These assays show that the inactivated protease has an interesting effect on assembly. 
One future test would be to express K92A with the inactivated protease and no portal to see if the 
protease is incorporated when no portal is present. This would show if there is a dependence of 
protease incorporation on the presence of the portal. Also, if there is no portal expressed with 
K92A, would the abnormal and partial assemblies still be made? Somehow, the combination of 
the portal, this delta domain mutation, and an inactivated protease causes this abnormal 
incorporation of portal and assembly defects. 
  166 
Hopefully, further tests with this interesting mutation can explain why it has a cleavage 
defect, and also shed more light on how the delta domain affects and regulates assembly and the 
incorporation of proteins into the growing capsid. 
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Figure A-6. Miniprohead prep results of K92A expressed with portal (pVP0 K92A) 
 
WT with portal (pVP0) was used as a control. A) Pellet, supernatant, and PEG samples were run on a 0.9% agarose 
gel. WT produced proheads and heads. K92A produced proheads, heads, and a capsomer fuzzy spot in the 
supernatant fraction. B) On the SDS gel, WT produced cleaved 31 kDa mcp whereas K92A produced cleaved and 
uncleaved mcp. These results were similar to K92A expressed without the portal. The presence of the portal does 
not enhance capsid processing and maturation for this mutation. 
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APPENDIX B 
B.1 STABILIZING THE DELTA DOMAIN 
The delta domain is less ordered than the rest of the capsid protein, which has made visualization 
difficult. If we can stabilize the delta domain using disulfide bonds, we may be able to visualize 
more of the delta domain and the possible conformations it can make. There are 10 Serines in the 
delta domain: S2, S14, S31, S36, S41, S53, S66, S76, and S88. These residues can be mutated to 
cysteines and the presence of thiol (-SH) groups in these mutants allows the formation of 
disulfide bonds that would crosslink the delta domain. This would theoretically stabilize the 
domain and possibly allow us to visualize more of protein. From this, we could learn more about 
how delta domains interact with neighboring delta domains. These disulfide bonds would mostly 
likely occur between residues that would normally be able to make contact in the WT capsid.  
Brandi Baros, a previous graduate student made 8 of 10 serine to cysteine mutants and 
knocked out the protease gene for mutants S41C, S66C, S76C, and S78C. Her experiments 
suggested that disulfide bonds were forming in some of these mutant Prohead I samples (Baros 
2002). Other members of the lab created more protease knockouts of these S to C mutants and 
found that S41C Prohead I particles did not dissociate unless in the presence of a reducing agent 
(Duda, unpublished). Ying Sheng, a rotation student, conducted more in depth experiments with 
these 8 mutants, testing capsid stability. As mentioned earlier, Prohead I is not very stable and 
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can dissociate into capsomers. Mutant proheads were tested for their ability to dissociate or 
stabilize the capsid. Previous HK97 studies have shown that glucose can dissociate Proheads into 
capsomers. Dithiothreitol (DTT), a reducing agent, can counteract disulfide bonds, and in 
combination with glucose, dissociates Proheads into capsomers. By comparing the presence of 
proheads or capsomers in these mutants, we can determine if any particular disulfide bond is 
between delta domains and/or within one delta domain. Ying’s studies confirmed that S41C 
stabilized the capsid because it could only be dissociated in the presence of 1 M DTT. She found 
similar results with S76C and S78C. Ying had also made S2C, and I tested this mutant and found 
that it did not increase capsid stabilization. To continue her project, I made S88C and studied its 
effect on capsid stability. Figure B-1A and B show the results of miniprohead prep results of 
S88C. S88C shows WT like phenotypes (is able to cleave mcp and produce proheads and heads). 
S88C was also able to complement phage with an amber mutation in the capsid gene like WT. 
The presence of the cysteine did not affect the phenotype.   
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Figure B-1. Miniprohead prep of S88C shows WT like phenotypes 
 
Pellet, supernatant, and PEG samples were run on a 0.9% agarose gel, and 12% low cross-linking SDS gel. A) On 
the agarose gel, S88C showed WT like phenotypes and produced proheads and heads. B) On the SDS gel, S88C 
produced cleaved mcp like WT. 
 
 
Native agarose gels are able to show if there are disulfide bonds between capsomers. If 
there are proheads present, then we can assume that a disulfide bond is present between 
capsomers, preventing their dissociation into capsomers. Figure B-2 shows WT, S41C, and S88C 
in the presence of glucose with or without DTT. Untreated PI is as a control. The left gel shows 
samples after 3.5 hours; the right gel shows samples after 24 hours. WT Prohead I dissociates 
into capsomers when mixed with glucose (lanes 1, 2). S41C and S88C are stable in glucose, even 
after 24 hours (lanes 2, 3, 10, 11). With the addition of DTT, S41C shows some dissociation after 
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3.5 hours (lane 6) while S88C is mostly dissociated after 3.5 hours (lane 7). After 24 hours, both 
S41C and S88C have dissociated into capsomers (lanes 13, 14). Though S88C is not as stable as 
S41C, this mutation is a promising candidate in stabilizing the delta domain for visualization. 
This showed that S88C makes disulfide bonds between neighboring capsomers.  
 Similarly, native acrylamide gels that visualize HK97 pentamers and hexamers and can 
show if there are disulfide bonds between capsomers. If there is a disulfide bond between 
between capsomers, then the capsid would be more resistant to dissociation and you would not 
detect hexamer and pentamer bands. Figure B-3 shows native samples in glucose with our 
without the addition of DTT. A 6% native polyacrylamide gel was used. WT PII is used as a 
control. PII is stable and resistant to dissociation, so no hexamers or pentamers is present with 
this sample. Without DTT, S41C and S88C proheads were intact. With DTT, S41C and S88C 
dissociated into hexamers and pentamers. This native gel provided more support that S88C forms 
disulfide bonds between capsomers.  
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Figure B-2. S88C forms disulfide bonds in delta domains between capsomers, which only allows capsid 
dissociation in the presence of DTT. 
 
Prohead samples were incubated for 3.5 (left gel) or 24 (right gel) hours at room temperature in 20% glucose + 1 M 
DTT. Untreated PI is shown as a control. Prohead I particles dissociate into capsomers in the presence of glucose 
(lanes 2, 9). S41C has been shown to stabilize the capsid and was used as a positive control. With glucose, S41C and 
S88C produced proheads (lanes 3, 4, 10, 11). With the addition of DTT, some of the S41C proheads began to 
dissociate into capsomers (lane 6) after 3.5 hours and they were completely dissociated after 24 hours (lane 13). 
S88C was mostly dissociated after 3.5 hours with DTT (lane 7) and was completely dissociated after 24 hours (lane 
14). S88C is more stable than S41C, which is more stable than WT Prohead I.  
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Figure B-3. Testing for prohead dissociation with or without DTT 
 
Samples incubated with our without 1 M DTT were run on a 6% native polyacrylamide gel (with no top stack). WT 
PII is used as a negative control. Incubation with glucose and no DTT did not dissociate the proheads. Only when 
DTT was added did the capsids dissociate into hexmaers and pentamers. This showed that there is some stability 
with these mutations due to disulfide bonds forming in delta domains between capsomers.  
 
 
Non-reducing acrylamide gels show HK97 mcp and linked mcp in dimers or higher order 
associations and can be used to determine if there are delta domain disulfide bonds between and 
within capsomers. The presence of mcp dimers or higher order associations would indicate a 
disulfide bond between capsomers. S41C and S88C produced mcp dimers (Figure B-4). S41C 
produced a stronger dimer band, while S88c produced a weaker dimer band that ran slightly 
slower. S88C is able to form capsid protein dimers, indicating that this mutation has caused the 
formation of disulfide bond between neighboring capsomers that have stabilized the capsid.  
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Figure B-4. S88C can form major capsid protein dimers due to disulfide bonds between delta domains 
 
WT cleaved mcp was used as a control. Samples were prepared in non-reducing buffer and run on a 12% non-
reducing acrylamide gel. WT produced cleaved mcp. S41C and S88C both produced uncleaved mcp and mcp dimers 
in the gel. The S41C dimer band is stronger than S88C dimer band. The S88C dimer ran at a higher molecular 
weight than S41C. The presence of dimers again show that capsid subunits are linked together by disulfide bonds 
between delta domains. 
 
The Del 2nd Hinge mutant was able to stabilize the delta domain to create the strong 
towers and bridge densities inside the capsid. However, this mutant produced capsomers, 
indicating a stability issue. It is possible to combine this deletion mutation with a S to C 
mutation, which would prevent the dissociation of proheads. This may help resolve a better 
density map of the capsid and the delta domains. The S41C Prohead I has been reconstructed and 
surprisingly the delta domains have adopted a different conformation than WT. From the map, it 
seems that the delta domains between hexamers and pentamers are interacting to create start-like 
patterns inside the capsid (Sheng, Alasdair, Conway, Duda, Hendrix, unpublished). It would be 
very interesting to reconstruct the S88C Prohead I and visualize the new conformation that the 
delta domains have made. 
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